{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:51:33Z","timestamp":1794005493326,"version":"4.8.0"},"reference-count":1307,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":394,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jacc.2023.04.003","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T14:38:46Z","timestamp":1689863926000},"page":"833-955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":601,"title":["2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA Guideline for the Management of Patients With Chronic\u00a0Coronary Disease"],"prefix":"10.1016","volume":"82","author":[{"given":"Salim S.","family":"Virani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Kristin","family":"Newby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne V.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Bittner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LaPrincess C.","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan Halli","family":"Demeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave L.","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F.","family":"Fearon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhruv S.","family":"Kazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhaval","family":"Kolte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharam J.","family":"Kumbhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"LoFaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhruv","family":"Mahtta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Mark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margo","family":"Minissian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Marie","family":"Navar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariann R.","family":"Piano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy W.","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviany R.","family":"Taqueti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randal J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"van Diepen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Wiggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene S.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2023.04.003_bib1","series-title":"Finding What Works In Healthcare: Standards for Systematic Reviews","year":"2011"},{"key":"10.1016\/j.jacc.2023.04.003_bib2","series-title":"Clinical Practice Guidelines We Can Trust","year":"2011"},{"key":"10.1016\/j.jacc.2023.04.003_bib3","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.jacc.2014.03.016","article-title":"ACC\/AHA statement on cost\/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines","volume":"63","author":"Anderson","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib4","unstructured":"ACCF\/AHA Task Force on Practice Guidelines. Methodology Manual and Policies From the ACCF\/AHA Task Force on Practice Guidelines. American College of Cardiology and American Heart Association. 2010. Accessed June 3, 2020. https:\/\/www.acc.org\/Guidelines\/About-Guidelines-and-Clinical-Documents\/Methodology and https:\/\/professional.heart.org\/-\/media\/phd-files\/guidelines-and-statements\/methodology_manual_and_policies_ucm_319826.pdf"},{"key":"10.1016\/j.jacc.2023.04.003_bib5","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.jacc.2015.09.001","article-title":"Further evolution of the ACC\/AHA clinical practice guideline recommendation classification system: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"67","author":"Halperin","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib6","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.jacc.2014.07.012","volume":"64","author":"Arnett","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib7","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.jacc.2019.02.012","article-title":"Recent innovations, modifications, and evolution of ACC\/AHA clinical practice guidelines: an update for our constituencies: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Levine","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib8","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.jacc.2014.03.016","article-title":"ACC\/AHA statement on cost\/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines","volume":"63","author":"Anderson","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib10","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","volume":"60","author":"Fihn","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib11","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.jacc.2014.07.017","volume":"64","author":"Fihn","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib12","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1016\/j.jacc.2011.02.011","volume":"57","author":"Wright","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib13","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/j.jacc.2021.07.053","article-title":"2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"78","author":"Gulati","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib15","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib16","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O'Gara","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib17","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib18","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.jacc.2011.10.824","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation","volume":"58","author":"Smith","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib19","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1016\/j.jacc.2013.11.004","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society","volume":"63","author":"Jensen","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib20","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jacc.2016.03.513","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"68","author":"Levine","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib21","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib22","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"January","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib24","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.jacc.2020.11.018","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"77","author":"Otto","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib25","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib26","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1161\/CIRCULATIONAHA.106.180945","volume":"115","author":"Balady","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib27","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIR.0b013e3182447787","article-title":"Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association","volume":"125","author":"Levine","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib28","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1161\/CIR.0000000000000019","article-title":"Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association","volume":"129","author":"Lichtman","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib29","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1161\/HYP.0000000000000018","article-title":"Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension","volume":"65","author":"Rosendorff","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2023.04.003_bib30","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1161\/CIR.0000000000000456","article-title":"Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a scientific statement from the American Heart Association","volume":"134","author":"Wiggins","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib31","doi-asserted-by":"crossref","first-page":"e505","DOI":"10.1161\/CIR.0000000000000462","article-title":"Recommended dietary pattern to achieve adherence to the American Heart Association\/American College of Cardiology (AHA\/ACC) guidelines: a scientific statement from the American Heart Association","volume":"134","author":"Van Horn","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib32","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1161\/CIR.0000000000000564","article-title":"Spontaneous coronary artery dissection: current state of the science: a scientific statement from the American Heart Association","volume":"137","author":"Hayes","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib33","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1161\/CIR.0000000000000695","article-title":"Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association","volume":"140","author":"Feinstein","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib34","doi-asserted-by":"crossref","first-page":"e884","DOI":"10.1161\/CIR.0000000000000772","article-title":"Cardiovascular considerations in caring for pregnant patients: a scientific statement from the American Heart Association","volume":"141","author":"Mehta","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib35","doi-asserted-by":"crossref","first-page":"e779","DOI":"10.1161\/CIR.0000000000000766","article-title":"Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association","volume":"141","author":"Arnold","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib36","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/CIRCULATIONAHA.119.041914","article-title":"The mind-heart-body connection","volume":"140","author":"Levine","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib37","doi-asserted-by":"crossref","first-page":"e411","DOI":"10.1161\/CIR.0000000000000931","article-title":"Personal-level protective actions against particulate matter air pollution exposure: a scientific statement from the American Heart Association","volume":"142","author":"Rajagopalan","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib38","doi-asserted-by":"crossref","first-page":"e811","DOI":"10.1161\/CIR.0000000000001056","article-title":"Cardio-oncology drug interactions: a scientific statement from the American Heart Association","volume":"145","author":"Beavers","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib39","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.jacc.2011.01.008","volume":"57","author":"Aronow","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib40","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.jacc.2012.03.003","volume":"59","author":"Patel","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib41","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1016\/j.jacc.2018.10.027","article-title":"2018 ACC expert consensus decision pathway on tobacco cessation treatment: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents","volume":"72","author":"Barua","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib42","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jacc.2020.05.037","article-title":"2020 Expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"76","author":"Das","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib43","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jacc.2021.06.011","article-title":"2021 ACC expert consensus decision pathway on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"78","author":"Virani","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib44","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jacc.2020.09.011","volume":"77","author":"Kumbhani","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib45","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0000000000001078","article-title":"Life's Essential 8: updating and enhancing the American Heart Association's construct of cardiovascular health: a presidential advisory from the American Heart Association","volume":"146","author":"Lloyd-Jones","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib46","series-title":"ACCF\/AHA Task Force on Practice Guidelines. Methodology Manual and Policies From the ACCF\/AHA Task Force on Practice Guidelines","year":"2010"},{"key":"10.1016\/j.jacc.2023.04.003_bib47","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics\u20142022 update: a report from the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib48","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","volume":"60","author":"Fihn","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib51","series-title":"Data from: Institute for Health Metrics and Evaluation","year":"2019"},{"key":"10.1016\/j.jacc.2023.04.003_bib52","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/CIRCULATIONAHA.107.743963","article-title":"Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy","volume":"117","author":"Shaw","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib53","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s12350-012-9548-3","volume":"19","author":"Shaw","year":"2012","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib54","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jcin.2014.01.161","article-title":"Prognostic value of \"routine\" cardiac stress imaging 5 years after percutaneous coronary intervention: the prospective long-term observational BASKET (Basel Stent Kosteneffektivitats Trial) LATE IMAGING study","volume":"7","author":"Zellweger","year":"2014","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2023.04.003_bib55","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jacc.2011.11.024","article-title":"Coronary artery disease progression late after successful stent implantation","volume":"59","author":"Zellweger","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib56","doi-asserted-by":"crossref","first-page":"550","DOI":"10.2967\/jnumed.107.046771","article-title":"Value and limitations of target-vessel ischemia in predicting late clinical events after drug-eluting stent implantation","volume":"49","author":"Zellweger","year":"2008","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib57","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ahj.2012.05.018","article-title":"Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention","volume":"164","author":"Shaw","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib58","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.jacc.2019.06.074","article-title":"Ischemia on PET MPI may identify patients with improvement in angina and health status post-revascularization","volume":"74","author":"Patel","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib59","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.jacc.2019.07.055","article-title":"Extent of myocardial ischemia on positron emission tomography and survival benefit with early revascularization","volume":"74","author":"Patel","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib60","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/jamacardio.2020.0822","article-title":"Association of sex with severity of coronary artery disease, ischemia, and symptom burden in patients with moderate or severe ischemia: secondary analysis of the ISCHEMIA randomized clinical trial","volume":"5","author":"Reynolds","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib61","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/eurheartj\/ehm617","article-title":"MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial","volume":"29","author":"Schwitter","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib62","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/eurheartj\/ehs022","volume":"34","author":"Schwitter","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib63","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.jacc.2020.07.060","article-title":"Gadobutrol-enhanced cardiac magnetic resonance imaging for detection of coronary artery disease","volume":"76","author":"Arai","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib64","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.114.002666","article-title":"Diagnostic accuracy of stress myocardial perfusion imaging compared to invasive coronary angiography with fractional flow reserve meta-analysis","volume":"8","author":"Takx","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2023.04.003_bib65","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/jamacardio.2019.0035","article-title":"Prognostic value of vasodilator stress cardiac magnetic resonance imaging: a multicenter study with 48000 patient-years of follow-up","volume":"4","author":"Heitner","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib66","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jacc.2017.06.028","article-title":"Stress perfusion coronary flow reserve versus cardiac magnetic resonance for known or suspected CAD","volume":"70","author":"Kato","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib67","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jcmg.2017.02.006","article-title":"Stress perfusion CMR in patients with known and suspected CAD: prognostic value and optimal ischemic threshold for revascularization","volume":"10","author":"Vincenti","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2023.04.003_bib68","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.jacc.2019.07.074","article-title":"Cardiac magnetic resonance stress perfusion imaging for evaluation of patients with chest pain","volume":"74","author":"Kwong","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib69","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/CIRCULATIONAHA.114.011939","article-title":"Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization","volume":"131","author":"Taqueti","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib70","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2018.10.056","article-title":"Comparison of coronary computed tomography angiography, fractional flow reserve, and perfusion imaging for ischemia diagnosis","volume":"73","author":"Driessen","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib71","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1001\/jamacardio.2017.2471","article-title":"Comparison of coronary CT angiography, SPECT, PET, and hybrid imaging for diagnosis of ischemic heart disease determined by fractional flow reserve","volume":"2","author":"Danad","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib72","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/eurheartj\/ehz389","article-title":"Myocardial blood flow reserve assessed by positron emission tomography myocardial perfusion imaging identifies patients with a survival benefit from early revascularization","volume":"41","author":"Patel","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib73","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/ehjci\/jez258","article-title":"Prognostic value of [15O]H2O positron emission tomography-derived global and regional myocardial perfusion","volume":"21","author":"Bom","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2023.04.003_bib74","first-page":"1282","article-title":"The prognostic significance of quantitative myocardial perfusion: an artificial intelligence-based approach using perfusion mapping","volume":"141","author":"Knott","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib75","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib76","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease","volume":"367","author":"De Bruyne","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib77","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib78","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1916370","article-title":"Health-status outcomes with invasive or conservative care in coronary disease","volume":"382","author":"Spertus","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib79","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A\u00a0randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","author":"Frye","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib80","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.jcmg.2019.04.020","article-title":"Randomized comparison of clinical effectiveness of pharmacologic SPECT and PET MPI in symptomatic CAD patients","volume":"12","author":"Patel","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2023.04.003_bib81","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/clc.20139","article-title":"Chest pain on exercise treadmill test predicts future cardiac hospitalizations","volume":"30","author":"Ho","year":"2007","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib82","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/01.CIR.0000121360.31954.1F","article-title":"Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial","volume":"109","author":"Hambrecht","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib83","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/HCR.0000000000000156","article-title":"Effect of high-intensity interval versus continuous exercise training on functional capacity and quality of life in patients with coronary artery disease: a randomized clinical trial","volume":"36","author":"Jaureguizar","year":"2016","journal-title":"J\u00a0Cardiopulm Rehabil Prev"},{"key":"10.1016\/j.jacc.2023.04.003_bib84","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1148\/radiol.15141216","article-title":"Accuracy of CT for selecting candidates for coronary artery bypass graft surgery: combination with the SYNTAX score","volume":"276","author":"Suh","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.jacc.2023.04.003_bib85","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ijcard.2016.06.264","article-title":"A\u00a0systematic review and meta-analysis of multidetector computed tomography in the assessment of coronary artery bypass grafts","volume":"221","author":"Chan","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib86","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/j.jacc.2011.08.047","article-title":"Prognostic assessment of coronary artery bypass patients with 64-slice computed tomography angiography: anatomical information is incremental to clinical risk prediction","volume":"58","author":"Small","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib87","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007607","article-title":"Impact of fractional flow reserve derived from coronary computed tomography angiography on heart team treatment decision-making in patients with multivessel coronary artery disease: insights from the SYNTAX III REVOLUTION Trial","volume":"12","author":"Andreini","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2023.04.003_bib88","first-page":"3689","article-title":"Coronary computed tomography angiography for heart team decision-making in multivessel coronary artery disease","volume":"39","author":"Collet","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib89","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/j.jacc.2021.07.053","article-title":"2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR Guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"78","author":"Gulati","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib90","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib91","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.nuclcard.2006.08.017","article-title":"Predicting therapeutic benefit from myocardial revascularization procedures: are measurements of both resting left ventricular ejection fraction and stress-induced myocardial ischemia necessary?","volume":"13","author":"Hachamovitch","year":"2006","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib92","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1161\/01.CIR.0000072790.23090.41","article-title":"Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography","volume":"107","author":"Hachamovitch","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib93","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehq500","article-title":"Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy","volume":"32","author":"Hachamovitch","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib94","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1056\/NEJMoa1716734","article-title":"Magnetic resonance perfusion or fractional flow reserve in coronary disease","volume":"380","author":"Nagel","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib95","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/eurheartj\/ehi102","article-title":"Impact of gender on risk stratification by exercise and dobutamine stress echocardiography: long-term mortality in 4234 women and 6898 men","volume":"26","author":"Shaw","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib96","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.echo.2010.05.004","article-title":"Prognostic implications of stress echocardiography and impact on patient outcomes: an effective gatekeeper for coronary angiography and revascularization","volume":"23","author":"Yao","year":"2010","journal-title":"Am Soc Echocardiogr"},{"key":"10.1016\/j.jacc.2023.04.003_bib97","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial","volume":"391","author":"Al-Lamee","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib98","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A\u00a0randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","author":"Frye","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib99","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1916374","article-title":"Health status after invasive or conservative care in coronary and advanced kidney disease","volume":"382","author":"Spertus","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib100","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005079","article-title":"Effect of coronary anatomy and myocardial ischemia on long-term survival in patients with stable ischemic heart disease","volume":"12","author":"Weintraub","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.04.003_bib101","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1161\/CIRCULATIONAHA.116.023266","article-title":"Excess cardiovascular risk in women relative to men referred for coronary angiography is associated with severely impaired coronary flow reserve, not obstructive disease","volume":"135","author":"Taqueti","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib102","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/eurheartj\/ehx721","article-title":"Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction","volume":"39","author":"Taqueti","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib103","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jacc.2013.11.043","article-title":"Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps)","volume":"63","author":"Norgaard","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib104","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/2012.jama.11274","article-title":"Diagnostic accuracy of fractional flow reserve from anatomic CT angiography","volume":"308","author":"Min","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib105","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1093\/eurheartj\/ehv444","volume":"36","author":"Douglas","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib106","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jcmg.2019.03.003","article-title":"1-Year impact on medical practice and clinical outcomes of FFRCT: the ADVANCE registry","volume":"13","author":"Patel","year":"2020","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2023.04.003_bib107","doi-asserted-by":"crossref","first-page":"821","DOI":"10.7326\/0003-4819-147-12-200712180-00001","article-title":"An externally validated model for predicting long-term survival after exercise treadmill testing in patients with suspected coronary artery disease and a normal electrocardiogram","volume":"147","author":"Lauer","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib108","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jcmg.2008.11.015","article-title":"Prognostic value of coronary computed tomographic angiography for prediction of cardiac events in patients with suspected coronary artery disease","volume":"2","author":"Hadamitzky","year":"2009","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2023.04.003_bib109","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/jamacardio.2019.0035","article-title":"Prognostic value of vasodilator stress cardiac magnetic resonance imaging: a multicenter study with 48000 patient-years of follow-up","volume":"4","author":"Heitner","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib110","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1001\/jamacardio.2016.5501","article-title":"Identification of patients with stable chest pain deriving minimal value from noninvasive testing: the PROMISE minimal-risk tool, a secondary analysis of a randomized clinical trial","volume":"2","author":"Fordyce","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib111","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib112","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib113","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A\u00a0randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","author":"Frye","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib114","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.120.050304","article-title":"Initial invasive versus conservative management of stable ischemic heart disease in patients with a history of heart failure or left ventricular dysfunction","volume":"142","author":"Lopes","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib115","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib116","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/CIRCULATIONAHA.120.049755","article-title":"Outcomes in the ISCHEMIA trial based on coronary artery disease and ischemia severity","volume":"144","author":"Reynolds","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib117","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005079","article-title":"Effect of coronary anatomy and myocardial ischemia on long-term survival in patients with stable ischemic heart disease","volume":"12","author":"Weintraub","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.04.003_bib118","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/j.jacc.2021.07.053","article-title":"2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR Guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"78","author":"Gulati","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib119","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/ehjci\/jex014","article-title":"Comparison of the prognostic value of negative non-invasive cardiac investigations in patients with suspected or known coronary artery disease-a meta-analysis","volume":"18","author":"Smulders","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2023.04.003_bib120","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1916370","article-title":"Health-status outcomes with invasive or conservative care in coronary disease","volume":"382","author":"Spertus","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib121","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jacc.2003.07.010","article-title":"Transient ischemic dilation ratio of the left ventricle is a significant predictor of future cardiac events in patients with otherwise normal myocardial perfusion SPECT","volume":"42","author":"Abidov","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib122","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0735-1097(03)00085-8","article-title":"Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management","volume":"41","author":"Berman","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib123","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jcmg.2011.06.009","article-title":"Myocardial perfusion imaging is a strong predictor of death in women","volume":"4","author":"Cerci","year":"2011","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2023.04.003_bib124","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jacc.2012.09.043","article-title":"Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry","volume":"61","author":"Dorbala","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M15-1801","article-title":"Prognostic value of cardiovascular magnetic resonance and single-photon emission computed tomography in suspected coronary heart disease: long-term follow-up of a prospective, diagnostic accuracy cohort study","volume":"165","author":"Greenwood","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib126","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1161\/01.CIR.0000072790.23090.41","article-title":"Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography","volume":"107","author":"Hachamovitch","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib127","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jacc.2004.08.069","article-title":"A\u00a0prognostic score for prediction of cardiac mortality risk after adenosine stress myocardial perfusion scintigraphy","volume":"45","author":"Hachamovitch","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib128","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehq500","article-title":"Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy","volume":"32","author":"Hachamovitch","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib129","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijcard.2006.07.190","article-title":"Prognostic significance of exercise stress echocardiography in 3329 outpatients (5-year longitudinal study)","volume":"119","author":"Leischik","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib130","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.nuclcard.2008.06.168","article-title":"Independent and incremental prognostic value of left ventricular ejection fraction determined by stress gated rubidium 82 PET imaging in patients with known or suspected coronary artery disease","volume":"15","author":"Lertsburapa","year":"2008","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib131","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0167-5273(03)00149-9","article-title":"Incremental prognostic value of myocardial perfusion 99m-technetium-sestamibi SPECT in the elderly","volume":"93","author":"Lima","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib132","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jacc.2017.06.030","article-title":"Biomarker-based risk model to predict cardiovascular mortality in patients with stable coronary disease","volume":"70","author":"Lindholm","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib133","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0735-1097(02)01778-3","article-title":"Outcome after abnormal exercise echocardiography for patients with good exercise capacity: prognostic importance of the extent and severity of exercise-related left ventricular dysfunction","volume":"39","author":"McCully","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib134","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.nuclcard.2004.06.128","article-title":"Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: a meta-analysis","volume":"11","author":"Navare","year":"2004","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib135","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.amjcard.2012.05.048","article-title":"Meta-analysis of optimal risk stratification in patients >65 years of age","volume":"110","author":"Rai","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib136","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12350-013-9830-z","article-title":"Long-term mortality following normal exercise myocardial perfusion SPECT according to coronary disease risk factors","volume":"21","author":"Rozanski","year":"2014","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib137","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.nuclcard.2006.03.019","article-title":"Prognostic value of poststress left ventricular volume and ejection fraction by gated myocardial perfusion SPECT in women and men: gender-related differences in normal limits and outcomes","volume":"13","author":"Sharir","year":"2006","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib138","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s12350-012-9548-3","volume":"19","author":"Shaw","year":"2012","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib139","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12350-011-9468-7","article-title":"Nomograms for estimating coronary artery disease prognosis with gated stress myocardial perfusion SPECT","volume":"19","author":"Shaw","year":"2012","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000323841","article-title":"Prognosis of a normal positron emission tomography 82Rb myocardial perfusion imaging study in women with no history of coronary disease","volume":"117","author":"Van Tosh","year":"2010","journal-title":"Cardiology"},{"key":"10.1016\/j.jacc.2023.04.003_bib141","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0735-1097(84)80254-5","article-title":"Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease","volume":"3","author":"Weiner","year":"1984","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib142","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0735-1097(03)00923-9","article-title":"Practical applications in stress echocardiography: risk stratification and prognosis in patients with known or suspected ischemic heart disease","volume":"42","author":"Yao","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib143","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/ehjci\/jez258","article-title":"Prognostic value of [15O]H2O positron emission tomography-derived global and regional myocardial perfusion","volume":"21","author":"Bom","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2023.04.003_bib144","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.jacc.2013.06.017","article-title":"Influence of sex on risk stratification with stress myocardial perfusion Rb-82 positron emission tomography: results from the PET (positron emission tomography) prognosis multicenter registry","volume":"62","author":"Kay","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib145","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.107.717512","article-title":"Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: a combined positron emission tomography\/computed tomography study","volume":"117","author":"Schenker","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib146","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jacc.2015.05.069","article-title":"Plaque characterization by coronary computed tomography angiography and the likelihood of acute coronary events in mid-term follow-up","volume":"66","author":"Motoyama","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib147","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jamacardio.2017.4973","article-title":"Use of high-risk coronary atherosclerotic plaque detection for risk stratification of patients with stable chest pain: a secondary analysis of the PROMISE randomized clinical trial","volume":"3","author":"Ferencik","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib148","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/CIRCULATIONAHA.119.044720","article-title":"Low-attenuation noncalcified plaque on coronary computed tomography angiography predicts myocardial infarction: results from the multicenter SCOT-HEART trial (Scottish Computed Tomography of the HEART)","volume":"141","author":"Williams","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib149","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCULATIONAHA.109.907659","article-title":"Incremental prognostic significance of combined cardiac magnetic resonance imaging, adenosine stress perfusion, delayed enhancement, and left ventricular function over preimaging information for the prediction of adverse events","volume":"123","author":"Bingham","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib150","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.jcmg.2018.08.018","article-title":"Global coronary flow reserve measured during stress cardiac magnetic resonance imaging is an independent predictor of adverse cardiovascular events","volume":"12","author":"Indorkar","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2023.04.003_bib151","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1415516","article-title":"Outcomes of anatomical versus functional testing for coronary artery disease","volume":"372","author":"Douglas","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib152","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1161\/CIRCULATIONAHA.116.024360","article-title":"Prognostic value of noninvasive cardiovascular testing in patients with stable chest pain: insights from the PROMISE trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)","volume":"135","author":"Hoffmann","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib153","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","volume":"60","author":"Fihn","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib154","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.jacc.2014.07.017","volume":"64","author":"Fihn","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib155","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0735-1097(96)87733-3","article-title":"Task force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management","volume":"27","author":"Califf","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib156","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1056\/NEJM199109193251204","article-title":"Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease","volume":"325","author":"Mark","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib157","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","article-title":"Percutaneous revascularization for ischemic left ventricular dysfunction","volume":"387","author":"Perera","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib158","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.jacc.2007.01.086","article-title":"Diagnostic accuracy of multidetector computed tomography coronary angiography in patients with dilated cardiomyopathy","volume":"49","author":"Andreini","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib159","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib160","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJMoa072771","article-title":"Effect of PCI on quality of life in patients with stable coronary disease","volume":"359","author":"Weintraub","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib161","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib162","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jama.2012.12559","article-title":"Beta-blocker use and clinical outcomes in stable outpatients with and without coronary artery disease","volume":"308","author":"Bangalore","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib163","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(04)16980-8","article-title":"Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial","volume":"364","author":"Poole-Wilson","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib164","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.jacc.2009.01.037","article-title":"Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial","volume":"53","author":"Wilson","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib165","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/eurheartj\/ehy504","article-title":"Anti-anginal drugs\u2014beliefs and evidence: systematic review covering 50 years of medical treatment","volume":"40","author":"Ferrari","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib166","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ehjqcco\/qcv010","article-title":"Prediction of residual angina after percutaneous coronary intervention","volume":"1","author":"Arnold","year":"2015","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.jacc.2023.04.003_bib167","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.117.003971","article-title":"Predicting the benefits of percutaneous coronary intervention on 1-year angina and quality of life in stable ischemic heart disease: risk models from the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation)","volume":"11","author":"Zhang","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.04.003_bib168","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ahj.2010.12.005","article-title":"Angina frequency after myocardial infarction and quality of life in older versus younger adults: the Prospective Registry Evaluating Myocardial Infarction: Event and Recovery study","volume":"161","author":"Longmore","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib169","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/jama.290.2.215","article-title":"Depressive symptoms and health-related quality of life: the Heart and Soul Study","volume":"290","author":"Ruo","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib170","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1916370","article-title":"Health-status outcomes with invasive or conservative care in coronary disease","volume":"382","author":"Spertus","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib171","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.cjca.2014.07.008","article-title":"Cholesterol end points predict outcome in patients with coronary disease: quality improvement metrics from the enhancing secondary prevention in coronary artery disease (ESP-CAD) trial","volume":"30","author":"McAlister","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib172","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.clinthera.2017.10.005","article-title":"Lipid management after first diagnosis of coronary artery disease: contemporary results from an observational cohort study","volume":"39","author":"Waldeyer","year":"2017","journal-title":"Clin Ther"},{"key":"10.1016\/j.jacc.2023.04.003_bib173","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.amjmed.2021.11.011","article-title":"Association of low-density lipoprotein testing after an atherosclerotic cardiovascular event with subsequent statin adherence and intensification","volume":"135","author":"Rana","year":"2022","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib174","doi-asserted-by":"crossref","first-page":"575","DOI":"10.18549\/PharmPract.2015.02.575","article-title":"A\u00a0pharmacist-led follow-up program for patients with established coronary heart disease in North Norway: a randomized controlled trial","volume":"13","author":"Garcia","year":"2015","journal-title":"Pharm Pract (Granada)"},{"key":"10.1016\/j.jacc.2023.04.003_bib175","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12933-015-0296-y","article-title":"Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology","volume":"14","author":"Gyberg","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacc.2023.04.003_bib176","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001499","article-title":"Health-related quality of life 1-3 years post-myocardial infarction: its impact on prognosis","volume":"8","author":"Pocock","year":"2021","journal-title":"Open Heart"},{"key":"10.1016\/j.jacc.2023.04.003_bib177","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ahj.2016.02.015","article-title":"Patient and physician discordance in reporting symptoms of angina among stable coronary artery disease patients: insights from the Angina Prevalence and Provider Evaluation of Angina Relief (APPEAR) study","volume":"175","author":"Shafiq","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib178","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/archinternmed.2009.295","article-title":"The prevalence of weekly angina among patients with chronic stable angina in primary care practices","volume":"169","author":"Beltrame","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib179","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.7406","article-title":"Comparison of patient-reported vs physician-estimated angina in patients undergoing elective and urgent percutaneous coronary intervention","volume":"3","author":"Saxon","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2023.04.003_bib180","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/ehjqcco\/qcw016","article-title":"Effect of angina under-recognition on treatment in outpatients with stable ischaemic heart disease","volume":"2","author":"Qintar","year":"2016","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.jacc.2023.04.003_bib181","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1161\/CIRCOUTCOMES.116.002781","article-title":"Predictors of physician under-recognition of angina in outpatients with stable coronary artery disease","volume":"9","author":"Arnold","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.04.003_bib182","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4103\/jehp.jehp_65_18","article-title":"Investigating the effect of education on health literacy and its relation to health-promoting behaviors in health center","volume":"7","author":"Bayati","year":"2018","journal-title":"J\u00a0Educ Health Promot"},{"issue":"suppl 1","key":"10.1016\/j.jacc.2023.04.003_bib183","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/10810730.2013.825668","article-title":"The relationship between health, education, and health literacy: results from the Dutch Adult Literacy and Life Skills Survey","volume":"18","author":"van der Heide","year":"2013","journal-title":"J\u00a0Health Commun"},{"key":"10.1016\/j.jacc.2023.04.003_bib184","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.710","article-title":"Achieving optimal adherence to medical therapy by telehealth: findings from the ORBITA medication adherence sub-study","volume":"9","author":"Thompson","year":"2021","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.jacc.2023.04.003_bib185","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1161\/CIRCULATIONAHA.120.051913","article-title":"Digital care transformation: interim report from the first 5000 patients enrolled in a remote algorithm-based cardiovascular risk management program to improve lipid and hypertension control","volume":"143","author":"Scirica","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib186","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.athoracsur.2006.01.033","article-title":"Severity of angina as a predictor of quality of life changes six months after coronary artery bypass surgery","volume":"81","author":"Peric","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2023.04.003_bib187","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0003-4975(01)03213-1","article-title":"Changes in health-related quality of life following coronary artery bypass graft surgery","volume":"72","author":"Rumsfeld","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2023.04.003_bib188","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0002-9149(01)01852-5","article-title":"Predictors of quality of life following acute coronary syndromes","volume":"88","author":"Rumsfeld","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib189","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1161\/CIRCOUTCOMES.114.000967","article-title":"Development and validation of a short version of the Seattle angina questionnaire","volume":"7","author":"Chan","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.04.003_bib190","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/MLR.0b013e3181e57962","article-title":"US pharmacists' effect as team members on patient care: systematic review and meta-analyses","volume":"48","author":"Chisholm-Burns","year":"2010","journal-title":"Med Care"},{"key":"10.1016\/j.jacc.2023.04.003_bib191","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1177\/1060028017711454","article-title":"Impact of diabetes care by pharmacists as part of health care team in ambulatory settings: a systematic review and meta-analysis","volume":"51","author":"Fazel","year":"2017","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacc.2023.04.003_bib192","doi-asserted-by":"crossref","first-page":"110","DOI":"10.7326\/M17-1805","article-title":"Comparative effectiveness of implementation strategies for blood pressure control in hypertensive patients: a systematic review and meta-analysis","volume":"168","author":"Mills","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib193","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.amepre.2014.03.004","article-title":"Team-based care and improved blood pressure control: a community guide systematic review","volume":"47","author":"Proia","year":"2014","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib194","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2337\/dc17-0426","article-title":"Five-year effectiveness of the multidisciplinary risk assessment and management programme-diabetes mellitus (RAMP-DM) on diabetes-related complications and health service uses: a population-based and propensity-matched cohort study","volume":"41","author":"Wan","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2023.04.003_bib195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12872-019-1214-0","article-title":"Impact of multi-disciplinary treatment strategy on systolic heart failure outcome","volume":"19","author":"Chen","year":"2019","journal-title":"BMC Cardiovascular Disorders"},{"key":"10.1016\/j.jacc.2023.04.003_bib196","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12933-015-0267-3","article-title":"Long-term effects of the multidisciplinary risk assessment and management program for patients with diabetes mellitus (RAMP-DM): a population-based cohort study","volume":"14","author":"Jiao","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacc.2023.04.003_bib197","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/heartjnl-2015-308050","article-title":"Effective components of nurse-coordinated care to prevent recurrent coronary events: a systematic review and meta-analysis","volume":"102","author":"Snaterse","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.04.003_bib198","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/pop.2017.0090","article-title":"Health care resource utilization for outpatient cardiovascular disease and diabetes care delivery among advanced practice providers and physician providers in primary care","volume":"21","author":"Virani","year":"2018","journal-title":"Popul Health Manag"},{"key":"10.1016\/j.jacc.2023.04.003_bib199","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/JXX.0000000000000555","article-title":"Health care costs associated with primary care physicians versus nurse practitioners and physician assistants","volume":"33","author":"Rajan","year":"2021","journal-title":"J\u00a0Am Assoc Nurse Pract"},{"key":"10.1016\/j.jacc.2023.04.003_bib200","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.117.004188","article-title":"Cluster-randomized trial to evaluate a centralized clinical pharmacy service in private family medicine offices","volume":"11","author":"Carter","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.04.003_bib201","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1090198115601092","article-title":"The effect of interdisciplinary interventions on risk factors for lifestyle disease","volume":"43","author":"Tapsell","year":"2016","journal-title":"Health Educ Behav"},{"key":"10.1016\/j.jacc.2023.04.003_bib202","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1001\/archinternmed.2009.316","article-title":"The potency of team-based care interventions for hypertension: a meta-analysis","volume":"169","author":"Carter","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib203","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib204","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009116","article-title":"Informed shared decision-making programme on the prevention of myocardial infarction in type 2 diabetes: a randomised controlled trial","volume":"5","author":"Buhse","year":"2015","journal-title":"BMJ Open"},{"issue":"suppl 4","key":"10.1016\/j.jacc.2023.04.003_bib205","doi-asserted-by":"crossref","first-page":"S610","DOI":"10.1007\/s11606-010-1390-1","article-title":"Using the Teamlet Model to improve chronic care in an academic primary care practice","volume":"25","author":"Chen","year":"2010","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib206","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/jch.12077","article-title":"Physician-pharmacist co-management and 24-hour blood pressure control","volume":"15","author":"Chen","year":"2013","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jacc.2023.04.003_bib207","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s11606-011-1794-6","article-title":"A\u00a0randomized trial to improve patient-centered care and hypertension control in underserved primary care patients","volume":"26","author":"Cooper","year":"2011","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib208","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/clc.22963","volume":"41","author":"Fentanes","year":"2018","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib209","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.clinthera.2014.06.030","article-title":"Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial","volume":"36","author":"Hirsch","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.jacc.2023.04.003_bib210","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1007\/s11606-008-0791-x","article-title":"A\u00a0randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertension","volume":"23","author":"Hunt","year":"2008","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib211","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/phar.1727","article-title":"Evaluation of pharmacists' work in a physician-pharmacist collaborative model for the management of hypertension","volume":"36","author":"Isetts","year":"2016","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jacc.2023.04.003_bib212","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/2150131916645580","article-title":"Team-based hypertension management to improve blood pressure control","volume":"7","author":"Kravetz","year":"2016","journal-title":"J\u00a0Prim Care Community Health"},{"key":"10.1016\/j.jacc.2023.04.003_bib213","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1001\/archinte.168.21.2355","article-title":"A\u00a0randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN)","volume":"168","author":"McLean","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib214","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12913-016-1603-3","article-title":"Implementing shared decision making in federally qualified health centers, a quasi-experimental design study: the Office-Guidelines Applied to Practice (Office-GAP) program","volume":"16","author":"Olomu","year":"2016","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jacc.2023.04.003_bib215","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1370\/afm.1161","article-title":"Participatory decision making, patient activation, medication adherence, and intermediate clinical outcomes in type 2 diabetes: a STARNet study","volume":"8","author":"Parchman","year":"2010","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib216","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1161\/HYPERTENSIONAHA.115.06023","article-title":"Cost-effectiveness of a physician-pharmacist collaboration intervention to improve blood pressure control","volume":"66","author":"Polgreen","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2023.04.003_bib217","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ijcard.2015.03.336","article-title":"Person-centred care after acute coronary syndrome, from hospital to primary care\u2013a randomised controlled trial","volume":"187","author":"Fors","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib218","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12933-014-0127-6","article-title":"Effects of the Multidisciplinary Risk Assessment and Management Program for Patients with Diabetes Mellitus (RAMP-DM) on biomedical outcomes, observed cardiovascular events and cardiovascular risks in primary care: a longitudinal comparative study","volume":"13","author":"Jiao","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacc.2023.04.003_bib219","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jash.2016.01.010","article-title":"Physician-pharmacist collaboration versus usual care for treatment-resistant hypertension","volume":"10","author":"Smith","year":"2016","journal-title":"J\u00a0Am Soc Hypertens"},{"key":"10.1016\/j.jacc.2023.04.003_bib220","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1192\/bjp.2018.70","article-title":"Long-term clinical and cost-effectiveness of collaborative care (versus usual care) for people with mental-physical multimorbidity: cluster-randomised trial","volume":"213","author":"Camacho","year":"2018","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jacc.2023.04.003_bib221","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.pec.2019.11.001","article-title":"Effectiveness of a nurse-led multidisciplinary self-management program for patients with coronary heart disease in communities: a randomized controlled trial","volume":"103","author":"Jiang","year":"2020","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.jacc.2023.04.003_bib222","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1370\/afm.1343","article-title":"Treatment adjustment and medication adherence for complex patients with diabetes, heart disease, and depression: a randomized controlled trial","volume":"10","author":"Lin","year":"2012","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib223","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/1474515117743979","article-title":"Economic evaluation of a nurse-led home and clinic-based secondary prevention programme to prevent progressive cardiac dysfunction in high-risk individuals: The Nurse-led Intervention for Less Chronic Heart Failure (NIL-CHF) randomized controlled study","volume":"17","author":"Maru","year":"2018","journal-title":"Eur J Cardiovasc Nurs"},{"key":"10.1016\/j.jacc.2023.04.003_bib224","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.jacc.2015.08.017","article-title":"Provider Type and Quality of Outpatient Cardiovascular Disease Care: Insights From the NCDR PINNACLE Registry","volume":"66","author":"Virani","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib225","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.jacc.2015.03.550","article-title":"2015 ACC health policy statement on cardiovascular team-based care and the role of advanced practice providers","volume":"65","author":"Brush","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib226","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.pec.2014.01.012","article-title":"A systematic\u00a0review of patient education in cardiac patients: do they increase knowledge and promote health behavior change?","volume":"95","author":"Ghisi","year":"2014","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.jacc.2023.04.003_bib227","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2147\/JMDH.S257273","article-title":"Impact of pharmacist-led interventions on medication adherence and clinical outcomes in patients with hypertension and hyperlipidemia: a scoping review of published literature","volume":"13","author":"Elnaem","year":"2020","journal-title":"J\u00a0Multidiscip Healthc"},{"key":"10.1016\/j.jacc.2023.04.003_bib228","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s12872-021-02178-0","article-title":"Effects of a pharmaceutical care intervention on clinical outcomes and patient adherence in coronary heart disease: the MIMeRiC randomized controlled trial","volume":"21","author":"Ostbring","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacc.2023.04.003_bib230","first-page":"CD008895","article-title":"Patient education in the management of coronary heart disease","volume":"6","author":"Anderson","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib231","doi-asserted-by":"crossref","first-page":"659","DOI":"10.7326\/0003-4819-143-9-200511010-00010","article-title":"Meta-analysis: secondary prevention programs for patients with coronary artery disease","volume":"143","author":"Clark","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib232","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/2047487319871714","article-title":"Attending Heart School and long-term outcome after myocardial infarction: a decennial SWEDEHEART registry study","volume":"27","author":"Wallert","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib233","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1097\/JCN.0000000000000392","article-title":"Internet-delivered self-management support for improving coronary heart disease and self-management-related outcomes: a systematic review","volume":"32","author":"Palacios","year":"2017","journal-title":"J\u00a0Cardiovasc Nurs"},{"key":"10.1016\/j.jacc.2023.04.003_bib234","series-title":"Health Literacy: A Prescription\u00a0to End Confusion","year":"2004"},{"key":"10.1016\/j.jacc.2023.04.003_bib235","series-title":"AHRQ Health Literacy Universal Precautions Toolkit","author":"Brega","year":"2015"},{"key":"10.1016\/j.jacc.2023.04.003_bib236","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archinternmed.2007.132","article-title":"A\u00a0randomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarction","volume":"168","author":"Smith","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib237","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/ejhpharm-2018-001725","article-title":"Medication adherence interventions and outcomes: an overview of systematic reviews","volume":"26","author":"Wilhelmsen","year":"2019","journal-title":"Eur J Hosp Pharm"},{"key":"10.1016\/j.jacc.2023.04.003_bib238","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.119.005730","article-title":"Assessing patient preferences for shared decision-making in peripheral artery disease","volume":"12","author":"Provance","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.04.003_bib239","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026342","article-title":"Shared decision-making about cardiovascular disease medication in older people: a qualitative study of patient experiences in general practice","volume":"9","author":"Jansen","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacc.2023.04.003_bib240","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/archinte.1996.00440120070006","article-title":"What role do patients wish to play in treatment decision making?","volume":"156","author":"Deber","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib241","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/CIRCOUTCOMES.116.002641","article-title":"PCI choice decision aid for stable coronary artery disease: a randomized trial","volume":"9","author":"Coylewright","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.04.003_bib242","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/jamainternmed.2013.6057","article-title":"Decision-making preferences among patients with an acute myocardial infarction","volume":"173","author":"Krumholz","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib243","first-page":"CD001431","article-title":"Decision aids for people facing health treatment or screening decisions","volume":"4","author":"Stacey","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib244","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/hex.13244","article-title":"Processes for evidence summarization for patient decision aids: a Delphi consensus study","volume":"24","author":"Scalia","year":"2021","journal-title":"Health Expect"},{"key":"10.1016\/j.jacc.2023.04.003_bib245","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1177\/0272989X211014163","article-title":"Systematic development of patient decision aids: an update from the IPDAS collaboration","volume":"41","author":"Witteman","year":"2021","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jacc.2023.04.003_bib246","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1177\/0272989X21996328","article-title":"Current best practice for presenting probabilities in patient decision aids: fundamental principles","volume":"41","author":"Bonner","year":"2021","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jacc.2023.04.003_bib247","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11883-021-00949-w","article-title":"Social determinants of health and cardiovascular disease: current state and future directions towards healthcare equity","volume":"23","author":"Jilani","year":"2021","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacc.2023.04.003_bib248","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1161\/CIRCULATIONAHA.117.029652","article-title":"Socioeconomic status and cardiovascular outcomes: challenges and interventions","volume":"137","author":"Schultz","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib249","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.jacc.2021.09.011","article-title":"Socioeconomic determinants of health and cardiovascular outcomes in women: JACC review topic of the week","volume":"78","author":"Lindley","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib250","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1089\/pop.2019.0158","article-title":"A\u00a0review of tools to screen for social determinants of health in the United States: a practice brief","volume":"23","author":"Moen","year":"2020","journal-title":"Popul Health Manag"},{"key":"10.1016\/j.jacc.2023.04.003_bib251","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1001\/jama.289.23.3106","article-title":"Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial","volume":"289","author":"Berkman","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib252","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/jech.50.3.245","article-title":"A\u00a0prospective study of social networks in relation to total mortality and cardiovascular disease in men in the USA","volume":"50","author":"Kawachi","year":"1996","journal-title":"J\u00a0Epidemiol Community Health"},{"key":"10.1016\/j.jacc.2023.04.003_bib253","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.ahj.2009.03.019","article-title":"Adding socioeconomic status to Framingham scoring to reduce disparities in coronary risk assessment","volume":"157","author":"Fiscella","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib254","first-page":"838","article-title":"The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study","volume":"55","author":"Brindle","year":"2005","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.jacc.2023.04.003_bib255","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib256","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1161\/CIR.0000000000000228","article-title":"Social determinants of risk and outcomes for cardiovascular disease: a scientific statement from the American Heart Association","volume":"132","author":"Havranek","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib257","series-title":"Closing the gap in a generation: health equity through action on the social determinants of health","year":"2008"},{"key":"10.1016\/j.jacc.2023.04.003_bib258","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1016\/j.jacc.2021.05.051","article-title":"Race and ethnicity considerations in patients with coronary artery disease and stroke: JACC focus seminar 3\/9","volume":"78","author":"Mital","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib259","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1001\/jamacardio.2019.3805","article-title":"A\u00a0theoretical framework for clinical implementation of social determinants of health","volume":"4","author":"Hammond","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib260","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/eurheartj\/ehaa134","article-title":"Medicine and society: social determinants of health and cardiovascular disease","volume":"41","author":"Roger","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib261","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1161\/CIRCULATIONAHA.121.057617","article-title":"American Heart Association's 2024 impact goal: every person deserves the opportunity for a full, healthy life","volume":"144","author":"Lloyd-Jones","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib262","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.7326\/M19-2410","article-title":"Envisioning a better U.S. health care system for all: reducing barriers to care and addressing social determinants of health","volume":"172","author":"Butkus","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib263","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jamiaopen\/ooy051","article-title":"Documenting social determinants of health-related clinical activities using standardized medical vocabularies","volume":"2","author":"Arons","year":"2019","journal-title":"JAMA Open"},{"key":"10.1016\/j.jacc.2023.04.003_bib264","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1161\/CIR.0000000000000758","article-title":"The American Heart Association 2030 impact goal: a presidential advisory from the American Heart Association","volume":"141","author":"Angell","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib265","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1016\/j.jacc.2021.04.025","article-title":"Paving the way for health equity in cardiology: why does it matter?","volume":"77","author":"Itchhaporia","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib266","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1161\/CIR.0000000000000914","article-title":"Assessing and addressing cardiovascular health in LGBTQ adults: a scientific statement from the American Heart Association","volume":"142","author":"Caceres","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib267","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1161\/CIR.0000000000001003","article-title":"Assessing and addressing cardiovascular health in people who are transgender and gender diverse: a scientific statement from the American Heart Association","volume":"144","author":"Streed","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib268","series-title":"Standardized Screening for Health-Related Social Needs in Clinical Settings: The Accountable Health Communities Screening Tool. NAM Perspectives Discussion Paper","author":"Billioux","year":"2017"},{"key":"10.1016\/j.jacc.2023.04.003_bib269","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3122\/jabfm.2018.03.170419","article-title":"Clinician experiences with screening for social needs in primary care","volume":"31","author":"Tong","year":"2018","journal-title":"J\u00a0Am Board Fam Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib270","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.37765\/ajmc.2020.88504","article-title":"Social determinants of health score: does it help identify those at higher cardiovascular risk?","volume":"26","author":"Palacio","year":"2020","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jacc.2023.04.003_bib271","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/CIR.0000000000000579","article-title":"Health literacy and cardiovascular disease: fundamental relevance to primary and secondary prevention: a scientific statement from the American Heart Association","volume":"138","author":"Magnani","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib272","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.jacc.2015.03.550","article-title":"2015 ACC health policy statement on cardiovascular team-based care and the role of advanced practice providers","volume":"65","author":"Brush","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib273","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1377\/hlthaff.2015.0349","article-title":"Cardiovascular disease screening by community health workers can be cost-effective in low-resource countries","volume":"34","author":"Gaziano","year":"2015","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.jacc.2023.04.003_bib274","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1056\/NEJMp1815382","article-title":"Realizing the value of community health workers: new opportunities for sustainable financing","volume":"380","author":"Lapidos","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib275","doi-asserted-by":"crossref","DOI":"10.2196\/13849","article-title":"Incorporating social determinants of health in electronic health records: qualitative study of current practices among top vendors","volume":"7","author":"Freij","year":"2019","journal-title":"JMIR Med Inform"},{"key":"10.1016\/j.jacc.2023.04.003_bib276","article-title":"Social determinants of health 201 for health care: plan, do, study, act","volume":"2021","author":"Magnan","year":"2021","journal-title":"NAM Perspect"},{"key":"10.1016\/j.jacc.2023.04.003_bib277","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.2105\/AJPH.2020.305747","article-title":"Universal screening of social determinants of health at a large US academic medical center","volume":"110","author":"Meyer","year":"2020","journal-title":"Am J Public Health"},{"key":"10.1016\/j.jacc.2023.04.003_bib278","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1056\/NEJMp1413945","article-title":"Patients in context: EHR capture of social and behavioral determinants of health","volume":"372","author":"Adler","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib279","article-title":"Big data, social determinants of coronary heart disease and barriers for data access","volume":"2047487320922366","author":"Gajardo","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib280","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jamacardio.2021.0487","article-title":"Association of socioeconomic disadvantage with long-term mortality after myocardial infarction: the Mass General Brigham YOUNG-MI Registry","volume":"6","author":"Berman","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib281","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1089\/jwh.2007.0596","volume":"17","author":"Shaw","year":"2008","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.jacc.2023.04.003_bib282","article-title":"Low educational attainment is a predictor of adverse outcomes in patients with coronary artery disease","volume":"8","author":"Kelli","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.04.003_bib283","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.119.005977","article-title":"Association of outpatient practice-level socioeconomic disadvantage with quality of care and outcomes among older adults with coronary artery disease: implications for value-based payment","volume":"13","author":"Wadhera","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.04.003_bib284","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jacc.2010.09.021","article-title":"Association of mortality with years of education in patients with ST-segment elevation myocardial infarction treated with fibrinolysis","volume":"57","author":"Mehta","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib285","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/HJR.0b013e328304feac","article-title":"Interaction between income and education in predicting long-term survival after acute myocardial infarction","volume":"15","author":"Gerber","year":"2008","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.jacc.2023.04.003_bib286","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/HCR.0000000000000659","article-title":"A\u00a0review of disparities in cardiac rehabilitation: evidence, drivers and solutions","volume":"41","author":"Mathews","year":"2021","journal-title":"J\u00a0Cardiopulm Rehabil Prev"},{"key":"10.1016\/j.jacc.2023.04.003_bib287","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.cjca.2013.08.011","article-title":"Neighbourhood income and cardiac rehabilitation access as determinants of nonattendance and noncompletion","volume":"29","author":"Lemstra","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib288","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.117.004054","article-title":"Neighborhood socioeconomic disadvantage and care after myocardial infarction in the National Cardiovascular Data Registry","volume":"11","author":"Udell","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.04.003_bib289","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0298","article-title":"Effect of greening vacant land on mental health of community-dwelling adults: a cluster randomized trial","volume":"1","author":"South","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2023.04.003_bib290","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1017\/S1368980014002742","article-title":"Healthy food access for urban food desert residents: examination of the food environment, food purchasing practices, diet and BMI","volume":"18","author":"Dubowitz","year":"2015","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.jacc.2023.04.003_bib291","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1001\/jama.2016.5898","article-title":"Association of neighborhood walkability with change in overweight, obesity, and diabetes","volume":"315","author":"Creatore","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib292","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/aje\/kwx082","article-title":"Associations of neighborhood crime and safety and with changes in body mass index and waist circumference: the Multi-Ethnic Study of Atherosclerosis","volume":"186","author":"Powell-Wiley","year":"2017","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib293","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.psym.2013.10.008","article-title":"Physical environment may modify the association between depressive symptoms and change in waist circumference: the multi-ethnic study of atherosclerosis","volume":"55","author":"Remigio-Baker","year":"2014","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jacc.2023.04.003_bib294","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/01.psy.0000145819.94041.52","article-title":"Social networks are associated with lower mortality rates among women with suspected coronary disease: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation study","volume":"66","author":"Rutledge","year":"2004","journal-title":"Psychosom Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib295","doi-asserted-by":"crossref","DOI":"10.2196\/14512","article-title":"Back to the future: achieving health equity through health informatics and digital health","volume":"8","author":"Brewer","year":"2020","journal-title":"JMIR Mhealth Uhealth"},{"key":"10.1016\/j.jacc.2023.04.003_bib296","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s12265-021-10098-9","article-title":"Sociodemographic characteristics predicting digital health intervention use after acute myocardial infarction","volume":"14","author":"Shah","year":"2021","journal-title":"J\u00a0Cardiovasc Transl Res"},{"key":"10.1016\/j.jacc.2023.04.003_bib297","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/MLR.0000000000001636","article-title":"Cost-effectiveness of a digital health intervention for acute myocardial infarction recovery","volume":"59","author":"Bhardwaj","year":"2021","journal-title":"Med Care"},{"key":"10.1016\/j.jacc.2023.04.003_bib298","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1080\/00981389.2019.1645795","article-title":"Social determinants of health: the how, who, and where screenings are occurring; a systematic review","volume":"58","author":"O'Brien","year":"2019","journal-title":"Soc Work Health Care"},{"key":"10.1016\/j.jacc.2023.04.003_bib299","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.annemergmed.2020.08.010","article-title":"Screening for health-related social needs of emergency department patients","volume":"77","author":"Samuels-Kalow","year":"2021","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib300","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1001\/jamainternmed.2018.4630","article-title":"Effect of community health worker support on clinical outcomes of low-income patients across primary care facilities: a randomized clinical trial","volume":"178","author":"Kangovi","year":"2018","journal-title":"JAMA Internal Medicine"},{"key":"10.1016\/j.jacc.2023.04.003_bib301","series-title":"A\u00a0Playbook for Fostering Hospital\u2013community Partnerships to Build a Culture of Health","year":"2017"},{"issue":"3","key":"10.1016\/j.jacc.2023.04.003_bib302","first-page":"CD009825","article-title":"Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease","author":"Rees","year":"2019","journal-title":"Cochrane Database Sys Review"},{"key":"10.1016\/j.jacc.2023.04.003_bib303","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/01.CIR.99.6.779","article-title":"Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study","volume":"99","author":"de Lorgeril","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib304","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1001\/jamainternmed.2013.9768","article-title":"Better diet quality and decreased mortality among myocardial infarction survivors","volume":"173","author":"Li","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib305","first-page":"2790","article-title":"Whole- and refined-grain consumption and longitudinal changes in cardiometabolic risk factors in the Framingham offspring cohort","volume":"151","author":"Sawicki","year":"2021","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.jacc.2023.04.003_bib306","doi-asserted-by":"crossref","first-page":"f6879","DOI":"10.1136\/bmj.f6879","article-title":"Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis","volume":"347","author":"Threapleton","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.04.003_bib307","first-page":"CD011737","article-title":"Reduction in saturated fat intake for cardiovascular disease","volume":"5","author":"Hooper","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib308","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1001\/jama.2011.1729","article-title":"Urinary sodium and potassium excretion and risk of cardiovascular events","volume":"306","author":"O'Donnell","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib309","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1056\/NEJM200101043440101","article-title":"Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group","volume":"344","author":"Sacks","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib310","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3945\/ajcn.115.116046","article-title":"Dietary fat intake and risk of cardiovascular disease and all-cause mortality in a population at high risk of cardiovascular disease","volume":"102","author":"Guasch-Ferr\u00e9","year":"2015","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacc.2023.04.003_bib311","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3945\/ajcn.112.049064","article-title":"Intake of trans fat and all-cause mortality in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) cohort","volume":"97","author":"Kiage","year":"2013","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1016\/j.jacc.2023.04.003_bib312","first-page":"CD003177","article-title":"Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease","author":"Abdelhamid","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib313","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3945\/an.116.013516","article-title":"Dietary supplements and risk of cause-specific death, cardiovascular disease, and cancer: a systematic review and meta-analysis of primary prevention trials","volume":"8","author":"Schwingshackl","year":"2017","journal-title":"Adv Nutr"},{"key":"10.1016\/j.jacc.2023.04.003_bib314","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1056\/NEJMoa1203859","article-title":"n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia","volume":"367","author":"Bosch","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib315","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/CIRCULATIONAHA.106.673491","article-title":"Calcium\/vitamin D supplementation and cardiovascular events","volume":"115","author":"Hsia","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib316","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jamacardio.2019.1870","article-title":"Vitamin D supplementation and cardiovascular disease risks in more than 83 000 individuals in 21 randomized clinical trials: a meta-analysis","volume":"4","author":"Barbarawi","year":"2019","journal-title":"JAMA Cardiology"},{"key":"10.1016\/j.jacc.2023.04.003_bib317","doi-asserted-by":"crossref","first-page":"l4673","DOI":"10.1136\/bmj.l4673","article-title":"Association between vitamin D supplementation and mortality: systematic review and meta-analysis","volume":"366","author":"Zhang","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.04.003_bib318","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJM200001203420302","article-title":"Vitamin E supplementation and cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib319","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.117.004224","article-title":"Association of multivitamin and mineral supplementation and risk of cardiovascular disease: a systematic review and meta-analysis","volume":"11","author":"Kim","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.04.003_bib320","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/archinte.167.15.1610","article-title":"A\u00a0randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the women's antioxidant cardiovascular study","volume":"167","author":"Cook","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib321","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12916-014-0158-6","article-title":"Dietary calcium intake and mortality risk from cardiovascular disease and all causes: a meta-analysis of prospective cohort studies","volume":"12","author":"Wang","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib322","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3390\/nu13020368","article-title":"Calcium supplements and risk of cardiovascular disease: a meta-analysis of clinical trials","volume":"13","author":"Myung","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.jacc.2023.04.003_bib323","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.293.11.1338","article-title":"Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial","volume":"293","author":"Lonn","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib324","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"suppl 2","key":"10.1016\/j.jacc.2023.04.003_bib325","first-page":"S2","article-title":"Chronic stable angina guidelines\u2014is there an emerging international consensus?","volume":"19","author":"Lopez-Sendon","year":"2012","journal-title":"Br J Card"},{"issue":"suppl 1","key":"10.1016\/j.jacc.2023.04.003_bib326","first-page":"A024","article-title":"Effects of diet on 10-year atherosclerotic cardiovascular disease risk using the pooled cohort equations risk calculator: results from the Dash trial","volume":"143","author":"Jeong","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib327","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib328","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.amjcard.2015.10.012","article-title":"Should antihypertensive treatment recommendations differ in patients with and without coronary heart disease? (From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT])","volume":"117","author":"Alderman","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib329","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0000000000001078","article-title":"Life's Essential 8: updating and enhancing the American Heart Association's construct of cardiovascular health: a presidential advisory from the American Heart Association","volume":"146","author":"Lloyd-Jones","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib330","doi-asserted-by":"crossref","first-page":"AMP069","DOI":"10.1161\/circ.135.suppl_1.mp069","article-title":"Dietary factors associated with cardiovascular outcomes: 25 year findings from the coronary artery risk development in young adults (CARDIA) study","volume":"135","author":"Van Horn","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib331","doi-asserted-by":"crossref","first-page":"e505","DOI":"10.1161\/CIR.0000000000000462","article-title":"Recommended dietary pattern to achieve adherence to the American Heart Association\/American College of Cardiology (AHA\/ACC) guidelines: a scientific statement from the American Heart Association","volume":"134","author":"Van Horn","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib332","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/01.CIR.0000137822.39831.F1","article-title":"Antioxidant vitamin supplements and cardiovascular disease","volume":"110","author":"Kris-Etherton","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib334","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1136\/bmj.304.6833.1015","article-title":"Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up","volume":"304","author":"Singh","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.04.003_bib335","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib336","doi-asserted-by":"crossref","first-page":"e779","DOI":"10.1161\/CIR.0000000000000766","article-title":"Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association","volume":"141","author":"Arnold","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib337","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa025039","article-title":"Adherence to a Mediterranean diet and survival in a Greek population","volume":"348","author":"Trichopoulou","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib338","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2017.05.047","article-title":"Healthful and unhealthful plant-based diets and the risk of coronary heart disease in U.S. adults","volume":"70","author":"Satija","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib339","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1161\/01.ATV.0000233384.97125.bd","article-title":"The changing roles of dietary carbohydrates","volume":"26","author":"Griel","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2023.04.003_bib340","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0140-6736(18)31809-9","article-title":"Carbohydrate quality and human health: a series of systematic reviews and meta-analyses","volume":"393","author":"Reynolds","year":"2019","journal-title":"Lancet"},{"issue":"suppl 9B","key":"10.1016\/j.jacc.2023.04.003_bib341","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/S0002-9343(01)00987-1","article-title":"Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease","volume":"113","author":"Sacks","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib342","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1161\/CIR.0b013e318279acbf","article-title":"Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations","volume":"126","author":"Whelton","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib343","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.jacc.2021.03.320","article-title":"Effects of diet and sodium reduction on cardiac injury, strain, and inflammation: The DASH-Sodium Trial","volume":"77","author":"Juraschek","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib344","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jada.2010.02.007","article-title":"Dietary sources of sodium in China, Japan, the United Kingdom, and the United States, women and men aged 40 to 59 years: the INTERMAP study","volume":"110","author":"Anderson","year":"2010","journal-title":"J\u00a0Am Diet Assoc"},{"key":"10.1016\/j.jacc.2023.04.003_bib345","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3390\/ijerph18010357","article-title":"Patterns of red and processed meat consumption across North America: a nationally representative cross-sectional comparison of dietary recalls from Canada, Mexico, and the United States","volume":"18","author":"Frank","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jacc.2023.04.003_bib346","article-title":"Sugar-sweetened beverage intake and cardiovascular disease risk in the California teachers study","volume":"9","author":"Pacheco","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.04.003_bib347","first-page":"CD012292","article-title":"Environmental interventions to reduce the consumption of sugar-sweetened beverages and their effects on health","volume":"6","author":"Von Philipsborn","year":"2019","journal-title":"Cochrane Database of Syst Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib348","doi-asserted-by":"crossref","first-page":"h3978","DOI":"10.1136\/bmj.h3978","article-title":"Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies","volume":"351","author":"De Souza","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.04.003_bib349","first-page":"6A","article-title":"Genetic susceptibility of vitamin D receptor (VDR) gene variants (BsmI, TaqI and FokI) to coronary artery disease in Asian Indians","volume":"25","author":"Bhatti","year":"2019","journal-title":"Endocrine Practice"},{"key":"10.1016\/j.jacc.2023.04.003_bib350","doi-asserted-by":"crossref","first-page":"e857","DOI":"10.1097\/MD.0000000000000857","article-title":"Vitamin D plasma levels and in-hospital and 1-year outcomes in acute coronary syndromes: a prospective study","volume":"94","author":"De Metrio","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacc.2023.04.003_bib351","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.amjcard.2012.10.006","article-title":"Relation of severe deficiency of vitamin D to cardiovascular mortality during acute coronary syndromes","volume":"111","author":"Correia","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib352","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2337\/dc19-1708","article-title":"Effects of vitamin D supplementation on prevention of type 2 diabetes in patients with prediabetes: a systematic review and meta-analysis","volume":"43","author":"Zhang","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2023.04.003_bib353","first-page":"624","article-title":"Healthy plant-based diets are associated with lower risk of all-cause mortality in US adults","volume":"148","author":"Kim","year":"2018","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.jacc.2023.04.003_bib354","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1161\/CIRCOUTCOMES.111.000049","article-title":"Feasibility and utility of screening for depression and anxiety disorders in patients with cardiovascular disease","volume":"6","author":"Celano","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.04.003_bib355","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1017\/S003329171900388X","article-title":"Long-term cardiac outcomes of depression screening, diagnosis and treatment in patients with acute coronary syndrome: the DEPACS study","volume":"51","author":"Kim","year":"2021","journal-title":"Psychol Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib356","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/jamainternmed.2019.4518","article-title":"Effect of depression screening after acute coronary syndromes on quality of life: the CODIACS-QoL randomized clinical trial","volume":"180","author":"Kronish","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib357","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/eurheartj\/ehy913","article-title":"Depression and coronary heart disease: 2018 position paper of the ESC working group on coronary pathophysiology and microcirculation","volume":"41","author":"Vaccarino","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib358","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/jama.2018.9422","article-title":"Effect of escitalopram vs placebo treatment for depression on long-term cardiac outcomes in patients with acute coronary syndrome: a randomized clinical trial","volume":"320","author":"Kim","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib359","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1161\/CIRCULATIONAHA.116.025140","article-title":"Depression treatment and 1-year mortality after acute myocardial infarction: insights from the TRIUMPH registry (Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status)","volume":"135","author":"Smolderen","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib360","doi-asserted-by":"crossref","first-page":"e763","DOI":"10.1161\/CIR.0000000000000947","article-title":"Psychological health, well-being, and the mind-heart-body connection: a scientific statement from the American Heart Association","volume":"143","author":"Levine","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib362","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11883-020-00877-1","article-title":"The impact of psychological functioning on cardiovascular disease","volume":"22","author":"Masters","year":"2020","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacc.2023.04.003_bib363","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/CRD.0b013e31820e8106","article-title":"Depression and cardiac disease: a review","volume":"19","author":"Celano","year":"2011","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib364","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1525-1497.2005.00269.x","article-title":"Prevalence of depression in survivors of acute myocardial infarction","volume":"21","author":"Thombs","year":"2006","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib365","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijcard.2019.12.014","article-title":"Sex and gender-stratified risks of psychological factors for adverse clinical outcomes in patients with ischemic heart disease: a systematic review and meta-analysis","volume":"302","author":"Smaardijk","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib366","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226717","article-title":"Should social disconnectedness be included in primary-care screening for cardiometabolic disease? A systematic review of the relationship between everyday stress, social connectedness, and allostatic load","volume":"14","author":"Larrabee Sonderlund","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jacc.2023.04.003_bib367","doi-asserted-by":"crossref","DOI":"10.1093\/intqhc\/mzab081","article-title":"Healthcare quality assessments: no guarantees of same outcomes for different socio-economic stroke patients","volume":"33","author":"Kim","year":"2021","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.jacc.2023.04.003_bib368","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1001\/archpsyc.62.7.792","article-title":"Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction","volume":"62","author":"Taylor","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jacc.2023.04.003_bib369","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/archinternmed.2010.510","article-title":"Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care project (SUPRIM)","volume":"171","author":"Gulliksson","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib370","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00392-020-01697-8","article-title":"The impact of SSRIs on mortality and cardiovascular events in patients with coronary artery disease and depression: systematic review and meta-analysis","volume":"110","author":"Fernandes","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib371","article-title":"Association between work-related stress and coronary heart disease: a review of prospective studies through the job strain, effort-reward balance, and organizational justice models","volume":"7","author":"Sara","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.04.003_bib372","article-title":"Stress and achievement of cardiovascular health metrics: the American Heart Association Life's Simple 7 in blacks of the Jackson Heart Study","volume":"7","author":"Brewer","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.04.003_bib373","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.amjcard.2011.09.045","article-title":"Effect of Hurricane Katrina on incidence of acute myocardial infarction in New Orleans three years after the storm","volume":"109","author":"Jiao","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib374","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ahj.2012.01.006","article-title":"The relationship between perceived discrimination and coronary artery obstruction","volume":"163","author":"Ayotte","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib375","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/ajh\/hpab116","article-title":"Stress and depression are associated with life's simple 7 among African Americans with hypertension: findings from the Jackson Heart Study","volume":"34","author":"Langford","year":"2021","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2023.04.003_bib376","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s11136-018-1885-5","article-title":"Health-related quality of life in coronary heart disease: a systematic review and meta-analysis mapped against the International Classification of Functioning, Disability and Health","volume":"27","author":"Le","year":"2018","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jacc.2023.04.003_bib377","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/CIRCULATIONAHA.107.741058","article-title":"Depressive symptoms and the risk of atherosclerotic progression among patients with coronary artery bypass grafts","volume":"117","author":"Wellenius","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib378","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.psy.0000146332.53619.b2","article-title":"Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis","volume":"66","author":"Barth","year":"2004","journal-title":"Psychosom Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib379","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1161\/CIR.0000000000000019","article-title":"Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association","volume":"129","author":"Lichtman","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib380","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/ajh\/hpv047","article-title":"State of the art review: depression, stress, anxiety, and cardiovascular disease","volume":"28","author":"Cohen","year":"2015","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2023.04.003_bib381","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1001\/jama.2013.5566","article-title":"Effect of escitalopram on mental stress-induced myocardial ischemia: results of the REMIT trial","volume":"309","author":"Jiang","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib382","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.ahj.2015.09.013","article-title":"Association between anxiety and mortality in patients with coronary artery disease: a meta-analysis","volume":"170","author":"Celano","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib383","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.jacc.2012.06.044","article-title":"Perceived stress in myocardial infarction: long-term mortality and health status outcomes","volume":"60","author":"Arnold","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib384","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/01.MLR.0000093487.78664.3C","article-title":"The Patient Health Questionnaire-2: validity of a two-item depression screener","volume":"41","author":"Kroenke","year":"2003","journal-title":"Med Care"},{"key":"10.1016\/j.jacc.2023.04.003_bib385","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.genhosppsych.2015.11.005","article-title":"Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis","volume":"39","author":"Plummer","year":"2016","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.jacc.2023.04.003_bib386","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jpsychores.2010.10.009","article-title":"Depression screening in patients with coronary heart disease: a critical evaluation of the AHA guidelines","volume":"71","author":"Hasnain","year":"2011","journal-title":"J\u00a0Psychosom Res"},{"key":"10.1016\/j.jacc.2023.04.003_bib387","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/PSY.0000000000000632","article-title":"Comparison of treatment rates of depression after stroke versus myocardial infarction: a systematic review and meta-analysis of observational data","volume":"80","author":"Ladwig","year":"2018","journal-title":"Psychosom Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib388","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1001\/jama.289.23.3106","article-title":"Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial","volume":"289","author":"Berkman","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib389","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/jama.288.6.701","article-title":"Sertraline treatment of major depression in patients with acute MI or unstable angina","volume":"288","author":"Glassman","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib390","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1192\/bjp.bp.106.028647","article-title":"Effects of antidepressant treatment following myocardial infarction","volume":"190","author":"van Melle","year":"2007","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jacc.2023.04.003_bib391","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/PSY.0000000000000944","article-title":"Hybrid systematic review and network meta-analysis of randomized controlled trials of interventions for depressive symptoms in patients with coronary artery disease","volume":"83","author":"Doyle","year":"2021","journal-title":"Psychsom Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib392","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/PSY.0b013e318291d798","article-title":"A\u00a0meta-analysis of mental health treatments and cardiac rehabilitation for improving clinical outcomes and depression among patients with coronary heart disease","volume":"75","author":"Rutledge","year":"2013","journal-title":"Psychosom Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib393","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1161\/CIRCULATIONAHA.115.018926","article-title":"Enhancing cardiac rehabilitation with stress management training: a randomized, clinical efficacy trial","volume":"133","author":"Blumenthal","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib394","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/abm\/kaz020","article-title":"Mindfulness-based interventions for adults with cardiovascular disease: a systematic review and meta-analysis","volume":"54","author":"Scott-Sheldon","year":"2020","journal-title":"Ann Behav Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib395","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-54932-2","article-title":"Randomized trial of mindfulness-based stress reduction in cardiac patients eligible for cardiac rehabilitation","volume":"9","author":"Nijjar","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacc.2023.04.003_bib396","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/1474515115613204","article-title":"Psychosocial interventions for patients with coronary heart disease and depression: a systematic review and meta-analysis","volume":"15","author":"Ski","year":"2016","journal-title":"Eur J Cardiovasc Nurs"},{"key":"10.1016\/j.jacc.2023.04.003_bib397","doi-asserted-by":"crossref","first-page":"8848","DOI":"10.21037\/apm-21-1623","article-title":"Systematic review and meta-analysis of psychological intervention on patients with coronary heart disease","volume":"10","author":"Zhang","year":"2021","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib398","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/YIC.0000000000000248","article-title":"Efficacy\u00a0and acceptability of antidepressants in patients with ischemic heart disease: systematic review and meta-analysis","volume":"34","author":"Ostuzzi","year":"2019","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.jacc.2023.04.003_bib399","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/CIRCULATIONAHA.119.041914","article-title":"The mind-heart-body connection","volume":"140","author":"Levine","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib400","series-title":"Tobacco Use and Dependence Guideline Panel Treating Tobacco Use and Dependence: 2008 Update","year":"2008"},{"key":"10.1016\/j.jacc.2023.04.003_bib401","author":"Babb"},{"key":"10.1016\/j.jacc.2023.04.003_bib402","first-page":"38","article-title":"Tobacco use screening and counseling during physician office visits among adults--National Ambulatory Medical Care Survey and National Health Interview Survey, United States, 2005-2009","volume":"61","author":"Jamal","year":"2012","journal-title":"MMWR Suppl"},{"issue":"5","key":"10.1016\/j.jacc.2023.04.003_bib403","first-page":"CD000165","article-title":"Physician advice for smoking cessation","volume":"2013","author":"Stead","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.jacc.2023.04.003_bib404","first-page":"CD013308","article-title":"Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation","volume":"4","author":"Lindson","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib405","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.115.002458","article-title":"Efficacy and safety of smoking cessation interventions in patients with cardiovascular disease: a network meta-analysis of randomized controlled trials","volume":"10","author":"Suissa","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.04.003_bib406","first-page":"CD013229","article-title":"Behavioural interventions for smoking cessation: an overview and network meta-analysis","volume":"1","author":"Hartmann-Boyce","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib407","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1177\/2047487319832975","article-title":"Cardiovascular effects of electronic cigarettes: a systematic review and meta-analysis","volume":"26","author":"Skotsimara","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib408","first-page":"CD010216","article-title":"Electronic cigarettes for smoking cessation","volume":"4","author":"Hartmann-Boyce","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib409","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa1808779","article-title":"A\u00a0randomized trial of e-cigarettes versus nicotine-replacement therapy","volume":"380","author":"Hajek","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib410","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1056\/NEJM199903253401204","article-title":"Passive smoking and the risk of coronary heart disease-a meta-analysis of epidemiologic studies","volume":"340","author":"He","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib411","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/hrt.2006.107367","article-title":"Chronic exposure to second hand smoke and 30-day prognosis of patients hospitalised with acute coronary syndromes: the Greek study of acute coronary syndromes","volume":"93","author":"Panagiotakos","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.04.003_bib412","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib413","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jama.2019.10298","article-title":"Association of smoking cessation with subsequent risk of cardiovascular disease","volume":"322","author":"Duncan","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib414","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jacc.2019.05.049","article-title":"Cigarette smoking, smoking cessation, and long-term risk of 3 major atherosclerotic diseases","volume":"74","author":"Ding","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib415","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.amjcard.2018.01.017","article-title":"Smoking cessation in patients with acute coronary syndrome","volume":"121","author":"Franck","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib416","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jacc.2021.04.005","article-title":"The tobacco endgame: eradicating a worsening epidemic: a joint opinion from the American Heart Association, World Heart Federation, American College of Cardiology, and the European Society of Cardiology","volume":"78","author":"Willett","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib417","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.amjcard.2005.07.083","article-title":"Premature coronary heart disease, cigarette smoking, and the metabolic syndrome","volume":"96","author":"Tonstad","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib418","series-title":"Tobacco and Cardiovascular Disease: A Summary of Evidence","author":"Roy","year":"2017"},{"key":"10.1016\/j.jacc.2023.04.003_bib419","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.jacc.2010.03.002","article-title":"Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial","volume":"55","author":"Johnson","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib420","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1053\/euhj.1999.1658","article-title":"Impact of smoking cessation and smoking interventions in patients with coronary heart disease","volume":"20","author":"van Berkel","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib421","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1001\/jama.290.1.86","article-title":"Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review","volume":"290","author":"Critchley","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib422","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/ntr\/nty002","article-title":"Risk of coronary heart disease among smokeless tobacco users: results of systematic review and meta-analysis of global data","volume":"21","author":"Gupta","year":"2019","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.jacc.2023.04.003_bib423","doi-asserted-by":"crossref","first-page":"b3060","DOI":"10.1136\/bmj.b3060","article-title":"Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis","volume":"339","author":"Boffetta","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.04.003_bib424","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10654-012-9704-8","article-title":"Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies","volume":"27","author":"Hansson","year":"2012","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib425","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/CIRCULATIONAHA.113.007252","article-title":"Discontinuation of smokeless tobacco and mortality risk after myocardial infarction","volume":"130","author":"Arefalk","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib426","first-page":"CD008743","article-title":"Use of electronic health records to support smoking cessation","author":"Boyle","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib427","first-page":"CD010742","article-title":"System change interventions for smoking cessation","volume":"2","author":"Thomas","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib428","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1161\/CIR.0000000000000107","article-title":"Electronic cigarettes: a policy statement from the American Heart Association","volume":"130","author":"Bhatnagar","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib429","article-title":"Acute effects of heat-not-burn, electronic vaping, and traditional tobacco combustion cigarettes: the Sapienza University of Rome-Vascular Assessment of Proatherosclerotic Effects of Smoking (SUR -VAPES) 2 randomized trial","volume":"8","author":"Biondi-Zoccai","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.04.003_bib430","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1471-2261-14-78","article-title":"Acute effects of using an electronic nicotine-delivery device (electronic cigarette) on myocardial function: comparison with the effects of regular cigarettes","volume":"14","author":"Farsalinos","year":"2014","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacc.2023.04.003_bib431","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrcardio.2017.36","article-title":"Cardiovascular effects of electronic cigarettes","volume":"14","author":"Benowitz","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib432","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1016\/j.jacc.2019.09.067","article-title":"Cardiovascular effects of switching from tobacco cigarettes to electronic cigarettes","volume":"74","author":"George","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib433","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/CIRCULATIONAHA.117.029153","article-title":"Electronic cigarette smoking increases arterial stiffness and oxidative stress to a lesser extent than a single conventional cigarette: an acute and chronic study","volume":"137","author":"Ikonomidis","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib434","article-title":"Impact of electronic cigarettes on the cardiovascular system","volume":"6","author":"Qasim","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.04.003_bib435","article-title":"Twenty-four-hour cardiovascular effects of electronic cigarettes compared with cigarette smoking in dual users","volume":"9","author":"Benowitz","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.04.003_bib436","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1136\/heartjnl-2020-318150","article-title":"Vaping and cardiac disease","volume":"107","author":"Shahandeh","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.04.003_bib437","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1016\/j.jacc.2018.10.027","article-title":"2018 ACC expert consensus decision pathway on tobacco cessation treatment: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents","volume":"72","author":"Barua","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib438","first-page":"CD006886","article-title":"Psychosocial interventions for smoking cessation in patients with coronary heart disease","author":"Barth","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib439","doi-asserted-by":"crossref","first-page":"652","DOI":"10.4065\/80.5.652","article-title":"Nicotine replacement therapy and cardiovascular disease","volume":"80","author":"Ford","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2023.04.003_bib440","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1023\/A:1007757530765","article-title":"Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking","volume":"12","author":"Tzivoni","year":"1998","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacc.2023.04.003_bib441","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0735-1097(97)00079-X","article-title":"Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy","volume":"29","author":"Benowitz","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib442","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJM199612123352402","article-title":"The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease","volume":"335","author":"Joseph","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib443","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/jamainternmed.2018.0397","article-title":"Cardiovascular safety of varenicline, bupropion, and nicotine patch in smokers: a randomized clinical trial","volume":"178","author":"Benowitz","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.jacc.2023.04.003_bib444","first-page":"CD013308","article-title":"Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation","volume":"4","author":"Lindson","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.jacc.2023.04.003_bib445","first-page":"CD009329","article-title":"Pharmacological interventions for smoking cessation: an overview and network meta-analysis","volume":"2013","author":"Cahill","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.jacc.2023.04.003_bib446","first-page":"CD009670","article-title":"Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation","volume":"6","author":"Hartmann-Boyce","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib447","article-title":"Varenicline and adverse cardiovascular events: a systematic review and meta-analysis of randomized controlled trials","volume":"5","author":"Sterling","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.04.003_bib448","first-page":"CD006103","article-title":"Nicotine receptor partial agonists for smoking cessation","volume":"5","author":"Cahill","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib449","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1161\/CIRCULATIONAHA.104.492215","article-title":"Cardiovascular effects of secondhand smoke: nearly as large as smoking","volume":"111","author":"Barnoya","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib450","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/jama.1995.03520370089043","article-title":"Passive smoking and heart disease: mechanisms and risk","volume":"273","author":"Glantz","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib451","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jacc.2015.07.037","article-title":"Cardiovascular effects of exposure to cigarette smoke and electronic cigarettes: clinical perspectives from the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology","volume":"66","author":"Morris","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib452","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jacc.2019.11.025","article-title":"Marijuana use in patients with cardiovascular disease: JACC review topic of the week","volume":"75","author":"DeFilippis","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib453","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1016\/j.jacc.2018.02.047","article-title":"Cocaine and marijuana use among young adults with myocardial infarction","volume":"71","author":"DeFilippis","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib454","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1001\/jamapsychiatry.2017.2161","article-title":"Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001-2002 to 2012-2013: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"74","author":"Grant","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jacc.2023.04.003_bib455","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s11606-015-3391-6","article-title":"Validation of self-administered single-item screening questions (SISQs) for unhealthy alcohol and drug use in primary care patients","volume":"30","author":"McNeely","year":"2015","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib456","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1161\/CIRCULATIONAHA.110.940569","article-title":"Cardiovascular effects of cocaine","volume":"122","author":"Schwartz","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib457","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jacc.2010.01.006","article-title":"Alcohol consumption and mortality in patients with cardiovascular disease: a meta-analysis","volume":"55","author":"Costanzo","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib458","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s10654-011-9631-0","article-title":"Wine, beer or spirit drinking in relation to fatal and non-fatal cardiovascular events: a meta-analysis","volume":"26","author":"Costanzo","year":"2011","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib459","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.3849","article-title":"Association of habitual alcohol intake with risk of cardiovascular disease","volume":"5","author":"Biddinger","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2023.04.003_bib460","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1161\/CIRCULATIONAHA.105.574749","article-title":"Binge drinking and mortality after acute myocardial infarction","volume":"112","author":"Mukamal","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib461","doi-asserted-by":"crossref","first-page":"c6077","DOI":"10.1136\/bmj.c6077","article-title":"Patterns of alcohol consumption and ischaemic heart disease in culturally divergent countries: the Prospective Epidemiological Study of Myocardial Infarction (PRIME)","volume":"341","author":"Ruidavets","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.04.003_bib462","doi-asserted-by":"crossref","first-page":"e472","DOI":"10.1161\/CIR.0000000000001031","article-title":"2021 Dietary guidance to improve cardiovascular health: a scientific statement from the American Heart Association","volume":"144","author":"Lichtenstein","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib463","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1161\/CIR.0000000000000883","article-title":"Medical marijuana, recreational cannabis, and cardiovascular health: a scientific statement from the American Heart Association","volume":"142","author":"Page","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib464","doi-asserted-by":"crossref","first-page":"187","DOI":"10.7326\/M17-1548","article-title":"Associations between marijuana use and cardiovascular risk factors and outcomes: a systematic review","volume":"168","author":"Ravi","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib465","doi-asserted-by":"crossref","first-page":"e836","DOI":"10.1161\/CIR.0000000000000958","article-title":"Opioid-associated out-of-hospital cardiac arrest: distinctive clinical features and implications for health care and public responses: a scientific statement from the American Heart Association","volume":"143","author":"Dezfulian","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib466","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/heartjnl-2020-318119","article-title":"Recreational substance use among patients with premature atherosclerotic cardiovascular disease","volume":"107","author":"Mahtta","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.04.003_bib467","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1136\/bmj.319.7224.1523","article-title":"Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors","volume":"319","author":"Rimm","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.04.003_bib469","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/01.CIR.0000018653.19696.01","article-title":"Meta-analysis of wine and beer consumption in relation to vascular risk","volume":"105","author":"Di Castelnuovo","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib470","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(18)31310-2","article-title":"Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib471","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/heart.83.6.688","article-title":"Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans","volume":"83","author":"Heesch","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.04.003_bib472","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jcin.2021.01.030","article-title":"Management of cocaine-associated non-ST-segment elevation myocardial infarction: is an invasive approach beneficial?","volume":"14","author":"Mukherjee","year":"2021","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2023.04.003_bib473","article-title":"Association of nonacute opioid use and cardiovascular diseases: a scoping review of the literature","volume":"10","author":"Singleton","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.04.003_bib474","doi-asserted-by":"crossref","first-page":"531","DOI":"10.7326\/M18-2809","article-title":"Acute illness associated with cannabis use, by route of exposure: an observational study","volume":"170","author":"Monte","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib475","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.hrtlng.2006.12.001","article-title":"Sexual satisfaction among patients after coronary bypass surgery or percutaneous transluminal angioplasty: eight-year follow-up","volume":"36","author":"Lukkarinen","year":"2007","journal-title":"Heart Lung"},{"key":"10.1016\/j.jacc.2023.04.003_bib476","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jama.2011.336","article-title":"Association of episodic physical and sexual activity with triggering of acute cardiac events: systematic review and meta-analysis","volume":"305","author":"Dahabreh","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib477","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jama.1996.03530420033032","article-title":"Triggering myocardial infarction by sexual activity. Low absolute risk and prevention by regular physical exertion. Determinants of Myocardial Infarction Onset Study Investigators","volume":"275","author":"Muller","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib478","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/BF03349261","article-title":"The use of phosphodiesterase 5 inhibitors with concomitant medications","volume":"31","author":"Corona","year":"2008","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.jacc.2023.04.003_bib479","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIR.0b013e3182447787","article-title":"Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association","volume":"125","author":"Levine","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib480","first-page":"44","article-title":"Sudden cardiovascular death during sexual intercourse--results of a legal medicine autopsy study","volume":"88","author":"Parzeller","year":"1999","journal-title":"Z\u00a0Kardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib481","first-page":"235","article-title":"Blood pressure, sexual activity, and erectile function in hypertensive men: baseline findings from the Systolic Blood Pressure Intervention Trial (SPRINT)","volume":"16","author":"Foy","year":"2019","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib482","first-page":"804","article-title":"Minimally invasive coronary artery bypass grafting via a small thoracotomy versus off-pump: a case-matched study","volume":"40","author":"Lapierre","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jacc.2023.04.003_bib483","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/heartjnl-2018-313778","article-title":"Sexual rehabilitation for cardiac patients with erectile dysfunction: a randomised clinical trial","volume":"105","author":"Palm","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.04.003_bib484","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.cjca.2018.08.020","article-title":"The effect of cardiac rehabilitation attendance on sexual activity outcomes in cardiovascular disease patients: a systematic review","volume":"34","author":"Boothby","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib485","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib486","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib487","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(18)31942-1","article-title":"Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials","volume":"393","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib488","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib489","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib490","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib491","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1056\/NEJM199701163360301","article-title":"Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts","volume":"336","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib492","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(02)09328-5","article-title":"MRC\/BHF Heart protection study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib493","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.amjcard.2019.12.030","article-title":"Impact of lipid monitoring on treatment intensification of cholesterol lowering therapies (from the Veterans Affairs Healthcare System)","volume":"125","author":"Jia","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib494","article-title":"Association of low-density lipoprotein testing after an atherosclerotic cardiovascular event with subsequent statin adherence and intensification","author":"Rana","year":"2021","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib495","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/ehjcvp\/pvw006","article-title":"Variability of low-density lipoprotein cholesterol response with different doses of atorvastatin, rosuvastatin, and simvastatin: results from VOYAGER","volume":"2","author":"Karlson","year":"2016","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jacc.2023.04.003_bib496","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.2016.11004","article-title":"Cost-effectiveness of PCSK9 inhibitor therapy in patients with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease","volume":"316","author":"Kazi","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib497","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.jacc.2014.03.016","article-title":"ACC\/AHA statement on cost\/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines","volume":"63","author":"Anderson","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib498","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jacc.2016.11.070","article-title":"Atherothrombotic risk stratification and ezetimibe for secondary prevention","volume":"69","author":"Bohula","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib499","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib500","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/jamacardio.2019.2306","article-title":"Effect of simvastatin-ezetimibe compared with simvastatin monotherapy after acute coronary syndrome among patients 75 years or older: a secondary analysis of a randomized clinical trial","volume":"4","author":"Bach","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib501","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S2213-8587(18)30290-0","article-title":"Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial","volume":"6","author":"Bonaca","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2023.04.003_bib502","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamacardio.2017.2289","article-title":"Simulation of lipid-lowering therapy intensification in a population with atherosclerotic cardiovascular disease","volume":"2","author":"Cannon","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib503","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1161\/CIRCULATIONAHA.117.028503","volume":"135","author":"Virani","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib505","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7326\/M18-1776","article-title":"Cost-effectiveness of alirocumab: a just-in-time analysis based on the ODYSSEY outcomes trial","volume":"170","author":"Kazi","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib506","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib507","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib508","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/phar.2635","article-title":"Meta-analysis of clinical outcomes of PCSK9 modulators in patients with established ASCVD","volume":"41","author":"Talasaz","year":"2021","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jacc.2023.04.003_bib509","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jamacardio.2019.0886","article-title":"Effect of the PCSK9 inhibitor evolocumab on total cardiovascular events in patients with cardiovascular disease: a prespecified analysis from the FOURIER Trial","volume":"4","author":"Murphy","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib510","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1161\/CIRCULATIONAHA.118.034309","article-title":"Clinical benefit of evolocumab by severity and extent of coronary artery disease: analysis from FOURIER","volume":"138","author":"Sabatine","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib511","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jacc.2019.03.013","article-title":"Alirocumab in patients with polyvascular disease and recent acute coronary syndrome: ODYSSEY OUTCOMES trial","volume":"74","author":"Jukema","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib512","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1161\/CIRCULATIONAHA.119.042551","article-title":"Risk categorization using New American College of Cardiology\/American Heart Association guidelines for cholesterol management and its relation to alirocumab treatment following acute coronary syndromes","volume":"140","author":"Roe","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib513","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1701131","article-title":"Cognitive function in a randomized trial of evolocumab","volume":"377","author":"Giugliano","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib514","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/j.jacc.2020.03.029","article-title":"Cost-effectiveness of Alirocumab in patients with acute coronary syndromes: the ODYSSEY OUTCOMES trial","volume":"75","author":"Bhatt","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib515","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jamacardio.2019.1647","article-title":"Updated cost-effectiveness analysis of evolocumab in patients with very high-risk atherosclerotic cardiovascular disease","volume":"4","author":"Fonarow","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib516","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib517","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1803917","article-title":"Safety and efficacy of bempedoic acid to reduce LDL cholesterol","volume":"380","author":"Ray","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib518","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1001\/jama.2019.16585","article-title":"Effect of bempedoic acid vs placebo added to maximally tolerated statins on low-density lipoprotein cholesterol in patients at high risk for cardiovascular disease: the CLEAR Wisdom randomized clinical trial","volume":"322","author":"Goldberg","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib519","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","article-title":"Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib520","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Investigators","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib521","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1300955","article-title":"Effects of extended-release niacin with laropiprant in high-risk patients","volume":"371","author":"Landray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib522","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib523","doi-asserted-by":"crossref","first-page":"c6273","DOI":"10.1136\/bmj.c6273","article-title":"Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial","volume":"341","author":"Galan","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.04.003_bib524","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMoa1003603","article-title":"n-3 fatty acids and cardiovascular events after myocardial infarction","volume":"363","author":"Kromhout","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib525","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/CIRCULATIONAHA.120.052209","article-title":"Effects of n-3 fatty acid supplements in elderly patients after myocardial infarction: a randomized, controlled trial","volume":"143","author":"Kalstad","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib526","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib527","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.amjmed.2015.10.024","article-title":"2013 Cholesterol guidelines revisited: percent LDL cholesterol reduction or attained LDL cholesterol level or both for prognosis?","volume":"129","author":"Bangalore","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib528","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1161\/CIR.0000000000000456","article-title":"Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a scientific statement from the American Heart Association","volume":"134","author":"Wiggins","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib529","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jacl.2022.05.068","article-title":"NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient","volume":"16","author":"Cheeley","year":"2022","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacc.2023.04.003_bib530","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jacc.2021.07.022","article-title":"Side effect patterns in a crossover trial of statin, placebo, and no treatment","volume":"78","author":"Howard","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.jacc.2023.04.003_bib531","first-page":"00245","article-title":"Assessment and management of statin-associated muscle symptoms (SAMS): a clinical perspective from the National Lipid Association","volume":"S1933-2874","author":"Warden","year":"2022","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacc.2023.04.003_bib532","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jacc.2013.01.079","article-title":"Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications","volume":"62","author":"Martin","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib533","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1001\/jama.2013.280532","article-title":"Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile","volume":"310","author":"Martin","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib534","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib535","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","article-title":"Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)","volume":"137","author":"Bonaca","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib536","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1001\/jamacardio.2020.0882","article-title":"Efficacy of evolocumab on cardiovascular outcomes in patients with recent myocardial infarction: a prespecified secondary analysis from the FOURIER trial","volume":"5","author":"Gencer","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib537","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/CIRCULATIONAHA.122.059410","volume":"146","author":"Ridker","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib538","doi-asserted-by":"crossref","unstructured":"Alvarez Campano CG, Alvarez Campano CG, Macleod MJ, et\u00a0al. Marine-derived n-3 fatty acids therapy for stroke. Cochrane Database of Systematic Reviews. 2019;6:CD012815.","DOI":"10.1002\/14651858.CD012815.pub2"},{"key":"10.1016\/j.jacc.2023.04.003_bib539","series-title":"Inclisiran and bempedoic acid for patients with heterozygous familial hypercholesteremia and for secondary prevention of ASCVD: effectiveness and value; final evidence report","author":"Lin","year":"2021"},{"key":"10.1016\/j.jacc.2023.04.003_bib540","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","article-title":"Accord Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus","volume":"362","author":"Ginsberg","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib541","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1056\/NEJMoa2210645","article-title":"Triglyceride lowering with pemafibrate to reduce cardiovascular risk","volume":"387","author":"Das Pradhan","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib542","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","article-title":"The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association","volume":"132","author":"Gidding","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib543","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2011.04.003","article-title":"Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","volume":"5","author":"Goldberg","year":"2011","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacc.2023.04.003_bib545","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1001\/jama.294.19.2437","article-title":"High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial","volume":"294","author":"Pedersen","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib546","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archinte.1997.00440270105009","article-title":"Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II","volume":"157","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib547","first-page":"2083","article-title":"Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial","volume":"289","author":"Appel","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib548","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJM199704173361601","article-title":"A\u00a0clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group","volume":"336","author":"Appel","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib549","article-title":"Exercise training for blood pressure: a systematic review and meta-analysis","volume":"2","author":"Cornelissen","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.04.003_bib550","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.HYP.0000094221.86888.AE","article-title":"Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials","volume":"42","author":"Neter","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2023.04.003_bib551","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1016\/S2468-2667(17)30003-8","article-title":"The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis","volume":"2","author":"Roerecke","year":"2017","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.jacc.2023.04.003_bib552","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1056\/NEJM200101043440101","article-title":"Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group","volume":"344","author":"Sacks","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib553","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-136-7-200204020-00006","article-title":"Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials","volume":"136","author":"Whelton","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib554","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/archinte.159.3.285","article-title":"Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial","volume":"159","author":"Svetkey","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib555","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1093\/eurheartj\/ehz149","article-title":"Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk","volume":"40","author":"Bohm","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib556","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jamacardio.2017.1421","article-title":"Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis","volume":"2","author":"Bundy","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib557","doi-asserted-by":"crossref","first-page":"895","DOI":"10.7326\/M20-2037","article-title":"Effect of intensive blood pressure lowering on cardiovascular outcomes: a systematic review prepared for the 2020 U.S. Department of Veterans Affairs\/U.S. Department of Defense Guidelines","volume":"173","author":"D'Anci","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib558","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A\u00a0randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib559","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/jch.13581","article-title":"Determination of optimal on-treatment diastolic blood pressure range using automated measurements in subjects with cardiovascular disease\u2014analysis of a SPRINT trial subpopulation","volume":"21","author":"Sobieraj","year":"2019","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"issue":"suppl J","key":"10.1016\/j.jacc.2023.04.003_bib560","first-page":"J52","article-title":"The European trial on reduction of cardiac events with perindopril in stable coronary artery disease (EUROPA)","volume":"19","author":"Fox","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib561","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib562","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.04.003_bib563","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(04)16980-8","article-title":"Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial","volume":"364","author":"Poole-Wilson","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib564","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib565","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib566","article-title":"One-year landmark analysis of the effect of beta-blocker dose on survival after acute myocardial infarction","volume":"10","author":"Goldberger","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.04.003_bib567","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/HYPERTENSIONAHA.117.10786","article-title":"Hypertension, microvascular pathology, and prognosis after an acute myocardial infarction","volume":"72","author":"Carrick","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2023.04.003_bib568","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/hrt.38.2.155","article-title":"Effects of the cardioselective beta-adrenergic receptor blocking agent metoprolol in angina pectoris. Subacute study with exercise tests","volume":"38","author":"Ekelund","year":"1976","journal-title":"Br Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib569","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","article-title":"Beta blockade after myocardial infarction: systematic review and meta regression analysis","volume":"318","author":"Freemantle","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.04.003_bib570","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib571","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","volume":"60","author":"Fihn","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib572","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.jacc.2011.10.824","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation","volume":"58","author":"Smith","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib573","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.jacc.2014.07.017","volume":"64","author":"Fihn","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib574","doi-asserted-by":"crossref","first-page":"f1326","DOI":"10.1136\/bmj.f1326","article-title":"Effect of lower sodium intake on health: systematic review and meta-analyses","volume":"346","author":"Aburto","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.04.003_bib575","doi-asserted-by":"crossref","first-page":"f1325","DOI":"10.1136\/bmj.f1325","article-title":"Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials","volume":"346","author":"He","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.04.003_bib576","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","article-title":"A\u00a0calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial","volume":"290","author":"Pepine","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib577","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1161\/HYP.0000000000000018","article-title":"Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension","volume":"65","author":"Rosendorff","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2023.04.003_bib578","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.jacc.2011.01.008","volume":"57","author":"Aronow","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib579","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/S0140-6736(04)17355-8","article-title":"Atenolol in hypertension: is it a wise choice?","volume":"364","author":"Carlberg","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib580","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.1997.03540440058033","article-title":"Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials","volume":"277","author":"Whelton","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib581","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.mayocp.2013.10.030","article-title":"Isometric exercise training for blood pressure management: a systematic review and meta-analysis","volume":"89","author":"Carlson","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2023.04.003_bib582","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/hr.2015.111","article-title":"Isometric exercise training for blood pressure management: a systematic review and meta-analysis to optimize benefit","volume":"39","author":"Inder","year":"2016","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jacc.2023.04.003_bib584","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib585","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib586","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib587","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib588","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa2004967","article-title":"Cardiovascular outcomes with ertugliflozin in type 2 diabetes","volume":"383","author":"Cannon","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib589","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/CIRCULATIONAHA.117.029190","volume":"136","author":"Kosiborod","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib590","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","article-title":"Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis","volume":"6","author":"McGuire","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib591","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/eurheartj\/ehv728","article-title":"Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME(R) trial","volume":"37","author":"Fitchett","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib592","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib593","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib594","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJMoa1612917","article-title":"Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes","volume":"377","author":"Holman","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib595","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","article-title":"Lixisenatide in patients with type 2 diabetes and acute coronary syndrome","volume":"373","author":"Pfeffer","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib596","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(18)32261-X","article-title":"Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial","volume":"392","author":"Hernandez","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib597","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib598","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"381","author":"Husain","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib599","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"7","author":"Kristensen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2023.04.003_bib600","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIRCULATIONAHA.118.038868","article-title":"Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus","volume":"139","author":"Zelniker","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib601","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11892-020-1292-5","article-title":"A\u00a0systematic review of cost-effectiveness of sodium-glucose cotransporter inhibitors for type 2 diabetes","volume":"20","author":"Yoshida","year":"2020","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jacc.2023.04.003_bib602","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2020.1906","article-title":"Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes","volume":"323","author":"Petrie","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib603","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib604","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib605","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib606","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1161\/CIRCULATIONAHA.119.044138","article-title":"Effects of dapagliflozin on symptoms, function, and quality of life in patients with heart failure and reduced ejection fraction: results from the DAPA-HF Trial","volume":"141","author":"Kosiborod","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib607","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/eurheartj\/ehaa1007","article-title":"Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial","volume":"42","author":"Butler","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib608","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.14501","article-title":"Cost-effectiveness of dapagliflozin for the treatment of heart failure with reduced ejection fraction","volume":"4","author":"Isaza","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2023.04.003_bib609","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1001\/jamacardio.2021.1437","article-title":"Cost-effectiveness of dapagliflozin for treatment of patients with heart failure with reduced ejection fraction","volume":"6","author":"Parizo","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib610","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib611","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib612","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/s41591-021-01536-x","article-title":"The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial","volume":"27","author":"Nassif","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib613","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2022.5010","article-title":"Cost-effectiveness of empagliflozin in patients with heart failure with preserved ejection fraction","author":"Zheng","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib614","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib615","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib616","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S2213-8587(17)30313-3","article-title":"Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial","volume":"5","author":"Sabatine","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2023.04.003_bib617","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCULATIONAHA.114.014796","article-title":"Impact of diabetes mellitus on hospitalization for heart failure, cardiovascular events, and death: outcomes at 4 years from the Reduction of Atherothrombosis for Continued Health (REACH) Registry","volume":"132","author":"Cavender","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib618","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1177\/2047487317729252","article-title":"Real-world use and modeled impact of glucose-lowering therapies evaluated in recent cardiovascular outcomes trials: an NCDR(R) research to practice project","volume":"24","author":"Arnold","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib619","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/CIRCULATIONAHA.119.041730","article-title":"Use of guideline-recommended risk-reduction strategies among patients with diabetes and atherosclerotic cardiovascular disease: insights from Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD)","volume":"140","author":"Arnold","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib620","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/CIRCULATIONAHA.117.022680","article-title":"Are we ready to bell the cat? A call for cardiologists to embrace glucose-lowering therapies proven to improve cardiovascular outcomes","volume":"138","author":"Nassif","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib621","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2337\/dc14-1877","article-title":"Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, and lipids and active smoking in adults with diabetes with and without cardiovascular disease: a contemporary analysis","volume":"38","author":"Vazquez-Benitez","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2023.04.003_bib622","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jacc.2020.05.037","article-title":"2020 Expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"76","author":"Das","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib623","first-page":"S83","article-title":"Glycemic targets: standards of medical care in diabetes\u20142022","volume":"45","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2023.04.003_bib624","first-page":"S195","article-title":"Older adults: standards of medical care in diabetes\u20142022","volume":"45","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2023.04.003_bib625","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib626","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib627","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib628","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","year":"2008","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib629","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib630","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7326\/0003-4819-149-1-200807010-00005","article-title":"The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis","volume":"149","author":"Huang","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib631","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1210\/jc.2019-00198","article-title":"Treatment of diabetes in older adults: an Endocrine Society Clinical Practice Guideline","volume":"104","author":"LeRoith","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2023.04.003_bib632","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/jdi.12625","article-title":"Comparisons of weight changes between sodium-glucose cotransporter 2 inhibitors treatment and glucagon-like peptide-1 analogs treatment in type 2 diabetes patients: a meta-analysis","volume":"8","author":"Cai","year":"2017","journal-title":"J\u00a0Diabetes Investig"},{"key":"10.1016\/j.jacc.2023.04.003_bib633","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/dom.13125","article-title":"Liraglutide and cardiovascular outcomes in adults with overweight or obesity: a post hoc analysis from SCALE randomized controlled trials","volume":"20","author":"Davies","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jacc.2023.04.003_bib634","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1080\/07853890.2017.1306653","article-title":"Protective effect of glucagon-like peptide-1 agents on reperfusion injury for acute myocardial infarction: a meta-analysis of randomized controlled trials","volume":"49","author":"Huang","year":"2017","journal-title":"Ann Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib635","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S2213-8587(18)30023-8","article-title":"Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trial","volume":"6","author":"Ludvik","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2023.04.003_bib636","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s12020-019-02175-6","article-title":"The efficacy and safety of combinations of SGLT2 inhibitors and GLP-1 receptor agonists in the treatment of type 2 diabetes or obese adults: a systematic review and meta-analysis","volume":"67","author":"Guo","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/j.jacc.2023.04.003_bib637","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/dom.14108","article-title":"Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors as combination therapy for type 2 diabetes: a systematic review and meta-analysis","volume":"22","author":"Mantsiou","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jacc.2023.04.003_bib638","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1001\/archinte.167.16.1720","article-title":"Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons","volume":"167","author":"Bogers","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib639","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1056\/NEJM199910073411501","article-title":"Body-mass index and mortality in a prospective cohort of U.S. adults","volume":"341","author":"Calle","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib640","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/CIRCULATIONAHA.109.887521","article-title":"Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men","volume":"121","author":"Arnlov","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib641","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/archinternmed.2010.201","article-title":"Waist circumference and all-cause mortality in a large US cohort","volume":"170","author":"Jacobs","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib642","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jama.296.1.79","article-title":"Mortality and cardiac and vascular outcomes in extremely obese women","volume":"296","author":"McTigue","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib643","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/jamacardio.2018.0022","article-title":"Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity","volume":"3","author":"Khan","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib644","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/jama.2018.7777","article-title":"Behavioral and pharmacotherapy weight loss interventions to prevent obesity-related morbidity and mortality in adults: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"320","author":"LeBlanc","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib645","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1001\/jama.2014.14173","article-title":"Behavioral treatment of obesity in patients encountered in primary care settings: a systematic review","volume":"312","author":"Wadden","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib646","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1001\/jama.298.21.2507","article-title":"Cardiorespiratory fitness and adiposity as mortality predictors in older adults","volume":"298","author":"Sui","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib647","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1467-789X.2009.00653.x","article-title":"Physical activity, fitness and fatness: relations to mortality, morbidity and disease risk factors. A systematic review","volume":"11","author":"Fogelholm","year":"2010","journal-title":"Obes Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib648","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib649","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A\u00a0randomized, controlled trial of 3.0 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib650","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/jama.2021.23619","article-title":"Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial","volume":"327","author":"Rubino","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib651","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(18)31773-2","article-title":"Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial","volume":"392","author":"O'Neil","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib652","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.4065\/80.9.1157","article-title":"Safety and efficacy of bariatric surgery in patients with coronary artery disease","volume":"80","author":"Lopez-Jimenez","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2023.04.003_bib653","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.2011.1914","article-title":"Bariatric surgery and long-term cardiovascular events","volume":"307","author":"Sjostrom","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib654","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1161\/CIRCULATIONAHA.120.052386","article-title":"Bariatric surgery and cardiovascular outcomes in patients with obesity and cardiovascular disease: a population-based retrospective cohort study","volume":"143","author":"Doumouras","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib655","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1161\/CIRCULATIONAHA.120.048585","article-title":"Association of metabolic surgery with major adverse cardiovascular outcomes in patients with previous myocardial infarction and severe obesity: a nationwide cohort study","volume":"143","author":"Naslund","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib656","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMoa1003114","article-title":"Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects","volume":"363","author":"James","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib657","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: a scientific statement from the American Heart Association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib658","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM199806043382302","article-title":"Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study","volume":"338","author":"Berenson","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib659","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa020245","article-title":"Obesity and the risk of heart failure","volume":"347","author":"Kenchaiah","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib660","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1161\/01.CIR.0000018121.67607.CE","article-title":"Obesity accelerates the progression of coronary atherosclerosis in young men","volume":"105","author":"McGill","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib661","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1016\/j.jacc.2013.11.004","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society","volume":"63","author":"Jensen","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib662","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.jacc.2010.11.058","article-title":"Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data","volume":"57","author":"Coutinho","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib663","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jacc.2012.10.035","article-title":"Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of \"normal weight central obesity\"","volume":"61","author":"Coutinho","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib664","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1161\/CIRCULATIONAHA.106.676379","article-title":"International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries","volume":"116","author":"Balkau","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib665","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1001\/jama.2016.1558","article-title":"Effect of naltrexone-bupropion on major adverse cardiovascular events in overweight and obese patients with cardiovascular risk factors: a randomized clinical trial","volume":"315","author":"Nissen","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib666","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib667","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib668","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib669","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1056\/NEJMoa1112082","article-title":"Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects","volume":"367","author":"Carlsson","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib670","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1056\/NEJMoa033179","article-title":"Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease","volume":"350","author":"Klein","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib671","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1056\/NEJMoa1600869","article-title":"Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes","volume":"376","author":"Schauer","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib673","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib674","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.mayocpiqo.2021.06.009","article-title":"Multicomponent cardiac rehabilitation and cardiovascular outcomes in patients with stable angina: a systematic review and meta-analysis","volume":"5","author":"Saeidifard","year":"2021","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.04.003_bib675","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib676","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.008215","article-title":"Million Hearts cardiac rehabilitation think tank: accelerating new care models","volume":"14","author":"Beatty","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.04.003_bib677","doi-asserted-by":"crossref","first-page":"e705","DOI":"10.1161\/CIR.0000000000000749","article-title":"Exercise-related acute cardiovascular events and potential deleterious adaptations following long-term exercise training: placing the risks into perspective-an update: a scientific statement from the American Heart Association","volume":"141","author":"Franklin","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib678","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jcmg.2016.03.010","article-title":"Progression of CAC score and risk of incident CVD","volume":"9","author":"Radford","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2023.04.003_bib679","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/bjsports-2021-103994","article-title":"Risk of atrial fibrillation in athletes: a systematic review and meta-analysis","volume":"55","author":"Newman","year":"2021","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib680","first-page":"CD012264","article-title":"Exercise-based cardiac rehabilitation in heart transplant recipients","volume":"4","author":"Anderson","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib681","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1161\/CIRCULATIONAHA.118.036747","article-title":"Effect of high-intensity interval training in de novo heart transplant recipients in Scandinavia","volume":"139","author":"Nytroen","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib682","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1111\/j.1600-6143.2012.04221.x","article-title":"High-intensity interval training improves peak oxygen uptake and muscular exercise capacity in heart transplant recipients","volume":"12","author":"Nytroen","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jacc.2023.04.003_bib683","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.healun.2013.06.023","article-title":"Effect of high-intensity interval training on progression of cardiac allograft vasculopathy","volume":"32","author":"Nytroen","year":"2013","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2023.04.003_bib684","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14488","article-title":"A\u00a0randomized clinical study using optical coherence tomography to evaluate the short-term effects of high-intensity interval training on cardiac allograft vasculopathy: a HITTS substudy","volume":"36","author":"Rafique","year":"2022","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jacc.2023.04.003_bib685","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/ehf2.12329","article-title":"Timing of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients","volume":"5","author":"Asleh","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacc.2023.04.003_bib686","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.cjca.2016.01.009","article-title":"The first dedicated cardiac rehabilitation program for patients with spontaneous coronary artery dissection: description and initial results","volume":"32","author":"Chou","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib687","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.amjcard.2016.02.034","article-title":"Usefulness of cardiac rehabilitation after spontaneous coronary artery dissection","volume":"117","author":"Krittanawong","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib688","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1161\/CIR.0000000000000564","article-title":"Spontaneous coronary artery dissection: current state of the science: a scientific statement from the American Heart Association","volume":"137","author":"Hayes","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib689","article-title":"Safety and outcomes of cardiac rehabilitation for patients with spontaneous coronary artery dissection","volume":"1","author":"Imran","year":"2018","journal-title":"J\u00a0Rehabil Med Clin Commun"},{"key":"10.1016\/j.jacc.2023.04.003_bib690","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1161\/CIRCULATIONAHA.106.180945","volume":"115","author":"Balady","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib691","first-page":"CD001800","article-title":"Exercise-based cardiac rehabilitation for coronary heart disease","volume":"11","author":"Taylor","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib692","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41569-021-00611-7","article-title":"The role of cardiac rehabilitation in improving cardiovascular outcomes","volume":"19","author":"Taylor","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib693","first-page":"CD010876","article-title":"Exercise-based cardiac rehabilitation for adults after heart valve surgery","volume":"5","author":"Taylor","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib694","doi-asserted-by":"crossref","DOI":"10.1016\/j.appet.2020.105021","article-title":"High intensity interval training does not result in short- or long-term dietary compensation in cardiac rehabilitation: results from the FITR heart study","volume":"158","author":"Taylor","year":"2021","journal-title":"Appetite"},{"key":"10.1016\/j.jacc.2023.04.003_bib695","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/HCR.0000000000000565","article-title":"Adherence to high-intensity interval training in cardiac rehabilitation: a review and recommendations","volume":"41","author":"Taylor","year":"2021","journal-title":"J\u00a0Cardiopulm Rehabil Prev"},{"key":"10.1016\/j.jacc.2023.04.003_bib696","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.119.005902","article-title":"Tracking cardiac rehabilitation participation and completion among Medicare beneficiaries to inform the efforts of a national initiative","volume":"13","author":"Ritchey","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.04.003_bib697","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1136\/heartjnl-2014-305783","article-title":"Smartphone-based home care model improved use of cardiac rehabilitation in postmyocardial infarction patients: results from a randomised controlled trial","volume":"100","author":"Varnfield","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.04.003_bib698","first-page":"CD007130","article-title":"Home-based versus centre-based cardiac rehabilitation","volume":"6","author":"Anderson","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib699","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1177\/2047487314561168","article-title":"Telehealth interventions versus center-based cardiac rehabilitation of coronary artery disease: a systematic review and meta-analysis","volume":"22","author":"Huang","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib700","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1161\/CIR.0000000000000663","article-title":"Home-based cardiac rehabilitation: a scientific statement from the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology","volume":"140","author":"Thomas","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib701","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.28720","article-title":"Comparison of home-based vs center-based cardiac rehabilitation in hospitalization, medication adherence, and risk factor control among patients with cardiovascular disease","volume":"5","author":"Nkonde-Price","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2023.04.003_bib702","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/HCR.0b013e318203999d","article-title":"Core competencies for cardiac rehabilitation\/secondary prevention professionals: 2010 update: position statement of the American Association of Cardiovascular and Pulmonary Rehabilitation","volume":"31","author":"Hamm","year":"2011","journal-title":"J\u00a0Cardiopulm Rehabil Prev"},{"key":"10.1016\/j.jacc.2023.04.003_bib703","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1161\/CIR.0b013e318277728c","volume":"126","author":"King","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib704","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/CIRCULATIONAHA.109.876383","article-title":"Relationship between cardiac rehabilitation and long-term risks of death and myocardial infarction among elderly Medicare beneficiaries","volume":"121","author":"Hammill","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib705","article-title":"Dose of cardiac rehabilitation to reduce mortality and morbidity: a population-based study","volume":"10","author":"Medina-Inojosa","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"17","key":"10.1016\/j.jacc.2023.04.003_bib706","first-page":"30075","article-title":"Relationship between cardiac rehabilitation participation and health service expenditures within a universal health care system","volume":"s0025-s6196","author":"Alter","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2023.04.003_bib707","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13561-017-0173-3","article-title":"The cost-effectiveness of exercise-based cardiac rehabilitation: a systematic review of the characteristics and methodological quality of published literature","volume":"7","author":"Edwards","year":"2017","journal-title":"Health Econ Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib708","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1840894","article-title":"Cost-effectiveness of cardiac rehabilitation in patients with coronary artery disease: a meta-analysis","volume":"2019","author":"Takura","year":"2019","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.jacc.2023.04.003_bib709","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1001\/archinte.168.20.2194","article-title":"Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network","volume":"168","author":"Giannuzzi","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib710","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib711","first-page":"CD001800","article-title":"Exercise-based cardiac rehabilitation for coronary heart disease","volume":"11","author":"Dibben","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib712","first-page":"CD012786","article-title":"Exercise-based cardiac rehabilitation for adults with stable angina","volume":"2","author":"Long","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib713","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/heartjnl-2017-312832","article-title":"Cardiac rehabilitation and physical activity: systematic review and meta-analysis","volume":"104","author":"Dibben","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.04.003_bib714","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177658","article-title":"The effectiveness of modern cardiac rehabilitation: a systematic review of recent observational studies in non-attenders versus attenders","volume":"12","author":"Sumner","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2023.04.003_bib715","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.amjmed.2014.02.008","article-title":"Participation in cardiac rehabilitation, readmissions, and death after acute myocardial infarction","volume":"127","author":"Dunlay","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib716","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1177\/2047487319881839","article-title":"Cost-effectiveness of exercise therapy in patients with coronary heart disease, chronic heart failure and associated risk factors: a systematic review of economic evaluations of randomized clinical trials","volume":"27","author":"Oldridge","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib717","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2217\/fca-2018-0085","article-title":"A\u00a0systematic review of recent cardiac rehabilitation meta-analyses in patients with coronary heart disease or heart failure","volume":"15","author":"Oldridge","year":"2019","journal-title":"Future Cardiol"},{"issue":"1","key":"10.1016\/j.jacc.2023.04.003_bib718","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.12868","article-title":"Long-term effects of high-intensity interval training in heart transplant recipients: a 5-year follow-up study of a randomized controlled trial","volume":"31","author":"Yardley","year":"2017","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jacc.2023.04.003_bib719","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1111\/ajt.16087","article-title":"Long-term effects of high-intensity training vs moderate intensity training in heart transplant recipients: a 3-year follow-up study of the randomized-controlled HITTS study","volume":"20","author":"Rolid","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jacc.2023.04.003_bib720","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mayocp.2015.12.002","article-title":"Association between early cardiac rehabilitation and long-term survival in cardiac transplant recipients","volume":"91","author":"Rosenbaum","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2023.04.003_bib721","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/heartjnl-2017-312832","article-title":"Cardiac rehabilitation and physical activity: systematic review and meta-analysis","volume":"104","author":"Dibben","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.04.003_bib722","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/01.CIR.0000121360.31954.1F","article-title":"Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial","volume":"109","author":"Hambrecht","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib723","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1177\/2047487314561168","article-title":"Telehealth interventions versus center-based cardiac rehabilitation of coronary artery disease: a systematic review and meta-analysis","volume":"22","author":"Huang","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib724","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/HYPERTENSIONAHA.111.177071","article-title":"Impact of resistance training on blood pressure and other cardiovascular risk factors: a meta-analysis of randomized, controlled trials","volume":"58","author":"Cornelissen","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2023.04.003_bib725","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.754794","article-title":"Efficacy and safety of resistance training for coronary heart disease rehabilitation: a systematic review of randomized controlled trials","volume":"8","author":"Fan","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib726","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/1741826710393197","article-title":"Effect of combined aerobic and resistance training versus aerobic training alone in individuals with coronary artery disease: a meta-analysis","volume":"19","author":"Marzolini","year":"2012","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib727","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12966-020-01007-5","article-title":"Dose-response relationship between physical activity and mortality in adults with noncommunicable diseases: a systematic review and meta-analysis of prospective observational studies","volume":"17","author":"Geidl","year":"2020","journal-title":"Int J Behav Nutr Phys Act"},{"key":"10.1016\/j.jacc.2023.04.003_bib728","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12966-020-00978-9","article-title":"Systematic review of the prospective association of daily step counts with risk of mortality, cardiovascular disease, and dysglycemia","volume":"17","author":"Hall","year":"2020","journal-title":"Int J Behav Nutr Phys Act"},{"key":"10.1016\/j.jacc.2023.04.003_bib729","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106593","article-title":"Lifestyle interventions to reduce sedentary behaviour in clinical populations: a systematic review and meta-analysis of different strategies and effects on cardiometabolic health","volume":"148","author":"Nieste","year":"2021","journal-title":"Prev Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib730","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/dom.13016","article-title":"Breaking up sedentary time with seated upper body activity can regulate metabolic health in obese high-risk adults: a randomized crossover trial","volume":"19","author":"McCarthy","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jacc.2023.04.003_bib731","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/gerona\/gly252","article-title":"Metabolic effects of breaking prolonged sitting with standing or light walking in older South Asians and White Europeans: a randomized acute study","volume":"75","author":"Yates","year":"2020","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jacc.2023.04.003_bib732","doi-asserted-by":"crossref","first-page":"e705","DOI":"10.1161\/CIR.0000000000000749","article-title":"Exercise-related acute cardiovascular events and potential deleterious adaptations following long-term exercise training: placing the risks into perspective-an update: a scientific statement from the American Heart Association","volume":"141","author":"Franklin","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib733","first-page":"CD001800","article-title":"Exercise-based cardiac rehabilitation for coronary heart disease","volume":"11","author":"Dibben","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib734","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177658","article-title":"The effectiveness of modern cardiac rehabilitation: a systematic review of recent observational studies in non-attenders versus attenders","volume":"12","author":"Sumner","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2023.04.003_bib735","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijcard.2018.02.076","article-title":"High intensity interval training versus moderate intensity continuous training on exercise capacity and quality of life in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis","volume":"261","author":"Gomes Neto","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib736","article-title":"High-intensity interval training for patients with cardiovascular disease-is it safe? a systematic review","volume":"7","author":"Wewege","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.04.003_bib737","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1001\/jama.2018.14854","article-title":"The physical activity guidelines for Americans","volume":"320","author":"Piercy","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib738","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ijcard.2016.12.076","article-title":"Implementing resistance training in the rehabilitation of coronary heart disease: a systematic review and meta-analysis","volume":"230","author":"Xanthos","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib739","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1177\/2047487319850718","article-title":"The association of resistance training with mortality: a systematic review and meta-analysis","volume":"26","author":"Saeidifard","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib740","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/bjsports-2012-092038","article-title":"The importance of non-exercise physical activity for cardiovascular health and longevity","volume":"48","author":"Ekblom-Bak","year":"2014","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib741","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3389\/fphys.2017.00318","article-title":"An under-the-table leg-movement apparatus and changes in energy expenditure","volume":"8","author":"Koepp","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib742","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1080\/02640414.2019.1592800","article-title":"Dynamic sitting: measurement and associations with metabolic health","volume":"37","author":"van der Berg","year":"2019","journal-title":"J\u00a0Sports Sci"},{"key":"10.1016\/j.jacc.2023.04.003_bib743","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1186\/s12889-021-10965-9","article-title":"Daily stair climbing is associated with decreased risk for the metabolic syndrome","volume":"21","author":"Whittaker","year":"2021","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jacc.2023.04.003_bib744","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.jacc.2019.02.031","article-title":"Sitting time, physical activity, and risk of mortality in adults","volume":"73","author":"Stamatakis","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib745","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1479-5868-11-13","article-title":"Total sitting time and risk of myocardial infarction, coronary heart disease and all-cause mortality in a prospective cohort of Danish adults","volume":"11","author":"Bjork Petersen","year":"2014","journal-title":"Int J Behav Nutr Phys Act"},{"key":"10.1016\/j.jacc.2023.04.003_bib746","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12966-020-01020-8","article-title":"The effects of step-count monitoring interventions on physical activity: systematic review and meta-analysis of community-based randomised controlled trials in adults","volume":"17","author":"Chaudhry","year":"2020","journal-title":"Int J Behav Nutr Phys Act"},{"key":"10.1016\/j.jacc.2023.04.003_bib747","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.envres.2015.10.026","article-title":"Association between satellite-based estimates of long-term PM2.5 exposure and coronary artery disease","volume":"145","author":"McGuinn","year":"2016","journal-title":"Environ Res"},{"key":"10.1016\/j.jacc.2023.04.003_bib748","doi-asserted-by":"crossref","first-page":"6812","DOI":"10.1021\/acs.est.9b06663","article-title":"Long-term effects of high exposure to ambient fine particulate matter on coronary heart disease incidence: a population-based Chinese cohort study","volume":"54","author":"Li","year":"2020","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.jacc.2023.04.003_bib749","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/eurheartj\/ehl162","article-title":"Impact of urban atmospheric pollution on coronary disease","volume":"27","author":"Maitre","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib750","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0140-6736(16)00378-0","article-title":"Association between air pollution and coronary artery calcification within six metropolitan areas in the USA (the Multi-Ethnic Study of Atherosclerosis and Air Pollution): a longitudinal cohort study","volume":"388","author":"Kaufman","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib751","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(19)32008-2","article-title":"Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study","volume":"395","author":"Yusuf","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib752","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJMoa1817364","article-title":"Ambient particulate air pollution and daily mortality in 652 cities","volume":"381","author":"Liu","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib753","doi-asserted-by":"crossref","first-page":"h1295","DOI":"10.1136\/bmj.h1295","article-title":"Short term exposure to air pollution and stroke: systematic review and meta-analysis","volume":"350","author":"Shah","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.04.003_bib754","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2019.108610","article-title":"Cardiorespiratory effects of heatwaves: a systematic review and meta-analysis of global epidemiological evidence","volume":"177","author":"Cheng","year":"2019","journal-title":"Environ Res"},{"key":"10.1016\/j.jacc.2023.04.003_bib755","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243665","article-title":"Heatwaves, medications, and heat-related hospitalization in older Medicare beneficiaries with chronic conditions","volume":"15","author":"Layton","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2023.04.003_bib756","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2021.147958","article-title":"The role of extreme temperature in cause-specific acute cardiovascular mortality in Switzerland: a case-crossover study","volume":"790","author":"Saucy","year":"2021","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jacc.2023.04.003_bib757","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.scitotenv.2017.12.086","article-title":"Wildland fire smoke and human health","volume":"624","author":"Cascio","year":"2018","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jacc.2023.04.003_bib758","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1289\/ehp.1409277","article-title":"Critical review of health impacts of wildfire smoke exposure","volume":"124","author":"Reid","year":"2016","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.jacc.2023.04.003_bib759","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s40572-017-0150-3","article-title":"The urban heat island: implications for health in a changing environment","volume":"4","author":"Heaviside","year":"2017","journal-title":"Curr Environ Health Rep"},{"key":"10.1016\/j.jacc.2023.04.003_bib760","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMp2000331","article-title":"The climate crisis and clinical practice","volume":"382","author":"Salas","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib761","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019160","article-title":"Longitudinal study of occupational noise exposure and joint effects with job strain and risk for coronary heart disease and stroke in Swedish men","volume":"8","author":"Eriksson","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacc.2023.04.003_bib762","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.envres.2015.02.023","article-title":"The relationship between transportation noise exposure and ischemic heart disease: a meta-analysis","volume":"138","author":"Vienneau","year":"2015","journal-title":"Environ Res"},{"key":"10.1016\/j.jacc.2023.04.003_bib763","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1038\/s41467-021-23972-6","article-title":"Publisher correction: disproportionate exposure to urban heat island intensity across major US cities","volume":"12","author":"Hsu","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacc.2023.04.003_bib764","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.jacc.2020.12.003","article-title":"Taking a stand against air pollution-the impact on cardiovascular disease: a joint opinion from the World Heart Federation, American College of Cardiology, American Heart Association, and the European Society of Cardiology","volume":"77","author":"Brauer","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib765","doi-asserted-by":"crossref","first-page":"e411","DOI":"10.1161\/CIR.0000000000000931","article-title":"Personal-level protective actions against particulate matter air pollution exposure: a scientific statement from the American Heart Association","volume":"142","author":"Rajagopalan","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib766","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/01.ede.0000165817.40152.85","article-title":"A\u00a0meta-analysis of time-series studies of ozone and mortality with comparison to the national morbidity, mortality, and air pollution study","volume":"16","author":"Bell","year":"2005","journal-title":"Epidemiology"},{"key":"10.1016\/j.jacc.2023.04.003_bib768","series-title":"Data from: National Environmental Public Health Tracking Network. Chronic conditions and wildfire smoke","year":"2022"},{"key":"10.1016\/j.jacc.2023.04.003_bib769","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.04.003_bib770","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib771","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMoa2102137","article-title":"Comparative effectiveness of aspirin dosing in cardiovascular disease","volume":"384","author":"Jones","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib772","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/S0140-6736(15)60263-X","article-title":"Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials","volume":"385","author":"Palmerini","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib773","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.jacc.2014.09.008","article-title":"Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial","volume":"64","author":"Colombo","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib774","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/CIRCULATIONAHA.111.059022","article-title":"Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience\/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study","volume":"125","author":"Gwon","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib775","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/eurheartj\/ehu523","article-title":"ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting","volume":"36","author":"Schulz-Sch\u00fcpke","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib776","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1161\/CIRCULATIONAHA.120.046308","article-title":"Dual antiplatelet therapy after percutaneous coronary intervention and drug-eluting stents: a systematic review and network meta-analysis","volume":"142","author":"Khan","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib777","first-page":"1034","article-title":"Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients","volume":"38","author":"Palmerini","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib778","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/CIRCULATIONAHA.120.046251","article-title":"The safety and efficacy of aspirin discontinuation on a background of a P2Y(12) inhibitor in patients after percutaneous coronary intervention: a systematic review and meta-analysis","volume":"142","author":"O'Donoghue","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib779","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jacc.2012.06.043","article-title":"A\u00a0new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)","volume":"60","author":"Kim","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib780","first-page":"2510","article-title":"Three vs Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting Stents: The OPTIMIZE Randomized Trial","volume":"310","author":"Feres","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib781","first-page":"390","article-title":"Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials","volume":"37","author":"Udell","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib782","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib783","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1056\/NEJMoa1200933","article-title":"Vorapaxar in the secondary prevention of atherothrombotic events","volume":"366","author":"Morrow","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib784","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0140-6736(12)61269-0","article-title":"Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2\u00b0P-TIMI 50 trial","volume":"380","author":"Scirica","year":"2012","journal-title":"The Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib785","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1161\/CIRCULATIONAHA.114.015042","article-title":"Efficacy and safety of vorapaxar with and without a thienopyridine for secondary prevention in patients with previous myocardial infarction and no history of stroke or transient ischemic attack: results from TRA 2\u00b0P-TIMI 50","volume":"132","author":"Bohula","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib786","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijcard.2018.07.083","article-title":"Dual versus single antiplatelet therapy after coronary artery bypass graft surgery: an updated meta-analysis","volume":"269","author":"Cardoso","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib787","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib788","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.jacc.2014.09.037","article-title":"Coronary stent thrombosis with vorapaxar versus placebo: results from the TRA 2 degrees P-TIMI 50 trial","volume":"64","author":"Bonaca","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib789","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib790","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials","volume":"382","author":"Bhala","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib791","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/jamacardio.2019.6175","article-title":"Optimal antithrombotic regimens for patients with atrial fibrillation undergoing percutaneous coronary intervention: an updated network meta-analysis","volume":"5","author":"Lopes","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib792","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.120.050304","article-title":"Initial invasive versus conservative management of stable ischemic heart disease in patients with a history of heart failure or left ventricular dysfunction: insights from the ISCHEMIA trial","volume":"142","author":"Lopes","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib793","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1161\/CIRCULATIONAHA.119.044584","article-title":"Stent thrombosis in patients with atrial fibrillation undergoing coronary stenting in the AUGUSTUS trial","volume":"141","author":"Lopes","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib794","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJMoa1904143","article-title":"Antithrombotic therapy for atrial fibrillation with stable coronary disease","volume":"381","author":"Yasuda","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib795","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","author":"Gibson","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib796","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/europace\/euz259","volume":"22","author":"Potpara","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.04.003_bib797","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jacc.2020.09.011","volume":"77","author":"Kumbhani","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib798","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1161\/CIRCULATIONAHA.120.046448","article-title":"Role of combination antiplatelet and anticoagulation therapy in diabetes mellitus and cardiovascular disease: insights from the COMPASS trial","volume":"141","author":"Bhatt","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib799","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/CIRCULATIONAHA.120.046048","article-title":"The COMPASS trial: net clinical benefit of low-dose rivaroxaban plus aspirin as compared with aspirin in patients with chronic vascular disease","volume":"142","author":"Steffel","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib800","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib801","article-title":"Clinical outcomes of concomitant use of proton pump inhibitors and dual antiplatelet therapy: a systematic review and meta-analysis","volume":"12","author":"Guo","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jacc.2023.04.003_bib802","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jacc.2016.03.513","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"68","author":"Levine","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib803","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib804","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","article-title":"Effect of\u00a0aspirin on cardiovascular events and bleeding in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib805","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0140-6736(18)31924-X","article-title":"Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial","volume":"392","author":"Gaziano","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib806","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1112277","article-title":"Rivaroxaban in patients with a recent acute coronary syndrome","volume":"366","author":"Mega","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib807","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1817083","article-title":"Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation","volume":"380","author":"Lopes","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib808","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1093\/eurheartj\/ehr113","article-title":"Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial","volume":"32","author":"Oldgren","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib809","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1105819","article-title":"Apixaban with antiplatelet therapy after acute coronary syndrome","volume":"365","author":"Alexander","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib810","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1001\/jamacardio.2017.5306","article-title":"Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: a systematic review and meta-analysis","volume":"3","author":"Chiarito","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib811","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.2147\/DDDT.S166544","article-title":"Effect and safety of antithrombotic therapies for secondary prevention after acute coronary syndrome: a network meta-analysis","volume":"12","author":"Mo","year":"2018","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.jacc.2023.04.003_bib812","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/eurheartj\/ehz871","article-title":"Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) atrial fibrillation working group","volume":"41","author":"Seligman","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib813","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"C. Antithrombotic","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.04.003_bib814","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/S0140-6736(21)01063-1","article-title":"Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial","volume":"397","author":"Koo","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib815","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1001\/jama.2019.8145","article-title":"Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial","volume":"321","author":"Watanabe","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib816","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1001\/jama.2020.7580","article-title":"Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleeding and cardiovascular events in patients with acute coronary syndrome: the TICO randomized clinical trial","volume":"323","author":"Kim","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib817","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(20)31791-8","article-title":"Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial","volume":"396","author":"Kim","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib818","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1908419","article-title":"Ticagrelor with or without aspirin in high-risk patients after PCI","volume":"381","author":"Mehran","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib819","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0140-6736(18)31858-0","volume":"392","author":"Vranckx","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib820","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1001\/jama.2019.8146","article-title":"Effect of P2Y12 inhibitor monotherapy vs dual antiplatelet therapy on cardiovascular events in patients undergoing percutaneous coronary intervention: the SMART-CHOICE randomized clinical trial","volume":"321","author":"Hahn","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib821","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/HCO.0000000000000333","article-title":"How long should dual antiplatelet therapy be used in diabetic patients after implantation of drug-eluting stents?","volume":"31","author":"Bittl","year":"2016","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib822","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11886-015-0683-8","article-title":"The Tradeoff Between Shorter and Longer Courses of Dual Antiplatelet Therapy After Implantation of Newer Generation Drug-Eluting Stents","volume":"18","author":"Bittl","year":"2016","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jacc.2023.04.003_bib823","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jacc.2016.03.512","volume":"68","author":"Bittl","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib824","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/00015385.2017.1305189","article-title":"Duration of dual anti-platelet therapy - State of the art after the DAPT and PEGASUS-TIMI 54 trials","volume":"72","author":"Pirlet","year":"2017","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib825","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/j.1538-7836.2012.04869.x","article-title":"Safety and efficacy of protease-activated receptor-1 antagonists in patients with coronary artery disease: a meta-analysis of randomized clinical trials","volume":"10","author":"Capodanno","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jacc.2023.04.003_bib826","first-page":"86","article-title":"Pharmaceutical approval update","volume":"34","author":"Goldenberg","year":"2009","journal-title":"P\u00a0T"},{"key":"10.1016\/j.jacc.2023.04.003_bib827","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamacardio.2019.1880","article-title":"Safety and efficacy of antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: a network meta-analysis of randomized controlled trials","volume":"4","author":"Lopes","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib828","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008349","article-title":"Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention: A Subgroup Analysis From the REDUAL PCI Trial","volume":"13","author":"Berry","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2023.04.003_bib829","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/CIRCULATIONAHA.120.050438","article-title":"Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention: a North American perspective: 2021 update","volume":"143","author":"Angiolillo","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib830","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.jcin.2021.04.043","article-title":"Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI","volume":"14","author":"Angiolillo","year":"2021","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2023.04.003_bib831","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1161\/CIRCULATIONAHA.120.046534","article-title":"Risk\/benefit tradeoff of antithrombotic therapy in patients with atrial fibrillation early and late after an acute coronary syndrome or percutaneous coronary intervention: Insights From AUGUSTUS","volume":"141","author":"Alexander","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib832","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/CIRCULATIONAHA.113.004834","article-title":"Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant","volume":"129","author":"Lamberts","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib833","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/clc.22750","article-title":"Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: association with ischemic and bleeding events","volume":"40","author":"Lemesle","year":"2017","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib834","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/CIRCULATIONAHA.119.044598","article-title":"Rivaroxaban plus aspirin versus aspirin alone in patients with prior percutaneous coronary intervention (COMPASS-PCI)","volume":"140","author":"Bainey","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib835","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa020496","article-title":"Warfarin, aspirin, or both after myocardial infarction","volume":"347","author":"Hurlen","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib836","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.jcin.2021.07.045","article-title":"Rivaroxaban monotherapy in patients with atrial fibrillation after coronary stenting: insights from the AFIRE trial","volume":"14","author":"Matoba","year":"2021","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2023.04.003_bib837","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jacc.2014.07.957","article-title":"Incidence, source, determinants, and prognostic impact of major bleeding in outpatients with stable coronary artery disease","volume":"64","author":"Hamon","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib838","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib839","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jacc.2021.10.028","article-title":"Magnetically-controlled capsule endoscopy for assessment of antiplatelet therapy-induced gastrointestinal injury","volume":"79","author":"Han","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib840","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib841","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/ehjcvp\/pvaa029","article-title":"Effect of beta-blocker therapy in patients with or without left ventricular systolic dysfunction after acute myocardial infarction","volume":"7","author":"Joo","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jacc.2023.04.003_bib842","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","article-title":"Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study","volume":"106","author":"Packer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib843","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib844","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/01.CIR.92.2.212","article-title":"Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease","volume":"92","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib845","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1056\/NEJM200105313442202","article-title":"A\u00a0trial of the beta-blocker bucindolol in patients with advanced chronic heart failure","volume":"344","author":"Eichhorn","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib846","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial","volume":"362","author":"Poole-Wilson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib847","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1067\/mhj.2002.120768","article-title":"Bisoprolol for the treatment of chronic heart failure: a meta-analysis on individual data of two placebo-controlled studies--CIBIS and CIBIS II. Cardiac Insufficiency Bisoprolol Study","volume":"143","author":"Leizorovicz","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib848","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.amjmed.2014.05.032","article-title":"Clinical outcomes with beta-blockers for myocardial infarction: a meta-analysis of randomized trials","volume":"127","author":"Bangalore","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib849","article-title":"One-year landmark analysis of the effect of beta-blocker dose on survival after acute myocardial infarction","volume":"10","author":"Goldberger","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.04.003_bib850","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1093\/eurheartj\/ehaa376","article-title":"Long-term beta-blocker therapy and clinical outcomes after acute myocardial infarction in patients without heart failure: nationwide cohort study","volume":"41","author":"Kim","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib851","first-page":"585","article-title":"Prognostic benefit of beta-blockers after acute coronary syndrome with preserved systolic function. Still relevant today?","volume":"68","author":"Raposeiras-Roubin","year":"2015","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.jacc.2023.04.003_bib852","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.jacc.2017.03.578","article-title":"Beta-blockers and mortality after acute myocardial infarction in patients without heart failure or ventricular dysfunction","volume":"69","author":"Dondo","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib853","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/eurheartj\/ehaa1058","article-title":"Effect of long-term beta-blocker treatment following myocardial infarction among stable, optimally treated patients without heart failure in the reperfusion era: a Danish, nationwide cohort study","volume":"42","author":"Holt","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib854","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.010159","article-title":"Left ventricular ejection fraction 1 year after acute myocardial infarction identifies the benefits of the long-term use of beta-blockers: analysis of data from the KAMIR-NIH registry","volume":"14","author":"Park","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2023.04.003_bib855","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/ehjcvp\/pvy034","article-title":"Effect of oral beta-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis","volume":"5","author":"Dahl Aarvik","year":"2019","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jacc.2023.04.003_bib856","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCOUTCOMES.114.001073","article-title":"Beta-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trial","volume":"7","author":"Bangalore","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.04.003_bib857","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jama.2012.12559","article-title":"Beta-blocker use and clinical outcomes in stable outpatients with and without coronary artery disease","volume":"308","author":"Bangalore","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib858","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jcin.2016.05.048","article-title":"Predictors, trends, and outcomes (among older patients >\/=65 years of age) associated with beta-blocker use in patients with stable angina undergoing elective percutaneous coronary intervention: insights from the NCDR registry","volume":"9","author":"Motivala","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2023.04.003_bib859","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib860","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib861","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0735-1097(96)00489-5","article-title":"Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators","volume":"29","author":"Vantrimpont","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib862","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/clc.4960150808","article-title":"The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group","volume":"15","author":"Boberg","year":"1992","journal-title":"Clin Cardiol"},{"issue":"suppl 1","key":"10.1016\/j.jacc.2023.04.003_bib863","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1023\/A:1007711025487","article-title":"Beta-blocking drugs and coronary heart disease","volume":"11","author":"Goldstein","year":"1997","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacc.2023.04.003_bib864","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group","volume":"334","author":"Packer","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib865","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib866","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/eurheartj\/ehy811","article-title":"Beta-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study","volume":"40","author":"Sorbets","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib867","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib868","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib869","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib870","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1054\/S1071-9164(03)00133-7","article-title":"A\u00a0comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS","volume":"9","author":"Domanski","year":"2003","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2023.04.003_bib871","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","article-title":"Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)","volume":"26","author":"Flather","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib872","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","volume":"60","author":"Fihn","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib873","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.cjca.2020.01.024","article-title":"Clinical Outcomes With Beta-Blocker Use in Patients With Recent History of Myocardial Infarction","volume":"36","author":"Jackevicius","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib874","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","article-title":"Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group","volume":"355","author":"Flather","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib875","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib876","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions","volume":"327","author":"Yusuf","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib877","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"A\u00a0clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group","volume":"333","author":"K\u00f8ber","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib878","first-page":"821","article-title":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib879","doi-asserted-by":"crossref","first-page":"j4","DOI":"10.1136\/bmj.j4","article-title":"Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials","volume":"356","author":"Bangalore","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.04.003_bib880","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1093\/eurheartj\/ehab225","article-title":"Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants","volume":"42","author":"Bosch","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib881","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/jama.292.18.2217","article-title":"Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure. The CAMELOT study: a randomized controlled trial","volume":"292","author":"Nissen","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib882","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)","volume":"362","author":"Fox","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib883","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib884","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/CIRCULATIONAHA.105.592733","article-title":"Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial","volume":"114","author":"Solomon","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib885","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/MCA.0000000000000303","article-title":"CAC score as a possible criterion for administration of angiotensin converting enzyme inhibitors and\/or angiotensin receptor blockers: the MultiEthnic Study of Atherosclerosis","volume":"26","author":"Darabian","year":"2015","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.jacc.2023.04.003_bib886","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0002-9149(01)01461-8","article-title":"The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function","volume":"87","author":"Pitt","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib887","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(08)61242-8","article-title":"Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial","volume":"372","author":"Yusuf","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib888","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.3346\/jkms.2019.34.e289","article-title":"Angiotensin receptor blockers as an alternative to angiotensin-converting enzyme inhibitors in patients with acute myocardial infarction undergoing percutaneous coronary intervention","volume":"34","author":"Lim","year":"2019","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.jacc.2023.04.003_bib889","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1161\/CIR.0000000000000534","article-title":"Cardiovascular health in African Americans: a scientific statement from the American Heart Association","volume":"136","author":"Carnethon","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib890","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jacc.2020.11.022","volume":"77","author":"Maddox","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib891","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib892","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib893","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa042739","article-title":"Angiotensin-converting-enzyme inhibition in stable coronary artery disease","volume":"351","author":"Braunwald","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib894","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/phar.2624","article-title":"Renin-angiotensin-aldosterone system inhibitors and major cardiovascular events and acute kidney injury in patients with coronary artery disease","volume":"41","author":"Sud","year":"2021","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jacc.2023.04.003_bib895","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib896","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib897","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib898","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Anti-inflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib899","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-dose methotrexate for the prevention of atherosclerotic events","volume":"380","author":"Ridker","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib900","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1001\/jama.289.21.2857","volume":"289","author":"Rott","year":"2003","journal-title":"Gout. JAMA"},{"issue":"abstract","key":"10.1016\/j.jacc.2023.04.003_bib901","first-page":"S35","article-title":"A\u00a0new mode of action for an old drug: colchicine decreases surface expression of adhesion molecules on both neutrophils (PMNs) and endothelium [abstract]","volume":"35","author":"Molad","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jacc.2023.04.003_bib902","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib903","first-page":"3227","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib904","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ahj.2022.06.002","article-title":"Select drug-drug interactions with colchicine and cardiovascular medications: a review","volume":"252","author":"Dixon","year":"2022","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib905","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1136\/heartjnl-2015-307691","article-title":"Acute\u00a0myocardial infarction and influenza: a meta-analysis of case-control studies","volume":"101","author":"Barnes","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.04.003_bib906","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.2013.279206","article-title":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis","volume":"310","author":"Udell","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib907","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.tcm.2020.06.003","article-title":"The impact of influenza vaccination in patients with cardiovascular disease: an overview of systematic reviews","volume":"31","author":"Rodrigues","year":"2021","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib908","first-page":"CD005050","article-title":"Influenza vaccines for preventing cardiovascular disease","author":"Clar","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib909","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/heartjnl-2019-315193","article-title":"Influenza vaccination in patients with heart failure: a systematic review and meta-analysis of observational studies","volume":"106","author":"Rodrigues","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.04.003_bib910","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.2020.23649","article-title":"Effect of high-dose trivalent vs standard-dose quadrivalent influenza vaccine on mortality or cardiopulmonary hospitalization in patients with high-risk cardiovascular disease: a randomized clinical trial","volume":"325","author":"Vardeny","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib911","article-title":"Effects of influenza vaccine on mortality and cardiovascular outcomes in patients with cardiovascular disease: a systematic review and meta-analysis","volume":"10","author":"Yedlapati","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.04.003_bib912","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.jacc.2021.02.017","article-title":"ACC health policy statement on cardiovascular disease considerations for COVID-19 vaccine prioritization: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"77","author":"Driggin","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib913","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.2021.24110","article-title":"Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021","volume":"327","author":"Oster","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib914","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.3122\/jabfm.2021.S1.200528","article-title":"Influenza vaccination and hospitalizations among COVID-19 infected adults","volume":"34","author":"Yang","year":"2021","journal-title":"J\u00a0Am Board Fam Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib915","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1136\/heartjnl-2012-301743","article-title":"Pneumococcal vaccination and risk of acute coronary syndromes in patients with pneumonia: population-based cohort study","volume":"98","author":"Eurich","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.04.003_bib916","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ehjqcco\/qcaa030","article-title":"Pneumococcal vaccination in adults at very high risk or with established cardiovascular disease: systematic review and meta-analysis","volume":"7","author":"Marques Antunes","year":"2021","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.jacc.2023.04.003_bib917","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1159\/000519469","article-title":"Associations between combined influenza and pneumococcal pneumonia vaccination and cardiovascular outcomes","volume":"146","author":"Ma","year":"2021","journal-title":"Cardiology"},{"key":"10.1016\/j.jacc.2023.04.003_bib918","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000493572","article-title":"Beneficial effects of vaccination on cardiovascular events: myocardial infarction, stroke, heart failure","volume":"141","author":"Fountoulaki","year":"2018","journal-title":"Cardiology"},{"key":"10.1016\/j.jacc.2023.04.003_bib920","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0002-9149(90)91033-3","article-title":"Double-blind comparison of once daily betaxolol versus propranolol four times daily in stable angina pectoris. Betaxolol Investigators Group","volume":"65","author":"Narahara","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib921","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0002-9149(91)90518-P","article-title":"Comparison of celiprolol and propranolol in stable angina pectoris. Celiprolol International Angina Study Group","volume":"67","author":"Frishman","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib922","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1001\/jama.281.20.1927","article-title":"Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina","volume":"281","author":"Heidenreich","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib923","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/eurheartj\/ehy504","article-title":"Anti-anginal drugs-beliefs and evidence: systematic review covering 50 years of medical treatment","volume":"40","author":"Ferrari","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib924","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1177\/2047487314533217","article-title":"Relative efficacy of antianginal drugs used as add-on therapy in patients with stable angina: a systematic review and meta-analysis","volume":"22","author":"Belsey","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib925","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0735-1097(95)00489-0","article-title":"Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris: results of the International Multicenter Angina Exercise (IMAGE) Study","volume":"27","author":"Savonitto","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib926","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.291.3.309","article-title":"Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial","volume":"291","author":"Chaitman","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib927","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jacc.2006.05.044","article-title":"Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial","volume":"48","author":"Stone","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib928","first-page":"293","article-title":"Chronic stable angina","volume":"375","author":"Ohman","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib929","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF00266360","article-title":"A\u00a0large scale comparative study in general practice with nitroglycerin spray and tablet formulations in elderly patients with angina pectoris","volume":"42","author":"Wight","year":"1992","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2023.04.003_bib930","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa1406430","article-title":"Ivabradine in stable coronary artery disease without clinical heart failure","volume":"371","author":"Fox","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib931","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","volume":"60","author":"Fihn","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib932","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1916370","article-title":"Health-status outcomes with invasive or conservative care in coronary disease","volume":"382","author":"Spertus","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib933","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0002-9149(83)80119-2","article-title":"Nifedipine in chronic stable angina: a double-blind placebo-controlled crossover trial","volume":"51","author":"Sherman","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib934","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0002-8703(89)90845-4","article-title":"A\u00a0four-week double-blind, placebo-controlled, parallel dose-response study of amlodipine in patients with stable exertional angina pectoris","volume":"118","author":"Taylor","year":"1989","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib935","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijcard.2010.05.019","article-title":"Nitrates for stable angina: a systematic review and meta-analysis of randomized clinical trials","volume":"146","author":"Wei","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib936","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/01.CIR.83.1.52","article-title":"Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group","volume":"83","author":"Goldstein","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib937","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/eurheartj\/ehi586","article-title":"Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina","volume":"26","author":"Tardif","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib938","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2165\/00003495-200767030-00005","article-title":"Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial","volume":"67","author":"Ruzyllo","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.jacc.2023.04.003_bib939","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0735-1097(99)00140-0","article-title":"The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes","volume":"33","author":"Arora","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib940","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","volume":"60","author":"Fihn","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib941","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/eurheartj\/ehaa820","article-title":"Management of refractory angina: an update","volume":"42","author":"Davies","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib942","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib943","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/jcpt.13330","article-title":"Enhanced external counterpulsation: a unique treatment for the \"no-option\" refractory angina patient","volume":"46","author":"Caceres","year":"2021","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.jacc.2023.04.003_bib944","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.jacc.2005.06.079","article-title":"A\u00a0blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease","volume":"46","author":"Leon","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib945","first-page":"CD003712","article-title":"Transmyocardial laser revascularization versus medical therapy for refractory angina","volume":"2015","author":"Briones","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib946","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.jacc.2014.07.017","volume":"64","author":"Fihn","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib947","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.jacc.2016.02.066","article-title":"Heavy metals, cardiovascular disease, and the unexpected benefits of chelation therapy","volume":"67","author":"Lamas","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib948","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2796.1992.tb00533.x","article-title":"EDTA treatment of intermittent claudication--a double-blind, placebo-controlled study","volume":"231","author":"Guldager","year":"1992","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib949","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/01.CIR.90.3.1194","article-title":"Chelation therapy for intermittent claudication. A double-blind, randomized, controlled trial","volume":"90","author":"van Rij","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib950","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0002-9610(91)90172-A","article-title":"Arteriographic findings in EDTA chelation therapy on peripheral arteriosclerosis","volume":"162","author":"Sloth-Nielsen","year":"1991","journal-title":"Am J Surg"},{"key":"10.1016\/j.jacc.2023.04.003_bib951","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jama.287.4.481","article-title":"Chelation therapy for ischemic heart disease: a randomized controlled trial","volume":"287","author":"Knudtson","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib952","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/jama.2013.2107","article-title":"Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial","volume":"309","author":"Lamas","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib953","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/CIRCOUTCOMES.113.000663","article-title":"The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT)","volume":"7","author":"Escolar","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.04.003_bib954","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2022.05.013","article-title":"The Trial to Assess Chelation Therapy 2 (TACT2): Rationale and design","volume":"252","author":"Lamas","year":"2022","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib955","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1916370","article-title":"Health-status outcomes with invasive or conservative care in coronary disease","volume":"382","author":"Spertus","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib956","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJMoa1803538","article-title":"Five-year outcomes with PCI guided by fractional flow reserve","volume":"379","author":"Xaplanteris","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib957","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1016\/j.jacc.2017.10.036","article-title":"Quality-of-life after everolimus-eluting stents or bypass surgery for left-main disease: results from the EXCEL trial","volume":"70","author":"Baron","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib958","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/jama.2013.279208","article-title":"Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial","volume":"310","author":"Abdallah","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib959","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/CIRCULATIONAHA.109.912642","article-title":"Health status after treatment for coronary artery disease and type 2 diabetes mellitus in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial","volume":"122","author":"Brooks","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib960","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/CIRCOUTCOMES.113.000139","article-title":"Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial","volume":"6","author":"Spertus","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.04.003_bib961","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1161\/CIRCULATIONAHA.119.042918","article-title":"Dobutamine stress echocardiography ischemia as a predictor of the placebo-controlled efficacy of percutaneous coronary intervention in stable coronary artery disease: the stress echocardiography-stratified analysis of ORBITA","volume":"140","author":"Al-Lamee","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib962","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(94)91963-1","article-title":"Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration","volume":"344","author":"Yusuf","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib963","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0002-9149(81)90156-9","article-title":"Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease: report of the Collaborative Study in Coronary Artery Surgery (CASS)","volume":"48","author":"Chaitman","year":"1981","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib964","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib965","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMoa1602001","article-title":"Coronary-artery bypass surgery in patients with ischemic cardiomyopathy","volume":"374","author":"Velazquez","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib966","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/CIRCULATIONAHA.121.056276","article-title":"Cost-effectiveness of coronary artery bypass surgery versus medicine in ischemic cardiomyopathy: the STICH randomized clinical trial","volume":"145","author":"Chew","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib967","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib968","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/CIRCULATIONAHA.109.911669","article-title":"Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease","volume":"122","author":"Hueb","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib969","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1093\/eurheartj\/ehab246","article-title":"Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis","volume":"42","author":"Navarese","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib970","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/CIRCULATIONAHA.120.047987","article-title":"Myocardial infarction in the ISCHEMIA trial: impact of different definitions on incidence, prognosis, and treatment comparisons","volume":"143","author":"Chaitman","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib971","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1056\/NEJMoa1408758","article-title":"Fractional flow reserve-guided PCI for stable coronary artery disease","volume":"371","author":"De Bruyne","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib972","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease","volume":"367","author":"De Bruyne","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib973","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijcard.2020.10.016","article-title":"Revascularization versus medical therapy for the treatment of stable coronary artery disease: a meta-analysis of contemporary randomized controlled trials","volume":"324","author":"Laukkanen","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib974","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/clc.23592","article-title":"Invasive therapy versus conservative therapy for patients with stable coronary artery disease: an updated meta-analysis","volume":"44","author":"Vij","year":"2021","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib975","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1161\/CIRCULATIONAHA.112.000646","article-title":"Bayesian methods affirm the use of percutaneous coronary intervention to improve survival in patients with unprotected left main coronary artery disease","volume":"127","author":"Bittl","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib976","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1700445","article-title":"Use of the instantaneous wave-free ratio or fractional flow reserve in PCI","volume":"376","author":"Davies","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib977","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa0807611","article-title":"Fractional flow reserve versus angiography for guiding percutaneous coronary intervention","volume":"360","author":"Tonino","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib978","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/CIRCULATIONAHA.117.031907","volume":"137","author":"Fearon","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib979","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.109.925396","article-title":"Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease","volume":"122","author":"Fearon","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib980","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1001\/jamasurg.2014.2059","article-title":"Safety and efficacy of implementing a multidisciplinary heart team approach for revascularization in patients with complex coronary artery disease: an observational cohort pilot study","volume":"149","author":"Chu","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jacc.2023.04.003_bib981","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJMoa0804626","article-title":"Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease","volume":"360","author":"Serruys","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib982","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijcard.2016.01.041","article-title":"Implementation and consistency of Heart Team decision-making in complex coronary revascularisation","volume":"206","author":"Pavlidis","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib983","doi-asserted-by":"crossref","first-page":"E103","DOI":"10.1002\/ccd.26276","article-title":"Revascularization heart team recommendations as an adjunct to appropriate use criteria for coronary revascularization in patients with complex coronary artery disease","volume":"88","author":"Sanchez","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2023.04.003_bib984","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib985","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease","volume":"367","author":"De Bruyne","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib986","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa1915925","article-title":"Management of coronary disease in patients with advanced kidney disease","volume":"382","author":"Bangalore","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib987","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/CIRCULATIONAHA.120.048194","article-title":"Routine revascularization versus initial medical therapy for stable ischemic heart disease: a systematic review and meta-analysis of randomized trials","volume":"142","author":"Bangalore","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib988","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1161\/CIRCULATIONAHA.118.035263","article-title":"Fractional flow reserve and quality-of-life improvement after percutaneous coronary intervention in patients with stable coronary artery disease","volume":"138","author":"Nishi","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib989","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/CIRCULATIONAHA.122.062714","article-title":"Survival after invasive or conservative management of stable coronary disease","volume":"147","author":"Hochman","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib990","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1016\/j.jacc.2017.04.050","article-title":"PCI volume benchmarks: still adequate for quality assessment in 2017?","volume":"69","author":"Kumbhani","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib991","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1056\/NEJMoa2112299","article-title":"Fractional flow reserve-guided PCI as compared with coronary bypass surgery","volume":"386","author":"Fearon","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib992","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003255","article-title":"Survival benefits of invasive versus conservative strategies in heart failure in patients with reduced ejection fraction and coronary artery disease: a meta-analysis","volume":"10","author":"Wolff","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2023.04.003_bib993","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","article-title":"Percutaneous revascularization for ischemic left ventricular dysfunction","volume":"387","author":"Perera","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib994","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/CIRCULATIONAHA.120.049755","article-title":"Outcomes in the ISCHEMIA trial based on coronary artery disease and ischemia severity","volume":"144","author":"Reynolds","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib995","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ahj.2022.01.017","article-title":"Causes of cardiovascular and noncardiovascular death in the ISCHEMIA trial","volume":"248","author":"Sidhu","year":"2022","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib996","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/S0140-6736(16)32052-9","article-title":"Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial","volume":"388","author":"M\u00e4kikallio","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib997","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1056\/NEJMoa1610227","article-title":"Everolimus-eluting stents or bypass surgery for left main coronary artery disease","volume":"375","author":"Stone","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib998","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1100452","article-title":"Randomized trial of stents versus bypass surgery for left main coronary artery disease","volume":"364","author":"Park","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib999","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1161\/CIRCULATIONAHA.109.899211","volume":"121","author":"Morice","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1000","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1161\/CIRCULATIONAHA.113.006689","article-title":"Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial","volume":"129","author":"Morice","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1001","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0140-6736(19)32972-1","article-title":"Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial","volume":"395","author":"Holm","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib1002","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ahj.2020.06.001","article-title":"Percutaneous coronary intervention or coronary artery bypass graft surgery for left main coronary artery disease: a meta-analysis of randomized trials","volume":"227","author":"Kuno","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib1003","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1161\/CIRCULATIONAHA.120.046039","article-title":"Ten-year outcomes after drug-eluting stents versus coronary artery bypass grafting for left main coronary disease: extended follow-up of the PRECOMBAT trial","volume":"141","author":"Park","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1004","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1093\/eurheartj\/ehaa135","article-title":"Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials","volume":"41","author":"Ahmad","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib1005","article-title":"Percutaneous coronary intervention versus coronary artery bypass graft for left main coronary artery disease: a meta-analysis","author":"Gallo","year":"2020","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2023.04.003_bib1006","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jacc.2016.05.089","article-title":"Left main coronary artery disease: secular trends in patient characteristics, treatments, and outcomes","volume":"68","author":"Lee","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1007","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.jacc.2017.09.1066","article-title":"Double Kissing Crush Versus Provisional Stenting for Left Main Distal Bifurcation Lesions: DKCRUSH-V Randomized Trial","volume":"70","author":"Chen","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1008","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jcin.2015.05.017","article-title":"Clinical outcome after DK crush versus culotte stenting of distal left main bifurcation lesions: the 3-year follow-up results of the DKCRUSH-III study","volume":"8","author":"Chen","year":"2015","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2023.04.003_bib1009","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/CIRCINTERVENTIONS.108.799494","article-title":"Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis","volume":"2","author":"Park","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2023.04.003_bib1010","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1616540","article-title":"Instantaneous wave-free ratio versus fractional flow reserve to guide PCI","volume":"376","author":"G\u00f6tberg","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1011","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.jacc.2007.01.087","article-title":"Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study","volume":"49","author":"Pijls","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1012","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jcin.2018.05.029","article-title":"Safety of the deferral of coronary revascularization on the basis of instantaneous wave-free ratio and fractional flow reserve measurements in stable coronary artery disease and acute coronary syndromes","volume":"11","author":"Escaned","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2023.04.003_bib1013","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ccd.28428","article-title":"Clinical relevance of ticagrelor monotherapy following 1-month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trial","volume":"96","author":"Kogame","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2023.04.003_bib1014","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/CIRCULATIONAHA.117.031907","volume":"137","author":"Fearon","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijcard.2021.09.054","article-title":"Instantaneous wave-free ratio compared with fractional flow reserve in PCI: a cost-minimization analysis","volume":"344","author":"Berntorp","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1017","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(13)60141-5","article-title":"Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial","volume":"381","author":"Mohr","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib1018","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1161\/CIRCULATIONAHA.113.006689","article-title":"Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial","volume":"129","author":"Morice","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1019","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJMoa0804626","article-title":"Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease","volume":"360","author":"Serruys","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1020","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0140-6736(19)31997-X","article-title":"Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial","volume":"394","author":"Thuijs","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib1021","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(18)30423-9","article-title":"Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data","volume":"391","author":"Head","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib1022","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1056\/NEJMoa2112299","article-title":"Fractional flow reserve-guided PCI as compared with coronary bypass surgery","volume":"386","author":"Fearon","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1023","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1161\/CIRCULATIONAHA.121.057021","article-title":"Effect of patient-reported pre-procedural physical and mental health on 10-year mortality after percutaneous or surgical coronary revascularization","volume":"146","author":"Ono","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1024","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jcin.2012.02.013","article-title":"Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries","volume":"5","author":"Head","year":"2012","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2023.04.003_bib1025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.carrev.2022.01.008","article-title":"The Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients With Multivessel or Left Main Coronary Artery Disease (OPTIMUM) registry: rationale and design","volume":"41","author":"Salisbury","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1026","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","article-title":"Strategies for multivessel revascularization in patients with diabetes","volume":"367","author":"Farkouh","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1027","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jacc.2018.11.001","article-title":"Long-term survival following multivessel revascularization in patients with diabetes: the FREEDOM follow-on study","volume":"73","author":"Farkouh","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1028","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jacc.2012.11.044","article-title":"Percutaneous coronary intervention versus coronary bypass surgery in United States veterans with diabetes","volume":"61","author":"Kamalesh","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1029","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/ejcts\/ezt017","article-title":"Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial","volume":"43","author":"Kappetein","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jacc.2023.04.003_bib1030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S2213-8587(13)70089-5","article-title":"Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials","volume":"1","author":"Verma","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1031","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1056\/NEJMoa1415447","article-title":"Trial of everolimus-eluting stents or bypass surgery for coronary disease","volume":"372","author":"Park","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1032","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/CIRCINTERVENTIONS.112.969915","article-title":"Long-term outcome of stents versus bypass surgery in diabetic and nondiabetic patients with multivessel or left main coronary artery disease: a pooled analysis of 5775 individual patient data","volume":"5","author":"Park","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2023.04.003_bib1033","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jacc.2016.06.021","article-title":"Medical treatment and revascularization options in patients with type 2 diabetes and coronary disease","volume":"68","author":"Mancini","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1034","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.jacc.2019.01.037","article-title":"Bypass surgery or stenting for left main coronary artery disease in patients with diabetes","volume":"73","author":"Milojevic","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1035","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1036","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jacc.2018.11.053","article-title":"PCI and CABG for treating stable coronary artery disease: JACC review topic of the week","volume":"73","author":"Doenst","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1037","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/S0140-6736(16)32052-9","article-title":"Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial","volume":"388","author":"M\u00e4kikallio","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib1038","article-title":"Percutaneous coronary intervention versus coronary artery bypass graft for left main coronary artery disease: a meta-analysis","author":"Gallo","year":"2020","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2023.04.003_bib1039","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/CIRCULATIONAHA.109.911669","article-title":"Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease","volume":"122","author":"Hueb","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1040","first-page":"667","article-title":"Twelve versus 30 month dual antiplatelet therapy after percutaneous coronary intervention using national health insurance review & assessment (HIRA) database","volume":"37","author":"Lee","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib1041","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1001\/jamainternmed.2020.4748","article-title":"Overall and cause-specific mortality in randomized clinical trials comparing percutaneous interventions with coronary bypass surgery: a meta-analysis","volume":"180","author":"Gaudino","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1042","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jacc.2016.06.024","article-title":"Outcomes after percutaneous coronary intervention or bypass surgery in patients with unprotected left main disease","volume":"68","author":"Cavalcante","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1043","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1056\/NEJMoa1610227","article-title":"Everolimus-eluting stents or bypass surgery for left main coronary artery disease","volume":"375","author":"Stone","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1044","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jacc.2017.06.053","article-title":"Spontaneous coronary artery dissection: clinical outcomes and risk of recurrence","volume":"70","author":"Saw","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1045","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/eurheartj\/ehz007","article-title":"Canadian spontaneous coronary artery dissection cohort study: in-hospital and 30-day outcomes","volume":"40","author":"Saw","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib1046","article-title":"Prevalence and clinical factors of migraine in patients with spontaneous coronary artery dissection","volume":"7","author":"Kok","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.04.003_bib1047","article-title":"Characteristics and clinical outcomes of patients with spontaneous coronary artery dissection","volume":"8","author":"Clare","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.04.003_bib1048","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.amjcard.2015.03.039","article-title":"Management and long-term prognosis of spontaneous coronary artery dissection","volume":"116","author":"Lettieri","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1049","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijcard.2016.01.188","article-title":"Prognostic impact of spontaneous coronary artery dissection in young female patients with acute myocardial infarction: a report from the Angina Pectoris-Myocardial Infarction Multicenter Investigators in Japan","volume":"207","author":"Nakashima","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1050","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/CIRCINTERVENTIONS.114.001659","article-title":"Spontaneous coronary artery dissection: revascularization versus conservative therapy","volume":"7","author":"Tweet","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2023.04.003_bib1051","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ccd.26383","article-title":"Spontaneous coronary artery dissection: angiographic follow-up and long-term clinical outcome in a predominantly medically treated population","volume":"89","author":"Rogowski","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2023.04.003_bib1052","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jacc.2019.06.065","article-title":"Revascularization in patients with spontaneous coronary artery dissection and ST-segment elevation myocardial infarction","volume":"74","author":"Lobo","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1053","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/CIRCINTERVENTIONS.114.001676","article-title":"Coronary artery tortuosity in spontaneous coronary artery dissection: angiographic characteristics and clinical implications","volume":"7","author":"Eleid","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2023.04.003_bib1054","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jacc.2017.07.726","article-title":"Insights into spontaneous coronary artery dissection: can recurrence be prevented?","volume":"70","author":"Tweet","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1055","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.18170","article-title":"Association of pregnancy with recurrence of spontaneous coronary artery dissection among women with prior coronary artery dissection","volume":"3","author":"Tweet","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2023.04.003_bib1056","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.3174\/ajnr.A7151","article-title":"Prevalence of cervical artery abnormalities on CTA in patients with spontaneous coronary artery dissection: fibromuscular dysplasia, dissection, aneurysm, and tortuosity","volume":"42","author":"Benson","year":"2021","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1057","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.amjcard.2019.02.040","article-title":"Risk factors, imaging findings, and sex differences in spontaneous coronary artery dissection","volume":"123","author":"Sharma","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1058","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.amjcard.2015.03.011","article-title":"Prevalence of extracoronary vascular abnormalities and fibromuscular dysplasia in patients with spontaneous coronary artery dissection","volume":"115","author":"Prasad","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1059","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1161\/CIR.0000000000000564","article-title":"Spontaneous coronary artery dissection: current state of the science: a scientific statement from the American Heart Association","volume":"137","author":"Hayes","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1060","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jacc.2020.05.084","article-title":"Spontaneous coronary artery dissection: JACC state-of-the-art review","volume":"76","author":"Hayes","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1061","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.amjcard.2016.02.034","article-title":"Usefulness of cardiac rehabilitation after spontaneous coronary artery dissection","volume":"117","author":"Krittanawong","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1062","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.cjca.2016.01.009","article-title":"The first dedicated cardiac rehabilitation program for patients with spontaneous coronary artery dissection: description and initial results","volume":"32","author":"Chou","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1063","article-title":"Safety and outcomes of cardiac rehabilitation for patients with spontaneous coronary artery dissection","volume":"1","author":"Imran","year":"2018","journal-title":"J\u00a0Rehabil Med Clin Commun"},{"key":"10.1016\/j.jacc.2023.04.003_bib1064","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/HCR.0000000000000111","article-title":"Cardiac rehabilitation after spontaneous coronary artery dissection","volume":"35","author":"Silber","year":"2015","journal-title":"J\u00a0Cardiopulm Rehabil Prev"},{"key":"10.1016\/j.jacc.2023.04.003_bib1065","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.006772","article-title":"Early natural history of spontaneous coronary artery dissection","volume":"11","author":"Waterbury","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2023.04.003_bib1066","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.recesp.2021.08.002","article-title":"Rationale and design of the BA-SCAD (Beta-blockers and Antiplatelet agents in patients with Spontaneous Coronary Artery Dissection) randomized clinical trial","volume":"75","author":"Alfonso","year":"2022","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.jacc.2023.04.003_bib1068","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1016\/j.jacc.2018.09.006","article-title":"Stratified medical therapy using invasive coronary function testing in angina: the CorMicA trial","volume":"72","author":"Ford","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1069","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcin.2019.11.001","article-title":"1-year outcomes of angina management guided by invasive coronary function testing (CorMicA)","volume":"13","author":"Ford","year":"2020","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2023.04.003_bib1070","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ahj.2014.03.001","article-title":"Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice","volume":"167","author":"Patel","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib1071","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/jama.2014.14681","article-title":"Nonobstructive coronary artery disease and risk of myocardial infarction","volume":"312","author":"Maddox","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib1072","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/eurheartj\/ehr331","article-title":"Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events","volume":"33","author":"Jespersen","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib1073","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.4244\/EIJY20M07_01","article-title":"An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries. Developed in collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation","volume":"16","author":"Kunadian","year":"2021","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2023.04.003_bib1074","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijcard.2017.08.068","article-title":"International standardization of diagnostic criteria for microvascular angina","volume":"250","author":"Ong","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1075","first-page":"2565","article-title":"International standardization of diagnostic criteria for vasospastic angina","volume":"38","author":"Beltrame","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib1076","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/j.jacc.2021.07.053","article-title":"2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"78","author":"Gulati","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1077","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1161\/01.CIR.0000039105.49749.6F","article-title":"Lifetime risk for developing congestive heart failure: the Framingham Heart Study","volume":"106","author":"Lloyd-Jones","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1078","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.ijcard.2012.11.065","article-title":"Worldwide risk factors for heart failure: a systematic review and pooled analysis","volume":"168","author":"Khatibzadeh","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1079","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1080","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jacc.2020.11.022","volume":"77","author":"Maddox","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1081","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1082","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0002-9149(01)01501-6","article-title":"Prevalence of coronary artery disease in patients with aortic stenosis with and without angina pectoris","volume":"87","author":"Rapp","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1083","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13019-014-0153-1","article-title":"Evaluation of the prevalence of coronary artery disease in patients with valvular heart disease","volume":"9","author":"Emren","year":"2014","journal-title":"J\u00a0Cardiothorac Surg"},{"key":"10.1016\/j.jacc.2023.04.003_bib1084","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.jacc.2020.11.018","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"77","author":"Otto","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1085","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1086","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.jacc.2019.08.1002","article-title":"Long-term evolution of premature coronary artery disease","volume":"74","author":"Collet","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1087","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/heartjnl-2020-318119","article-title":"Recreational substance use among patients with premature atherosclerotic cardiovascular disease","volume":"107","author":"Mahtta","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.04.003_bib1088","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.jacc.2019.02.059","article-title":"Familial hypercholesterolemia among young adults with myocardial infarction","volume":"73","author":"Singh","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1089","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0735-1097(02)02862-0","article-title":"Long-term follow-up of coronary artery disease presenting in young adults","volume":"41","author":"Cole","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1090","doi-asserted-by":"crossref","first-page":"433","DOI":"10.7326\/0003-4819-134-6-200103200-00007","article-title":"Risk factors for coronary heart disease in men 18 to 39 years of age","volume":"134","author":"Navas-Nacher","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1091","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.amjcard.2010.10.044","article-title":"Temporal trends (over 30 years), clinical characteristics, outcomes, and gender in patients\u00a0<\/=50 years of age having percutaneous coronary intervention","volume":"107","author":"Khawaja","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1092","first-page":"171","article-title":"Long-term prognosis and clinical characteristics of young adults (<\/=40 years old) who underwent percutaneous coronary intervention","volume":"64","author":"Konishi","year":"2014","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1093","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s40292-017-0183-6","article-title":"Long-term outcome of acute coronary syndromes in young patients","volume":"24","author":"Tini","year":"2017","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.jacc.2023.04.003_bib1094","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa1816454","article-title":"20-year follow-up of statins in children with familial hypercholesterolemia","volume":"381","author":"Luirink","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/2047487317708145","article-title":"Improving adherence to medication for secondary cardiovascular disease prevention","volume":"24","author":"Keenan","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1096","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.11051","article-title":"Evaluation of aspirin and statin therapy use and adherence in patients with premature atherosclerotic cardiovascular disease","volume":"3","author":"Mahtta","year":"2020","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.jacc.2023.04.003_bib1097","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1017\/S1047951116002201","article-title":"Acquired and congenital coronary artery abnormalities","volume":"27","author":"Young","year":"2017","journal-title":"Cardiol Young"},{"key":"10.1016\/j.jacc.2023.04.003_bib1098","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1099","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1161\/01.CIR.0000016175.49835.57","article-title":"Coronary anomalies: incidence, pathophysiology, and clinical relevance","volume":"105","author":"Angelini","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1100","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.amjmed.2019.10.020","article-title":"Risk factors and outcomes of very young adults who experience myocardial infarction: the partners YOUNG-MI registry","volume":"133","author":"Yang","year":"2020","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1101","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13075-018-1669-x","article-title":"Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study","volume":"20","author":"Lee","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jacc.2023.04.003_bib1102","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/01.MIB.0000441200.10454.4f","article-title":"Long-term risk of acute coronary syndrome in patients with inflammatory bowel disease: a 13-year nationwide cohort study in an Asian population","volume":"20","author":"Tsai","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jacc.2023.04.003_bib1103","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11883-020-00862-8","article-title":"Premature atherosclerotic cardiovascular disease: what have we learned recently?","volume":"22","author":"Mahtta","year":"2020","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacc.2023.04.003_bib1104","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.677544","article-title":"Portrait of Italian cardio-oncology: results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) survey cardiovascular disease-specific mortality in 270,618 patients with non-small cell lung cancer","volume":"8","author":"Canale","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1105","doi-asserted-by":"crossref","first-page":"e997","DOI":"10.1161\/CIR.0000000000000679","article-title":"Cardio-oncology rehabilitation to manage cardiovascular outcomes in cancer patients and survivors: a scientific statement from the American Heart Association","volume":"139","author":"Gilchrist","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1106","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/j.jacc.2020.03.067","article-title":"Mechanistic biomarkers informative of both cancer and cardiovascular disease: JACC state-of-the-art review","volume":"75","author":"Narayan","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1107","first-page":"619","article-title":"Common pathophysiology in cancer, atrial fibrillation, atherosclerosis, and thrombosis: JACC: Cardiooncology state-of-the-art review","volume":"3","author":"Leiva","year":"2021","journal-title":"J Am Coll Cardiol CardioOnc"},{"key":"10.1016\/j.jacc.2023.04.003_bib1108","first-page":"360","article-title":"Cardiovascular manifestations from therapeutic radiation: a multidisciplinary expert consensus statement from the International Cardio-Oncology Society","volume":"3","author":"Mitchell","year":"2021","journal-title":"J Am Coll Cardiol CardioOnc"},{"key":"10.1016\/j.jacc.2023.04.003_bib1109","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(19)32007-0","article-title":"Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study","volume":"395","author":"Dagenais","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib1110","first-page":"48","article-title":"Cardiovascular risk factors are associated with future cancer","volume":"3","author":"Lau","year":"2021","journal-title":"J Am Coll Cardiol CardioOnc"},{"key":"10.1016\/j.jacc.2023.04.003_bib1111","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1916623","article-title":"The effect of advances in lung-cancer treatment on population mortality","volume":"383","author":"Howlader","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1112","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/CIRCULATIONAHA.115.018347","article-title":"Vascular toxicities of cancer therapies: the old and the new-an evolving avenue","volume":"133","author":"Herrmann","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1113","first-page":"737","article-title":"How to treat prostate cancer with androgen deprivation and minimize cardiovascular risk: a therapeutic tightrope","volume":"3","author":"Narayan","year":"2021","journal-title":"J Am Coll Cardiol CardioOnc"},{"key":"10.1016\/j.jacc.2023.04.003_bib1114","doi-asserted-by":"crossref","first-page":"e811","DOI":"10.1161\/CIR.0000000000001056","article-title":"Cardio-oncology drug interactions: a scientific statement from the American Heart Association","volume":"145","author":"Beavers","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1115","first-page":"139","article-title":"Cardio-oncology in China: we are on the go!","author":"Zhang","year":"2020","journal-title":"J Am Coll Cardiol CardioOnc"},{"key":"10.1016\/j.jacc.2023.04.003_bib1116","doi-asserted-by":"crossref","first-page":"e1034","DOI":"10.1634\/theoncologist.2018-0773","article-title":"Prevention, monitoring, and management of cardiac dysfunction in patients with metastatic breast cancer","volume":"24","author":"Curigliano","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.jacc.2023.04.003_bib1117","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO Clinical Practice Guideline Update","volume":"38","author":"Key","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1118","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/heartjnl-2018-314364","article-title":"Pregnancy in women with pre-existent ischaemic heart disease: a systematic review with individualised patient data","volume":"105","author":"Lameijer","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.04.003_bib1119","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.jacc.2021.01.057","article-title":"Management of women with acquired cardiovascular disease from pre-conception through pregnancy and postpartum: JACC Focus Seminar 3\/5","volume":"77","author":"Park","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1120","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.jacc.2018.02.076","article-title":"Pregnancy outcomes in women with heart disease: the CARPREG II study","volume":"71","author":"Silversides","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1121","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/heartjnl-2019-315325","article-title":"Maternal and neonatal outcomes in women with history of coronary artery disease","volume":"106","author":"Cauldwell","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.04.003_bib1122","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jacc.2021.02.025","article-title":"Contraception and reproductive planning for women with cardiovascular disease: JACC Focus Seminar 5\/5","volume":"77","author":"Lindley","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1123","article-title":"Statins: drug safety communication\u2014FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy","year":"2021","journal-title":"US Food and Drug Administration (FDA)"},{"key":"10.1016\/j.jacc.2023.04.003_bib1124","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jacc.2018.10.075","article-title":"Use of medication for cardiovascular disease during pregnancy: JACC state-of-the-art review","volume":"73","author":"Halpern","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1125","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1016\/j.ajog.2007.09.009","article-title":"Increasing exposure to angiotensin-converting enzyme inhibitors in pregnancy","volume":"198","author":"Bowen","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1126","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib1127","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.288.1.49","article-title":"Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen\/progestin Replacement Study follow-up (HERS II)","volume":"288","author":"Grady","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib1128","first-page":"CD002229","article-title":"Hormone therapy for preventing cardiovascular disease in post-menopausal women","volume":"3","author":"Boardman","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib1129","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehs270","article-title":"Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology","volume":"34","author":"Roos-Hesselink","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib1130","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1016\/j.jacc.2020.08.071","article-title":"Cardiovascular care for pregnant women with cardiovascular disease","volume":"76","author":"Magun","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1131","article-title":"Long-term cardiovascular outcomes after pregnancy in women with heart disease","volume":"10","author":"Siu","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.04.003_bib1132","doi-asserted-by":"crossref","first-page":"e884","DOI":"10.1161\/CIR.0000000000000772","article-title":"Cardiovascular considerations in caring for pregnant patients: a scientific statement from the American Heart Association","volume":"141","author":"Mehta","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1133","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jacc.2021.02.033","article-title":"Team-based care of women with cardiovascular disease from pre-conception through pregnancy and postpartum: JACC Focus Seminar 1\/5","volume":"77","author":"Davis","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1134","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1056\/NEJM200008243430801","article-title":"Effects of estrogen replacement on the progression of coronary-artery atherosclerosis","volume":"343","author":"Herrington","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1135","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJMoa030830","article-title":"Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women","volume":"349","author":"Hodis","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1136","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.288.19.2432","article-title":"Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial","volume":"288","author":"Waters","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib1137","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.atherosclerosis.2005.12.015","article-title":"Randomized trial of hormone therapy in women after coronary bypass surgery. Evidence of differential effect of hormone therapy on angiographic progression of disease in saphenous vein grafts and native coronary arteries","volume":"189","author":"Ouyang","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2023.04.003_bib1138","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0378-5122(97)00080-7","article-title":"Long-term effects of hormone replacement therapy on symptoms of angina pectoris, quality of life and compliance in women with coronary artery disease","volume":"28","author":"Hall","year":"1998","journal-title":"Maturitas"},{"key":"10.1016\/j.jacc.2023.04.003_bib1139","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa010534","article-title":"A\u00a0clinical trial of estrogen-replacement therapy after ischemic stroke","volume":"345","author":"Viscoli","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1140","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(02)12001-0","article-title":"Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial","volume":"360","author":"Cherry","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib1141","doi-asserted-by":"crossref","first-page":"h1035","DOI":"10.1136\/bmj.h1035","article-title":"Statins and congenital malformations: cohort study","volume":"350","author":"Bateman","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.04.003_bib1142","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S1701-2163(15)30565-X","article-title":"The fetal safety of statins: a systematic review and meta-analysis","volume":"36","author":"Zarek","year":"2014","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jacc.2023.04.003_bib1143","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/pds.4176","article-title":"Statins during pregnancy: a cohort study using the General Practice Research Database to investigate pregnancy loss","volume":"26","author":"McGrogan","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jacc.2023.04.003_bib1144","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/MOL.0000000000000790","article-title":"Management of familial hypercholesterolemia in pregnancy","volume":"32","author":"Graham","year":"2021","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0049-3848(99)00233-9","article-title":"The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: results from the estrogen in women with atherosclerosis study","volume":"98","author":"Hoibraaten","year":"2000","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2023.04.003_bib1146","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.thromres.2020.05.008","article-title":"Estrogen and thrombosis: a bench to bedside review","volume":"192","author":"Abou-Ismail","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2023.04.003_bib1147","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/AOG.0000000000000411","article-title":"Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes","volume":"124","author":"Bergendal","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1148","doi-asserted-by":"crossref","first-page":"e4944","DOI":"10.1136\/bmj.e4944","article-title":"Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis","volume":"345","author":"Mantha","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.04.003_bib1149","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/HYPERTENSIONAHA.119.13080","article-title":"Gender-affirming hormone therapy, vascular health and cardiovascular disease in transgender adults","volume":"74","author":"Connelly","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2023.04.003_bib1150","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.jacc.2016.03.004","article-title":"Knowledge gaps in cardiovascular care of the older adult population: a scientific statement from the American Heart Association, American College of Cardiology, and American Geriatrics Society","volume":"67","author":"Rich","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1151","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.jacc.2017.12.068","article-title":"Coronary artery disease in patients >\/=80 years of age","volume":"71","author":"Madhavan","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1152","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.2147\/CIA.S178129","article-title":"Differences of patients' perceptions for elective diagnostic coronary angiography and percutaneous coronary intervention in stable coronary artery disease between elderly and younger patients","volume":"13","author":"Rittger","year":"2018","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.jacc.2023.04.003_bib1153","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.amjcard.2016.08.042","article-title":"Relation of statin use and mortality in community-dwelling frail older patients with coronary artery disease","volume":"118","author":"Pilotto","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1154","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1210\/jc.2019-00195","article-title":"Lipid-lowering agents in older individuals: a systematic review and meta-analysis of randomized clinical trials","volume":"104","author":"Ponce","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2023.04.003_bib1155","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/jgs.14207","article-title":"Effect of statin therapy on mortality in older adults hospitalized with coronary artery disease: a propensity-adjusted analysis","volume":"64","author":"Rothschild","year":"2016","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jacc.2023.04.003_bib1156","first-page":"152","article-title":"Long-term outcomes of high-risk elderly male patients with multivessel coronary disease: optimal medical therapy versus revascularization","volume":"13","author":"Tao","year":"2016","journal-title":"J\u00a0Geriatr Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1157","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jval.2017.10.004","article-title":"Sustained 3-year benefits in quality of life after percutaneous coronary interventions in the elderly: a prospective cohort study","volume":"21","author":"Yan","year":"2018","journal-title":"Value Health"},{"key":"10.1016\/j.jacc.2023.04.003_bib1158","first-page":"624","article-title":"Bleeding outcomes after non-emergency percutaneous coronary intervention in the very elderly","volume":"14","author":"Bogana Shanmugam","year":"2017","journal-title":"J\u00a0Geriatr Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1159","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jcin.2017.03.051","article-title":"Temporal trends, complications, and predictors of outcomes among nonagenarians undergoing percutaneous coronary intervention: insights from the Veterans Affairs clinical assessment, reporting, and tracking program","volume":"10","author":"Sawant","year":"2017","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2023.04.003_bib1160","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijcard.2016.12.093","article-title":"Clinical impact of complete revascularization in elderly patients with multi-vessel coronary artery disease undergoing percutaneous coronary intervention: a sub-analysis of the SHINANO registry","volume":"230","author":"Harada","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1161","first-page":"46","article-title":"A\u00a0systematic review on the quality of life benefits after percutaneous coronary intervention in the elderly","volume":"129","author":"Shan","year":"2014","journal-title":"Cardiology (Switzerland)"},{"key":"10.1016\/j.jacc.2023.04.003_bib1162","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.athoracsur.2014.01.088","article-title":"Acute kidney injury after on-pump or off-pump coronary artery bypass grafting in elderly patients","volume":"98","author":"Reents","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2023.04.003_bib1163","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1211666","article-title":"Off-pump versus on-pump coronary-artery bypass grafting in elderly patients","volume":"368","author":"Diegeler","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1164","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1016\/j.jacc.2021.04.016","article-title":"10-year follow-up after revascularization in elderly patients with complex coronary artery disease","volume":"77","author":"Ono","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1165","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/clc.23253","article-title":"Effect of increasing age on percutaneous coronary intervention vs coronary artery bypass grafting in older adults with unprotected left main coronary artery disease: a meta-analysis and meta-regression","volume":"42","author":"Khan","year":"2019","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1166","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/clc.23524","article-title":"Outcomes of percutaneous coronary intervention for chronic total occlusions in the elderly: a systematic review and meta-analysis","volume":"44","author":"Cui","year":"2021","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1167","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12889-018-5049-x","article-title":"The impact of age on the implementation of evidence-based medications in patients with coronary artery disease and its prognostic significance: a retrospective cohort study","volume":"18","author":"Xia","year":"2018","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jacc.2023.04.003_bib1168","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/ehf2.13715","article-title":"Long-term impact of beta-blocker in elderly patients without myocardial infarction after percutaneous coronary intervention","volume":"9","author":"Fukase","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacc.2023.04.003_bib1169","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0140-6736(17)32713-7","article-title":"Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial","volume":"391","author":"Varenne","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib1170","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jcin.2017.10.015","article-title":"Short-term versus long-term dual antiplatelet therapy after drug-eluting stent implantation in elderly patients: a meta-analysis of individual participant data from 6 randomized trials","volume":"11","author":"Lee","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2023.04.003_bib1171","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.amjcard.2019.11.029","volume":"125","author":"Ten Berg","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1172","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jacc.2013.05.023","article-title":"Prasugrel 5 mg in the very elderly attenuates platelet inhibition but maintains noninferiority to prasugrel 10 mg in nonelderly patients: the GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients","volume":"62","author":"Erlinge","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1173","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12928-016-0383-3","article-title":"Impact of transradial coronary intervention on bleeding complications in octogenarians","volume":"32","author":"Tammam","year":"2017","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.jacc.2023.04.003_bib1174","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.athoracsur.2017.11.079","article-title":"Early outcome of bilateral versus single internal mammary artery grafting in the elderly","volume":"105","author":"Rubino","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2023.04.003_bib1175","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jtcvs.2015.06.032","article-title":"Arterial coronary artery bypass grafting is safe and effective in elderly patients","volume":"150","author":"Medalion","year":"2015","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2023.04.003_bib1176","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/icvts\/ivw149","article-title":"Short- and long-term follow-up after minimally invasive direct coronary artery bypass in octogenarians","volume":"23","author":"Hoffmann","year":"2016","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jacc.2023.04.003_bib1177","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12265-016-9688-y","article-title":"Coronary artery bypass grafting in elderly patients: insights from a comparative analysis of total arterial and conventional revascularization","volume":"9","author":"Bortolussi","year":"2016","journal-title":"J\u00a0Cardiovasc Transl Res"},{"key":"10.1016\/j.jacc.2023.04.003_bib1178","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1874192401610010011","article-title":"Long-term outcome after percutaneous coronary intervention compared with minimally invasive coronary artery bypass surgery in the elderly","volume":"10","author":"Barsoum","year":"2016","journal-title":"Open Cardiovasc Med J"},{"key":"10.1016\/j.jacc.2023.04.003_bib1179","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2021.08.024","article-title":"EU-CaRE study: could exercise-based cardiac telerehabilitation also be cost-effective in elderly?","volume":"340","author":"Scherrenberg","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1180","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/jamacardio.2020.5218","article-title":"Effectiveness of home-based mobile guided cardiac rehabilitation as alternative strategy for nonparticipation in clinic-based cardiac rehabilitation among elderly patients in Europe: a randomized clinical trial","volume":"6","author":"Snoek","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1181","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12872-017-0706-z","article-title":"Predicting operative mortality in octogenarians for isolated coronary artery bypass grafting surgery: a retrospective study","volume":"17","author":"Luc","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacc.2023.04.003_bib1182","first-page":"559","article-title":"Age-dependent impact of the SYNTAX-score on longer-term mortality after percutaneous coronary intervention in an all-comer population","volume":"15","author":"Eickhoff","year":"2018","journal-title":"J\u00a0Geriatr Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1183","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2021.104544","article-title":"Frailty as a predictor of all-cause mortality in elderly patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis","volume":"98","author":"He","year":"2022","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.jacc.2023.04.003_bib1184","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1186\/s12877-021-02438-w","article-title":"Sarcopenia predicts adverse outcomes in an elderly population with coronary artery disease: a systematic review and meta-analysis","volume":"21","author":"Xue","year":"2021","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jacc.2023.04.003_bib1185","article-title":"Association of frailty and long-term survival in patients undergoing coronary artery bypass grafting","volume":"7","author":"Tran","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.04.003_bib1186","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001314","article-title":"Prospective cohort study of elderly patients with coronary artery disease: impact of frailty on quality of life and outcome","volume":"7","author":"Qayyum","year":"2020","journal-title":"Open Heart"},{"key":"10.1016\/j.jacc.2023.04.003_bib1187","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.2147\/CIA.S308569","article-title":"Impact of the malnutrition on mortality in elderly patients undergoing percutaneous coronary intervention","volume":"16","author":"Chen","year":"2021","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.jacc.2023.04.003_bib1188","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14274","article-title":"Prognostic significance of malnutrition scores in elderly patients for the prediction of contrast-induced acute kidney injury","volume":"75","author":"Efe","year":"2021","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jacc.2023.04.003_bib1189","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00380-020-01659-0","article-title":"Impact of nutritional index on long-term outcomes of elderly patients with coronary artery disease: sub-analysis of the SHINANO 5 year registry","volume":"36","author":"Maruyama","year":"2021","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jacc.2023.04.003_bib1190","article-title":"Low body mass index, serum creatinine, and cause of death in patients undergoing percutaneous coronary intervention","volume":"5","author":"Goel","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.04.003_bib1191","first-page":"39","article-title":"Optimizing geriatric care with the GERIATRIC 5Ms","volume":"65","author":"Molnar","year":"2019","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.jacc.2023.04.003_bib1192","first-page":"1393","article-title":"A\u00a0simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation","volume":"44","author":"Mehran","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1193","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1161\/CIRCULATIONAHA.105.541995","article-title":"Association of a continuous quality improvement initiative with practice and outcome variations of contemporary percutaneous coronary interventions","volume":"113","author":"Moscucci","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1194","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1056\/NEJMra1805256","article-title":"Contrast-associated acute kidney injury","volume":"380","author":"Mehran","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1195","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1196","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMoa041365","article-title":"Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction","volume":"351","author":"Anavekar","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1197","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/CIRCULATIONAHA.106.177321","volume":"114","author":"Brosius","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1198","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000046036","article-title":"Long-term outcome after percutaneous transluminal coronary angioplasty in patients with chronic renal failure with and without diabetic nephropathy","volume":"89","author":"Matzkies","year":"2001","journal-title":"Nephron"},{"key":"10.1016\/j.jacc.2023.04.003_bib1199","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.amjcard.2009.07.043","article-title":"Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease","volume":"104","author":"Sedlis","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1200","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1201","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/sj.ki.5002273","article-title":"Chronic kidney disease management in the United Kingdom: NEOERICA project results","volume":"72","author":"Stevens","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2023.04.003_bib1202","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1681\/ASN.2014070714","article-title":"Cause of death in patients with reduced kidney function","volume":"26","author":"Thompson","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1203","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic kidney disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.04.003_bib1204","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/ndt\/15.2.218","article-title":"Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure","volume":"15","author":"Schwarz","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2023.04.003_bib1205","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.2215\/CJN.04320709","article-title":"Coronary calcification in patients with chronic kidney disease and coronary artery disease","volume":"4","author":"Nakamura","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1206","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000090182","article-title":"Atherosclerosis and vascular calcification in chronic renal failure","volume":"28","author":"Campean","year":"2005","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.jacc.2023.04.003_bib1207","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamainternmed.2015.6102","article-title":"Representation of patients with kidney disease in trials of cardiovascular interventions: an updated systematic review","volume":"176","author":"Konstantinidis","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1208","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jacc.2019.08.1017","article-title":"Chronic kidney disease and coronary artery disease: JACC state-of-the-art review","volume":"74","author":"Sarnak","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1209","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ahj.2018.07.023","article-title":"International study of comparative health effectiveness with medical and invasive approaches-chronic kidney disease (ISCHEMIA-CKD): rationale and design","volume":"205","author":"Bangalore","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib1210","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/kisup.2015.2","article-title":"United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease","volume":"5","author":"Collins","year":"2015","journal-title":"Kidney Int Suppl (2011)"},{"key":"10.1016\/j.jacc.2023.04.003_bib1211","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7326\/0003-4819-157-4-201208210-00007","article-title":"Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis","volume":"157","author":"Palmer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1212","doi-asserted-by":"crossref","first-page":"445","DOI":"10.7326\/0003-4819-156-6-201203200-00007","article-title":"Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysis","volume":"156","author":"Palmer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1213","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.amjcard.2013.11.006","article-title":"Statin therapy in patients with chronic kidney disease undergoing percutaneous coronary intervention (from the Evaluation of Drug Eluting Stents and Ischemic Events Registry)","volume":"113","author":"Dasari","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1214","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.kint.2016.03.033","article-title":"Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease","volume":"90","author":"Charytan","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2023.04.003_bib1215","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jacc.2015.06.1334","article-title":"Revascularization in patients with multivessel coronary artery disease and chronic kidney disease: everolimus-eluting stents versus coronary artery bypass graft surgery","volume":"66","author":"Bangalore","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1216","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa1915925","article-title":"Management of coronary disease in patients with advanced kidney disease","volume":"382","author":"Bangalore","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1217","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1097\/01.ASN.0000083900.92829.F5","article-title":"Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease","volume":"14","author":"Reddan","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1218","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7326\/0003-4819-150-3-200902030-00006","article-title":"Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality","volume":"150","author":"Marenzi","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1219","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1001\/jama.291.19.2328","article-title":"Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial","volume":"291","author":"Merten","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib1220","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/archinte.162.3.329","article-title":"Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty","volume":"162","author":"Mueller","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1221","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jacc.2007.03.058","article-title":"Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention","volume":"50","author":"Laskey","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1222","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004383","article-title":"Preventive strategies for contrast-induced acute kidney injury in patients undergoing percutaneous coronary procedures: evidence from a hierarchical bayesian network meta-analysis of 124 trials and 28,240 patients","volume":"10","author":"Giacoppo","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2023.04.003_bib1223","article-title":"Efficacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2023.04.003_bib1224","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1161\/CIRCINTERVENTIONS.113.000778","article-title":"Risk of acute kidney injury after percutaneous coronary interventions using radial versus femoral vascular access: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium","volume":"7","author":"Kooiman","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2023.04.003_bib1225","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/j.jacc.2017.02.070","article-title":"Acute kidney injury after radial or femoral access for invasive acute coronary syndrome management: AKI-MATRIX","volume":"69","author":"And\u00f2","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1226","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.amjcard.2014.06.010","article-title":"Comparison of risk of acute kidney injury after primary percutaneous coronary interventions with the transradial approach versus the transfemoral approach (from the PRIPITENA urban registry)","volume":"114","author":"Cortese","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1227","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ahj.2020.12.019","article-title":"Acute kidney injury after radial or femoral artery access in ST-segment elevation myocardial infarction: AKI-SAFARI","volume":"234","author":"Marbach","year":"2021","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib1228","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.carrev.2021.04.026","article-title":"Impact of radial access on contrast-induced acute kidney injury in patients with coronary artery bypass grafts","volume":"36","author":"Stephan","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1229","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1161\/CIRCULATIONAHA.110.011700","article-title":"Relationship of the time interval between cardiac catheterization and elective coronary artery bypass surgery with postprocedural acute kidney injury","volume":"124","author":"Mehta","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1230","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/CIRCULATIONAHA.111.038943","article-title":"Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT)","volume":"124","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1232","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ count-guided interruption of antiretroviral treatment","volume":"355","author":"El-Sadr","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1233","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2174\/1871525711311010010","article-title":"Cardiovascular complications of HIV infection and treatment","volume":"11","author":"Garg","year":"2013","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"10.1016\/j.jacc.2023.04.003_bib1234","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1097\/QAD.0000000000001675","article-title":"Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk","volume":"31","author":"Gatell","year":"2017","journal-title":"Aids"},{"key":"10.1016\/j.jacc.2023.04.003_bib1235","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ijantimicag.2018.07.010","article-title":"Risk of cardiovascular disease associated with exposure to abacavir among individuals with HIV: a systematic review and meta-analyses of results from 17 epidemiologic studies","volume":"52","author":"Dorjee","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jacc.2023.04.003_bib1236","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1097\/QAD.0b013e328349c6ee","article-title":"Abacavir use and cardiovascular disease events: a meta-analysis of published and unpublished data","volume":"25","author":"Cruciani","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.jacc.2023.04.003_bib1237","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41569-019-0219-9","article-title":"HIV infection and coronary heart disease: mechanisms and management","volume":"16","author":"Hsue","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1238","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1161\/CIR.0000000000000695","article-title":"Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association","volume":"140","author":"Feinstein","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1239","first-page":"2","article-title":"Protective effects of methotrexate against ischemic cardiovascular disorders in patients treated for rheumatoid arthritis or psoriasis: novel therapeutic insights coming from a meta-analysis of the literature data","volume":"16","author":"De Vecchis","year":"2016","journal-title":"Anatol J Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1240","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2174\/1573397112666160404124655","article-title":"The effect of TNF\u03b1-inhibitors on cardiovascular events in patients with rheumatoid arthritis: an updated systematic review of the literature","volume":"12","author":"Sattin","year":"2016","journal-title":"Curr Rheumatol Rev"},{"key":"10.1016\/j.jacc.2023.04.003_bib1241","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacc.2023.04.003_bib1242","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacc.2023.04.003_bib1243","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1136\/annrheumdis-2021-220577","article-title":"Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis","volume":"80","author":"Ocon","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacc.2023.04.003_bib1244","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1245","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics\u20142021 update: a report from the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1246","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059551","article-title":"Risk of cardiovascular disease from antiretroviral therapy for HIV: a systematic review","volume":"8","author":"Bavinger","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2023.04.003_bib1247","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/cid\/cit232","article-title":"CD4 decline is associated with increased risk of cardiovascular disease, cancer, and death in virally suppressed patients with HIV","volume":"57","author":"Helleberg","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacc.2023.04.003_bib1248","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/cid\/cis489","article-title":"HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals","volume":"55","author":"Lang","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacc.2023.04.003_bib1249","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1001\/jama.2020.17025","article-title":"Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society-USA Panel","volume":"324","author":"Saag","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib1250","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/COH.0000000000000701","article-title":"The intersection of drug interactions and adverse reactions in contemporary antiretroviral therapy","volume":"16","author":"Nhean","year":"2021","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.jacc.2023.04.003_bib1251","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/cid\/ciq111","article-title":"Comparative effectiveness and toxicity of statins among HIV-infected patients","volume":"52","author":"Singh","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacc.2023.04.003_bib1252","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/QAD.0b013e328331d2ab","article-title":"Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trial","volume":"24","author":"Aslangul","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jacc.2023.04.003_bib1253","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jacc.2021.06.011","article-title":"2021 ACC expert consensus decision pathway on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"78","author":"Virani","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1254","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/cpt.407","article-title":"Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach","volume":"100","author":"Marsousi","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jacc.2023.04.003_bib1255","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/378131","volume":"37","author":"Dube","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacc.2023.04.003_bib1256","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/art.41293","article-title":"Biologics may prevent cardiovascular events in rheumatoid arthritis by inhibiting coronary plaque formation and stabilizing high-risk lesions","volume":"72","author":"Karpouzas","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1257","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/acr.23930","article-title":"Changes in lipid levels and incidence of cardiovascular events following tofacitinib treatment in patients with psoriatic arthritis: a pooled analysis across phase III and long-term extension studies","volume":"71","author":"Gladman","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jacc.2023.04.003_bib1258","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s40744-020-00248-x","article-title":"Effects of therapies on cardiovascular events in ankylosing spondylitis: a systematic review and meta-analysis","volume":"7","author":"Karmacharya","year":"2020","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.jacc.2023.04.003_bib1259","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/ehf2.12329","article-title":"Timing of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients","volume":"5","author":"Asleh","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacc.2023.04.003_bib1260","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.cardfail.2021.01.019","article-title":"Association of aspirin treatment with cardiac allograft vasculopathy progression and adverse outcomes after heart transplantation","volume":"27","author":"Asleh","year":"2021","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2023.04.003_bib1261","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","article-title":"The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients","volume":"29","author":"Costanzo","year":"2010","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2023.04.003_bib1262","doi-asserted-by":"crossref","DOI":"10.12659\/AOT.921266","article-title":"Everolimus-eluting second-generation stents for treatment of de novo lesions in patients with cardiac allograft vasculopathy","volume":"25","author":"Pyka","year":"2020","journal-title":"Ann Transplant"},{"key":"10.1016\/j.jacc.2023.04.003_bib1263","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ccd.26830","article-title":"Long-term clinical and angiographic outcomes of percutanenous coronary intervention with everolimus-eluting stents for the treatment of cardiac allograft vasculopathy","volume":"90","author":"Cheng","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2023.04.003_bib1264","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/joic.12071","article-title":"Clinical and angiographic outcomes with everolimus eluting stents for the treatment of cardiac allograft vasculopathy","volume":"27","author":"Azarbal","year":"2014","journal-title":"J\u00a0Interv Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1265","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1266","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.healun.2020.07.010","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 37th adult heart transplantation report-2020; focus on deceased donor characteristics","volume":"39","author":"Khush","year":"2020","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2023.04.003_bib1267","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.healun.2010.05.017","article-title":"International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010","volume":"29","author":"Mehra","year":"2010","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2023.04.003_bib1268","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jacc.2005.02.035","article-title":"Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years","volume":"45","author":"Kobashigawa","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1269","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13621","article-title":"The effect of pre-heart transplant body mass index on posttransplant outcomes: an analysis of the ISHLT registry data","volume":"33","author":"Doumouras","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jacc.2023.04.003_bib1270","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.healun.2013.06.023","article-title":"Effect of high-intensity interval training on progression of cardiac allograft vasculopathy","volume":"32","author":"Nytroen","year":"2013","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2023.04.003_bib1271","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/01.CIR.0000070421.38604.2B","article-title":"Use of rapamycin slows progression of cardiac transplantation vasculopathy","volume":"108","author":"Mancini","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1272","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1161\/CIRCULATIONAHA.111.040360","article-title":"Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantation","volume":"125","author":"Topilsky","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1273","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1161\/CIRCULATIONAHA.107.692996","article-title":"Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation","volume":"116","author":"Raichlin","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1274","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1111\/ajt.13214","article-title":"The effect of everolimus initiation and calcineurin inhibitor elimination on cardiac allograft vasculopathy in de novo recipients: one-year results of a Scandinavian randomized trial","volume":"15","author":"Arora","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jacc.2023.04.003_bib1275","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004050","article-title":"Effect of everolimus initiation and calcineurin inhibitor elimination on cardiac allograft vasculopathy in de novo heart transplant recipients","volume":"11","author":"Arora","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2023.04.003_bib1276","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00059-005-2685-6","article-title":"Impact of simvastatin therapy after heart transplantation an 11-year prospective evaluation","volume":"30","author":"Wenke","year":"2005","journal-title":"Herz"},{"key":"10.1016\/j.jacc.2023.04.003_bib1277","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.healun.2005.02.009","article-title":"Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients","volume":"24","author":"Kobashigawa","year":"2005","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2023.04.003_bib1278","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1161\/CIR.0000000000000456","article-title":"Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a scientific statement from the American Heart Association","volume":"134","author":"Wiggins","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1279","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1002\/ehf2.12784","article-title":"Statin intensity and risk for cardiovascular events after heart transplantation","volume":"7","author":"Golbus","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacc.2023.04.003_bib1280","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14424","article-title":"Early aspirin use, allograft rejection, and cardiac allograft vasculopathy in heart transplantation","volume":"35","author":"Bergmark","year":"2021","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jacc.2023.04.003_bib1281","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.healun.2017.06.015","article-title":"Early aspirin use and the development of cardiac allograft vasculopathy","volume":"36","author":"Kim","year":"2017","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"12","key":"10.1016\/j.jacc.2023.04.003_bib1282","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13133","article-title":"Early aspirin initiation following heart transplantation is associated with reduced risk of allograft vasculopathy during long-term follow-up","volume":"31","author":"Peled","year":"2017","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jacc.2023.04.003_bib1283","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.jcin.2010.09.014","volume":"3","author":"Kereiakes","year":"2010","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2023.04.003_bib1284","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jcin.2013.05.005","volume":"6","author":"Dangas","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2023.04.003_bib1285","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/CIRCULATIONAHA.115.018741","article-title":"Invasive assessment of coronary physiology predicts late mortality after heart transplantation","volume":"133","author":"Yang","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1286","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1093\/eurheartj\/ehab568","article-title":"Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation","volume":"42","author":"Ahn","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib1287","doi-asserted-by":"crossref","first-page":"19","DOI":"10.21037\/acs.2018.01.10","article-title":"Percutaneous coronary intervention versus coronary artery bypass grafting in heart transplant recipients with coronary allograft vasculopathy: a systematic review and meta-analysis of 1,520 patients","volume":"7","author":"Luc","year":"2018","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.jacc.2023.04.003_bib1288","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1161\/CIR.0000000000000456","article-title":"Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a scientific statement from the American Heart Association","volume":"134","author":"Wiggins","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1290","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1177\/2047487316639681","article-title":"The telephone lifestyle intervention 'Hartcoach' has modest impact on coronary risk factors: a randomised multicentre trial","volume":"23","author":"Leemrijse","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1291","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12529-012-9250-5","article-title":"Effect of a telephone-delivered coronary heart disease secondary prevention program (proactive heart) on quality of life and health behaviours: primary outcomes of a randomised controlled trial","volume":"20","author":"Hawkes","year":"2013","journal-title":"Int J Behav Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1292","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/2047487312460515","article-title":"Telephone-delivered health coaching improves anxiety outcomes after myocardial infarction: the 'ProActive Heart' trial","volume":"21","author":"O'Neil","year":"2014","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1293","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12160-014-9592-0","article-title":"Efficacy and feasibility of a tele-health intervention for acute coronary syndrome patients with depression: results of the \"MoodCare\" randomized controlled trial","volume":"48","author":"O'Neil","year":"2014","journal-title":"Ann Behav Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1294","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1177\/2047487314547655","article-title":"Long-term efficacy of a tele-health intervention for acute coronary syndrome patients with depression: 12-month results of the MoodCare randomized controlled trial","volume":"22","author":"O'Neil","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1295","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jacc.2017.05.041","article-title":"Community-based lifestyle intervention in patients with coronary artery disease: the RESPONSE-2 trial","volume":"70","author":"Minneboo","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1296","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12966-018-0677-1","article-title":"The effects of a lifestyle-focused text-messaging intervention on adherence to dietary guideline recommendations in patients with coronary heart disease: an analysis of the TEXT ME study","volume":"15","author":"Santo","year":"2018","journal-title":"Int J Behav Nutr Phys Act"},{"key":"10.1016\/j.jacc.2023.04.003_bib1297","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1298","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1001\/jamainternmed.2014.3773","article-title":"Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry","volume":"174","author":"Steg","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1299","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMoa2208335","article-title":"Routine functional testing or standard care in high-risk patients after PCI","volume":"387","author":"Park","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1300","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s12350-012-9569-y","article-title":"Tests that may be overused or misused in cardiology: the Choosing Wisely campaign","volume":"19","author":"Beller","year":"2012","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1301","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1093\/eurheartj\/eht201","article-title":"Long-term analysis of left ventricular ejection fraction in patients with stable multivessel coronary disease undergoing medicine, angioplasty or surgery: 10-year follow-up of the MASS II trial","volume":"34","author":"Garzillo","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib1302","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3904\/kjim.2015.30.1.49","article-title":"Clinical impact of routine follow-up coronary angiography after second- or third-generation drug-eluting stent insertion in clinically stable patients","volume":"30","author":"Choi","year":"2015","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1303","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jcin.2016.10.018","article-title":"The ReACT Trial: Randomized Evaluation of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention Trial","volume":"10","author":"Shiomi","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2023.04.003_bib1304","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016169","article-title":"Outcome of revascularisation in stable coronary artery disease without ischaemia: a Danish registry-based follow-up study","volume":"7","author":"Simonsen","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacc.2023.04.003_bib1305","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jcin.2010.01.010","article-title":"The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of \"oculostenotic\" reintervention in patients with intermediate lesions","volume":"3","author":"Uchida","year":"2010","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2023.04.003_bib1306","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11886-018-0957-z","article-title":"Routine angiographic follow-up after coronary artery disease revascularization: is seeing believing?","volume":"20","author":"Agrawal","year":"2018","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jacc.2023.04.003_bib1307","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001499","article-title":"Health-related quality of life 1-3 years post-myocardial infarction: its impact on prognosis","volume":"8","author":"Pocock","year":"2021","journal-title":"Open Heart"},{"key":"10.1016\/j.jacc.2023.04.003_bib1308","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/eurheartj\/ehz660","article-title":"Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry","volume":"41","author":"Sorbets","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.04.003_bib1309","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/CIRCULATIONAHA.121.054567","article-title":"International observational analysis of evolution and outcomes of chronic stable angina: the multinational CLARIFY study","volume":"144","author":"Mesnier","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1310","doi-asserted-by":"crossref","first-page":"575","DOI":"10.18549\/PharmPract.2015.02.575","article-title":"A\u00a0pharmacist-led follow-up program for patients with established coronary heart disease in North Norway: a randomized controlled trial","volume":"13","author":"Garcia","year":"2015","journal-title":"Pharm Pract (Granada)"},{"key":"10.1016\/j.jacc.2023.04.003_bib1311","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12933-015-0296-y","article-title":"Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology","volume":"14","author":"Gyberg","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1312","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.gheart.2015.11.003","article-title":"Time trends in lifestyle, risk factor control, and use of evidence-based medications in patients with coronary heart disease in Europe: results from 3 EUROASPIRE surveys, 1999-2013","volume":"12","author":"Kotseva","year":"2017","journal-title":"Glob Heart"},{"key":"10.1016\/j.jacc.2023.04.003_bib1313","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1001\/jama.2010.580","article-title":"Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005","volume":"303","author":"Wijeysundera","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib1314","doi-asserted-by":"crossref","DOI":"10.1161\/hcq.12.suppl_1.293","article-title":"Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial","volume":"12","author":"Zheng","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.04.003_bib1315","doi-asserted-by":"crossref","first-page":"e018","DOI":"10.1532\/hsf.2519","article-title":"The impact of text message on self-management for coronary heart disease: a meta-analysis of randomized controlled trials","volume":"23","author":"Wan","year":"2020","journal-title":"Heart Surg Forum"},{"key":"10.1016\/j.jacc.2023.04.003_bib1316","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2261-13-33","article-title":"Cost-effectiveness of a coronary heart disease secondary prevention program in patients with myocardial infarction: results from a randomised controlled trial (ProActive Heart)","volume":"13","author":"Turkstra","year":"2013","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacc.2023.04.003_bib1317","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1916370","article-title":"Health-status outcomes with invasive or conservative care in coronary disease","volume":"382","author":"Spertus","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.04.003_bib1318","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.diabres.2018.02.007","article-title":"Routine angiographic follow-up versus clinical follow-up in patients with diabetes following percutaneous coronary intervention with drug-eluting stents in Korean population","volume":"138","author":"Kim","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jacc.2023.04.003_bib1319","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1001\/jamacardio.2017.3051","article-title":"Nationwide coverage and cost-sharing for PCSK9 inhibitors among Medicare part D plans","volume":"2","author":"Kazi","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1320","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/jamacardio.2017.3451","article-title":"Association of prior authorization and out-of-pocket costs with patient access to PCSK9 inhibitor therapy","volume":"2","author":"Navar","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.04.003_bib1321","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1161\/CIRCULATIONAHA.119.041974","article-title":"Cost-related medication nonadherence in adults with atherosclerotic cardiovascular disease in the United States, 2013 to 2017","volume":"140","author":"Khera","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.04.003_bib1322","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jama.290.7.953","article-title":"Patient-physician communication about out-of-pocket costs","volume":"290","author":"Alexander","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.04.003_bib1323","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007094","article-title":"Heart failure and shared decision-making: patients open to medication-related cost discussions","volume":"13","author":"Rao","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2023.04.003_bib1324","article-title":"Discussing out-of-pocket costs with patients: shared decision making for sacubitril-valsartan in heart failure","volume":"8","author":"Smith","year":"2019","journal-title":"J\u00a0Am Heart Assoc"}],"updated-by":[{"DOI":"10.1016\/j.jacc.2023.09.794","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000}},{"DOI":"10.1016\/j.jacc.2024.03.399","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000}}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109723052816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109723052816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T08:19:46Z","timestamp":1738916386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109723052816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":1307,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0735109723052816"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2023.04.003","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA Guideline for the Management of Patients With Chronic\u00a0Coronary Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2023.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 BY THE American Heart Association, Inc., and the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}